12722831 |
Ishizawa T et al.:
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
J. Neuropathol. Exp. Neurol.
2003
62: 389-397
|
9930729 |
Lesort M et al.:
Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase.
J. Neurochem.
1999
72: 576-584
|
8250835 |
Sutherland C et al.:
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling.
Biochem. J.
1993
296: 15-19
|
8382613 |
Hughes K et al.:
Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation.
EMBO J.
1993
12: 803-808
|
9685326 |
Pap M et al.:
Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway.
J. Biol. Chem.
1998
273
|
8978681 |
Alessi DR et al.:
Mechanism of activation of protein kinase B by insulin and IGF-1.
EMBO J.
1996
15: 6541-6551
|
8978681 |
Alessi DR et al.:
Mechanism of activation of protein kinase B by insulin and IGF-1
EMBO J.
1996
15: 6541-6551
|
8978681 |
Alessi DR et al.:
Mechanism of activation of protein kinase B by insulin and IGF-1
EMBO J.
1996
15: 6541-6551
|
11527574 |
Grimes CA et al.:
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling
Prog. Neurobiol.
2001
65: 391-426
|
9468292 |
Welsh GI et al.:
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin.
FEBS Lett.
1998
421: 125-130
|
18852354 |
Schaffer BA et al.:
Association of GSK3B with Alzheimer disease and frontotemporal dementia
Arch. Neurol.
2008
65: 1368-1374
|
1899151 |
Moore CK et al.:
Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization
Transplant. Proc.
1991
23: 1055-1058
|
18932008 |
Mendes CT et al.:
Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease
Eur Arch Psychiatry Clin Neurosci
2009
259: 16-22
|
16944319 |
Verdile G et al.:
The role of presenilin and its interacting proteins in the biogenesis of Alzheimers beta amyloid.
Neurochem. Res.
2007
32: 609-623
|
16641999 |
Chen F et al.:
TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity
Nature
2006
440: 1208-1212
|
16641999 |
Chen F et al.:
TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity.
Nature
2006
440: 1208-1212
|
19779148 |
Kang JE et al.:
Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.
Science
2009
326: 1005-1007
|
10993067 |
Yu G et al.:
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing
Nature
2000
407: 48-54
|
10993067 |
Yu G et al.:
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing.
Nature
2000
407: 48-54
|
12660785 |
Takasugi N et al.:
The role of presenilin cofactors in the gamma-secretase complex.
Nature
2003
422: 438-441
|
12032140 |
Yang DS et al.:
Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins.
J. Biol. Chem.
2002
277
|
12032140 |
Yang DS et al.:
Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins
J. Biol. Chem.
2002
277
|
12044882 |
Tomita T et al.:
Complex N-glycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments.
FEBS Lett.
2002
520: 117-121
|
12048259 |
Edbauer D et al.:
Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation.
Proc. Natl. Acad. Sci. U.S.A.
2002
99: 8666-8671
|
14981233 |
Schubert M et al.:
Role for neuronal insulin resistance in neurodegenerative diseases
Proc. Natl. Acad. Sci. U.S.A.
2004
101: 3100-3105
|
19144826 |
Lee HK et al.:
The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid.
Mol. Biol. Cell
2009
20: 1533-1544
|
19144826 |
Lee HK et al.:
The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid
Mol. Biol. Cell
2009
20: 1533-1544
|
19712582 |
de la Monte SM et al.:
Insulin resistance and Alzheimers disease
BMB Rep
2009
42: 475-481
|
12904469 |
Schubert M et al.:
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation
J. Neurosci.
2003
23: 7084-7092
|
1904481 |
Perry G et al.:
Neuropil threads of Alzheimers disease show a marked alteration of the normal cytoskeleton
J. Neurosci.
1991
11: 1748-1755
|
8592647 |
Takashima A et al.:
Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons.
Neurosci. Lett.
1995
198: 83-86
|
15094077 |
Watson GS et al.:
Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimers disease
Eur. J. Pharmacol.
2004
490: 97-113
|
10672254 |
Hoyer S et al.:
Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats
Ann. N. Y. Acad. Sci.
1999
893: 301-303
|
11943765 |
Leem JY et al.:
Presenilin 1 is required for maturation and cell surface accumulation of nicastrin.
J. Biol. Chem.
2002
277
|
11146649 |
Sato N et al.:
Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.
Nat. Cell Biol.
2000
2: 863-870
|
12846562 |
Beher D et al.:
In vitro characterization of the presenilin-dependent gamma-secretase complex using a novel affinity ligand
Biochemistry
2003
42: 8133-8142
|
15189355 |
Shirotani K et al.:
Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1.
J. Neurochem.
2004
89: 1520-1527
|
15676027 |
Uchida Y et al.:
Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimers disease.
Genes Cells
2005
10: 165-179
|
19940183 |
Rudrabhatla P et al.:
Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins.
J. Neurosci.
2009
29
|
18635547 |
Rudrabhatla P et al.:
Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein.
J. Biol. Chem.
2008
283
|
18635547 |
Rudrabhatla P et al.:
Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein
J. Biol. Chem.
2008
283
|
19661622 |
Popp J et al.:
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimers disease.
J. Alzheimers Dis.
2009
18: 819-828
|
19661623 |
Goni-Oliver P et al.:
Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimers disease
J. Alzheimers Dis.
2009
18: 843-848
|
17626162 |
Kesavapany S et al.:
Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons
Mol. Biol. Cell
2007
18: 3645-3655
|
17626162 |
Kesavapany S et al.:
Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons.
Mol. Biol. Cell
2007
18: 3645-3655
|
10672251 |
Frolich L et al.:
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimers disease.
Ann. N. Y. Acad. Sci.
1999
893: 290-293
|
10231383 |
Li BS et al.:
Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells.
Eur. J. Biochem.
1999
262: 211-217
|
10670439 |
Boyt AA et al.:
The effect of insulin and glucose on the plasma concentration of Alzheimers amyloid precursor protein.
Neuroscience
2000
95: 727-734
|
17298085 |
Zhou S et al.:
Regulation of gamma-secretase activity in Alzheimers disease.
Biochemistry
2007
46: 2553-2563
|
12761548 |
Phiel CJ et al.:
GSK-3alpha regulates production of Alzheimers disease amyloid-beta peptides
Nature
2003
423: 435-439
|
19090986 |
Cashman JR et al.:
Immune defects in Alzheimers disease: new medications development.
BMC Neurosci
2008
9: S13
|
10341227 |
Kang DE et al.:
Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimers disease-linked PS1 mutants in the beta-catenin-signaling pathway
J. Neurosci.
1999
19: 4229-4237
|
12297048 |
Kang DE et al.:
Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis
Cell
2002
110: 751-762
|
11554609 |
Klunk WE et al.:
Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.
Life Sci.
2001
69: 1471-1484
|
14651959 |
Ryder J et al.:
Divergent roles of GSK3 and CDK5 in APP processing
Biochem. Biophys. Res. Commun.
2003
312: 922-929
|
14651959 |
Ryder J et al.:
Divergent roles of GSK3 and CDK5 in APP processing.
Biochem. Biophys. Res. Commun.
2003
312: 922-929
|
18189321 |
Chen Q et al.:
Loss of presenilin function causes Alzheimers disease-like neurodegeneration in the mouse.
J. Neurosci. Res.
2008
86: 1615-1625
|
19337449 |
Gotz J et al.:
An update on the toxicity of Abeta in Alzheimers disease.
Neuropsychiatr Dis Treat
2008
4: 1033-1042
|
17708691 |
Crouch PJ et al.:
Mitochondria in aging and Alzheimers disease.
Rejuvenation Res
2007
10: 349-357
|
19268425 |
Celsi F et al.:
Mitochondria, calcium and cell death: a deadly triad in neurodegeneration
Biochim. Biophys. Acta
2009
1787: 335-344
|
9051814 |
Guo Q et al.:
Alzheimers PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide
Neuroreport
1996
8: 379-383
|
16394273 |
Lee SY et al.:
PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release
FASEB J.
2006
20: 151-153
|
15659604 |
Crouch PJ et al.:
Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42
J. Neurosci.
2005
25: 672-679
|
15170327 |
Su Y et al.:
Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing
Biochemistry
2004
43: 6899-6908
|
15170327 |
Su Y et al.:
Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing
Biochemistry
2004
43: 6899-6908
|
16014628 |
Feyt C et al.:
Lithium chloride increases the production of amyloid-beta peptide independently from its inhibition of glycogen synthase kinase 3.
J. Biol. Chem.
2005
280
|
15485501 |
Good PF et al.:
A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimers disease.
J. Neurochem.
2004
91: 716-736
|
15634781 |
Ma G et al.:
APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development.
J. Neurosci.
2005
25: 192-198
|
19478559 |
Yoon EJ et al.:
Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis
Exp. Mol. Med.
2009
41: 611-617
|
15466863 |
Cole AR et al.:
GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons.
J. Biol. Chem.
2004
279
|
15466863 |
Cole AR et al.:
GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons
J. Biol. Chem.
2004
279
|
19793966 |
Jinwal UK et al.:
Chemical manipulation of hsp70 ATPase activity regulates tau stability
J. Neurosci.
2009
29
|
19449461 |
Koren J 3rd et al.:
Chaperone signalling complexes in Alzheimers disease
J. Cell. Mol. Med.
2009
13: 619-630
|
16724068 |
Uehara T et al.:
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Nature
2006
441: 513-517
|
16724068 |
Uehara T et al.:
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Nature
2006
441: 513-517
|
16724068 |
Uehara T et al.:
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Nature
2006
441: 513-517
|
12522269 |
Dou F et al.:
Chaperones increase association of tau protein with microtubules.
Proc. Natl. Acad. Sci. U.S.A.
2003
100: 721-726
|
12522269 |
Dou F et al.:
Chaperones increase association of tau protein with microtubules
Proc. Natl. Acad. Sci. U.S.A.
2003
100: 721-726
|
14962978 |
Petrucelli L et al.:
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Hum. Mol. Genet.
2004
13: 703-714
|
18061943 |
Bjorkdahl C et al.:
Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
J. Neurosci. Res.
2008
86: 1343-1352
|
18061943 |
Bjorkdahl C et al.:
Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments
J. Neurosci. Res.
2008
86: 1343-1352
|
19946466 |
Bonda DJ et al.:
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease
Aging (Albany NY)
2009
1: 382-388
|
20237268 |
Biswas SC et al.:
Sertad1 plays an essential role in developmental and pathological neuron death
J. Neurosci.
2010
30: 3973-3982
|
19647374 |
Bajic VP et al.:
The X-chromosome instability phenotype in Alzheimers disease: a clinical sign of accelerating aging? }, authors { names std { { name ml Bajic VP, affil str Institute of Biomedical Research, Galenika ad, 11000 Belgrade, Serbia. vladanbajic@yahoo.com }, { name ml Spremo-Potparevic B }, { name ml Zivkovic L }, { name ml Bonda DJ }, { name ml Siedlak SL }, { name ml Casadesus G }, { name ml Lee HG }, { name ml Smith MA } } }, from journal { title { iso-jta Med. Hypotheses, ml-jta Med Hypotheses, issn 1532-2777, name Medical hypotheses }, imp { date std { year 2009, month 12 }, volume 73, issue 6, pages 917-920, language eng, pubstatus ppublish, history { { pubstatus received, date std { year 2009, month 6, day 23 } }, { pubstatus accepted, date std { year 2009, month 6, day 24 } }, { pubstatus aheadofprint, date std { year 2009, month 7, day 31 } }, { pubstatus other, date std { year 2009, month 8, day 4, hour 9, minute 0 } }, { pubstatus pubmed, date std { year 2009, month 8, day 4, hour 9, minute 0 } }, { pubstatus medline, date std { year 2010, month 3, day 2, hour 6, minute 0 } } } } }, ids { pii S0306-9877(09)00478-2, doi 10.1016/j.mehy.2009.06.046, pubmed 19647374, other { db pmc, tag str PMC2787990 }, other { db mid, tag str NIHMS136441 }, other { db ELocationID doi, tag str 10.1016/j.mehy.2009.06.046 } } }, abstract Premature centromere division, or premature centromere separation (PCS), occurs when chromatid separation is dysfunctional, occurring earlier than usual during the interphase stage of mitosis. This phenomenon, seen in Roberts syndrome and various cancers, has also been documented in peripheral as well as neuronal cells of Alzheimers disease (AD). In the latter instances, fluorescent in situ hybridization (FISH), applied to the centromere region of the X-chromosome in interphase nuclei of lymphocytes from peripheral blood in AD patients, demonstrated premature chromosomal separation before mitotic metaphase directly after completion of DNA replication in G(2) phase of the cell cycle. Furthermore, and perhaps unexpectedly given the presumptive post-mitotic status of terminally differentiated neurons, neurons in AD patients also showed significantly increased levels of PCS of the X-chromosome. Taken together with other phenomena such as cell cycle re-activation and ectopic re-expression of cyclins and cyclin dependent proteins, we propose that AD is an oncogenic phenotype leading to accelerated aging of the affected brain
Med. Hypotheses
2009
73: 917-920
|
12624792 |
Pei JJ et al.:
Role of protein kinase B in Alzheimers neurofibrillary pathology.
Acta Neuropathol.
2003
105: 381-392
|
17276679 |
Ansar S et al.:
A non-toxic Hsp90 inhibitor protects neurons from Abeta-induced toxicity.
Bioorg. Med. Chem. Lett.
2007
17: 1984-1990
|
14963027 |
Shimura H et al.:
Binding of tau to heat shock protein 27 leads to decreased concentration of hyperphosphorylated tau and enhanced cell survival.
J. Biol. Chem.
2004
279
|
15132984 |
Nemes Z et al.:
Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimers neurofibrillary tangles.
FASEB J.
2004
18: 1135-1137
|
15615647 |
Kosik KS et al.:
Phosphorylated tau and the neurodegenerative foldopathies.
Biochim. Biophys. Acta
2005
1739: 298-310
|
14612456 |
Shimura H et al.:
CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival
J. Biol. Chem.
2004
279: 4869-4876
|
12888622 |
Gamblin TC et al.:
Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimers disease
Proc. Natl. Acad. Sci. U.S.A.
2003
100
|
20357768 |
de Calignon A et al.:
Caspase activation precedes and leads to tangles.
Nature
2010
464: 1201-1204
|
19191039 |
Sun AY et al.:
Botanical phenolics and brain health
Neuromolecular Med.
2008
10: 259-274
|
12793519 |
Joseph JA et al.:
Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model.
Nutr Neurosci
2003
6: 153-162
|
16177050 |
Rezai-Zadeh K et al.:
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
J. Neurosci.
2005
25: 8807-8814
|
16177050 |
Rezai-Zadeh K et al.:
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
J. Neurosci.
2005
25: 8807-8814
|
16624814 |
Obregon DF et al.:
ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein
J. Biol. Chem.
2006
281
|
15579468 |
Kanekura K et al.:
A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death
J. Biol. Chem.
2005
280: 4532-4543
|
16636099 |
Chen F et al.:
Reductions in levels of the Alzheimers amyloid beta peptide after oral administration of ginsenosides
FASEB J.
2006
20: 1269-1271
|
16636099 |
Chen F et al.:
Reductions in levels of the Alzheimers amyloid beta peptide after oral administration of ginsenosides
FASEB J.
2006
20: 1269-1271
|
15277073 |
Chauhan NB et al.:
Anti-amyloidogenic effect of Allium sativum in Alzheimers transgenic model Tg2576
J Herb Pharmacother
2003
3: 95-107
|
20385830 |
Han W et al.:
Linking type 2 diabetes and Alzheimers disease
Proc. Natl. Acad. Sci. U.S.A.
2010
107: 6557-6558
|
20231468 |
Takeda S et al.:
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes
Proc. Natl. Acad. Sci. U.S.A.
2010
107: 7036-7041
|
11880515 |
Westerman MA et al.:
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimers disease
J. Neurosci.
2002
22: 1858-1867
|
19242462 |
Cisse M et al.:
Alzheimers disease: A prion protein connection.
Nature
2009
457: 1090-1091
|
19829367 |
Mucke L et al.:
Neuroscience: Alzheimers disease
Nature
2009
461: 895-897
|
17082448 |
Roberson ED et al.:
100 years and counting: prospects for defeating Alzheimers disease.
Science
2006
314: 781-784
|
16842945 |
Chauhan NB et al.:
Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimers transgenic model Tg2576
J Ethnopharmacol
2006
108: 385-394
|
17380553 |
Chauhan NB et al.:
Amelioration of early cognitive deficits by aged garlic extract in Alzheimers transgenic mice
Phytother Res
2007
21: 629-640
|
17380553 |
Chauhan NB et al.:
Amelioration of early cognitive deficits by aged garlic extract in Alzheimers transgenic mice.
Phytother Res
2007
21: 629-640
|
14637120 |
Stackman RW et al.:
Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimers disease by chronic Ginkgo biloba treatment
Exp. Neurol.
2003
184: 510-520
|
17086105 |
Garcia-Alloza M et al.:
Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model
J. Neuropathol. Exp. Neurol.
2006
65: 1082-1089
|
15010693 |
Tohda C et al.:
Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins.
Neuropsychopharmacology
2004
29: 860-868
|
17010630 |
Hartman RE et al.:
Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimers disease
Neurobiol. Dis.
2006
24: 506-515
|
19104446 |
Julien C et al.:
Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease.
J. Neuropathol. Exp. Neurol.
2009
68: 48-58
|
19548013 |
Tong Y et al.:
COL25A1 triggers and promotes Alzheimers disease-like pathology in vivo
Neurogenetics
2010
11: 41-52
|
20126630 |
Frykman S et al.:
Synaptic and endosomal localization of active gamma-secretase in rat brain.
PLoS ONE
2010
5: E8948
|
16183991 |
Chen J et al.:
SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling
J. Biol. Chem.
2005
280
|
20061625 |
Huesa G et al.:
Altered distribution of RhoA in Alzheimers disease and AbetaPP overexpressing mice
J. Alzheimers Dis.
2010
19: 37-56
|
12603837 |
Siman R et al.:
Localization of presenilin-nicastrin complexes and gamma-secretase activity to the trans-Golgi network.
J. Neurochem.
2003
84: 1143-1153
|
19712581 |
Chung SH et al.:
Aberrant phosphorylation in the pathogenesis of Alzheimers disease
BMB Rep
2009
42: 467-474
|
10814741 |
Yasojima K et al.:
Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain.
Brain Res.
2000
865: 116-120
|
10412011 |
Yasojima K et al.:
Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA.
Brain Res.
1999
831: 301-305
|
10924763 |
Schwab C et al.:
Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases
Neurobiol. Aging
2000
21: 503-510
|
15345711 |
Beglopoulos V et al.:
Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice.
J. Biol. Chem.
2004
279
|
19521544 |
Engmann O et al.:
Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimers Disease.
Front Mol Neurosci
2009
2: 2
|
18691386 |
Sun KH et al.:
Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction
J. Neurochem.
2008
107: 265-278
|
9038181 |
Poon RY et al.:
Identification of functional domains in the neuronal Cdk5 activator protein.
J. Biol. Chem.
1997
272: 5703-5708
|
10604467 |
Patrick GN et al.:
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Nature
1999
402: 615-622
|
19776350 |
Sun KH et al.:
Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimers disease.
Mol. Biol. Cell
2009
20: 4611-4619
|
20462385 |
Candore G et al.:
Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications
Rejuvenation Res
2010
13: 301-313
|
11329064 |
Wyss-Coray T et al.:
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice
Nat. Med.
2001
7: 612-618
|
18801740 |
Lukiw WJ et al.:
An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells
J. Biol. Chem.
2008
283
|
17905482 |
Letiembre M et al.:
Screening of innate immune receptors in neurodegenerative diseases: a similar pattern
Neurobiol. Aging
2009
30: 759-768
|
11749806 |
Zeng HH et al.:
Antioxidant properties of phenolic diterpenes from Rosmarinus officinalis
Acta Pharmacol. Sin.
2001
22: 1094-1098
|
2529544 |
Griffin WS et al.:
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
Proc. Natl. Acad. Sci. U.S.A.
1989
86: 7611-7615
|
15290893 |
Mrak RE et al.:
Trisomy 21 and the brain
J. Neuropathol. Exp. Neurol.
2004
63: 679-685
|
17360493 |
Flajolet M et al.:
Regulation of Alzheimers disease amyloid-beta formation by casein kinase I
Proc. Natl. Acad. Sci. U.S.A.
2007
104: 4159-4164
|
17094809 |
Wilkinson BL et al.:
The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimers disease
J Neuroinflammation
2006
3: 30
|
20552018 |
Schonrock N et al.:
Neuronal microRNA deregulation in response to Alzheimers disease amyloid-beta
PLoS ONE
2010
5
|
20552018 |
Schonrock N et al.:
Neuronal microRNA deregulation in response to Alzheimers disease amyloid-beta.
PLoS ONE
2010
5
|
19406203 |
Sethi P et al.:
Micro-RNA abundance and stability in human brain: specific alterations in Alzheimers disease temporal lobe neocortex
Neurosci. Lett.
2009
459: 100-104
|
20489155 |
Wang WX et al.:
miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease.
Am. J. Pathol.
2010
177: 334-345
|
20126538 |
Nunez-Iglesias J et al.:
Joint genome-wide profiling of miRNA and mRNA expression in Alzheimers disease cortex reveals altered miRNA regulation
PLoS ONE
2010
5: E8898
|
20202123 |
Shioya M et al.:
Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3
Neuropathol. Appl. Neurobiol.
2010
36: 320-330
|
12787059 |
Castegna A et al.:
Proteomic identification of nitrated proteins in Alzheimers disease brain
J. Neurochem.
2003
85: 1394-1401
|
20472889 |
Arendt T et al.:
Selective cell death of hyperploid neurons in Alzheimers disease
Am. J. Pathol.
2010
177: 15-20
|
10867782 |
Hock C et al.:
Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas
Arch. Neurol.
2000
57: 846-851
|
15857398 |
Wang J et al.:
Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimers disease
J. Neurochem.
2005
93: 953-962
|
11733217 |
Butterfield DA et al.:
Evidence of oxidative damage in Alzheimers disease brain: central role for amyloid beta-peptide
Trends Mol Med
2001
7: 548-554
|
19654187 |
Wang Y et al.:
Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Hum. Mol. Genet.
2009
18: 4153-4170
|
17485462 |
Ko MH et al.:
The sterol carrier protein SCP-x/pro-SCP-2 gene has transcriptional activity and regulates the Alzheimer disease gamma-secretase
J. Biol. Chem.
2007
282
|
20451302 |
Persengiev S et al.:
Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis
Neurobiol. Aging
2011
32: 2316
|
20413881 |
Nelson PT et al.:
MiR-107 is reduced in Alzheimers disease brain neocortex: validation study
J. Alzheimers Dis.
2010
21: 75-79
|
20110602 |
Ciaramella A et al.:
Increased pro-inflammatory response by dendritic cells from patients with Alzheimers disease
J. Alzheimers Dis.
2010
19: 559-572
|
20134203 |
Morales I et al.:
Neuroimmunomodulation in the pathogenesis of Alzheimers disease
Neuroimmunomodulation
2010
17: 202-204
|
20122289 |
Zotova E et al.:
Inflammation in Alzheimers disease: relevance to pathogenesis and therapy
Alzheimers Res Ther
2010
2: 1
|
20696495 |
Wilkinson BL et al.:
Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimers disease
Neurobiol. Aging
2012
33: 197
|
20696495 |
Wilkinson BL et al.:
Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimers disease
Neurobiol. Aging
2012
33: 197
|
16645044 |
Wang R et al.:
Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia
FASEB J.
2006
20: 1275-1277
|
16645641 |
Xu Y et al.:
Intracellular domains of amyloid precursor-like protein 2 interact with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3beta expression
Cell Death Differ.
2007
14: 79-91
|
20594619 |
Robakis NK et al.:
Mechanisms of AD neurodegeneration may be independent of Abeta and its derivatives
Neurobiol. Aging
2011
32: 372-379
|
19641596 |
Zhang C et al.:
Presenilins are essential for regulating neurotransmitter release
Nature
2009
460: 632-636
|
18184791 |
Baki L et al.:
Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling
J. Neurosci.
2008
28: 483-490
|
19261853 |
Liu Z et al.:
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinsons disease
Proc. Natl. Acad. Sci. U.S.A.
2009
106: 4635-4640
|
20739979 |
Ledford H et al.:
Key Alzheimers findings questioned.
Nature
2010
466: 1031
|
20552043 |
Guglielmotto M et al.:
Oxidative stress mediates the pathogenic effect of different Alzheimers disease risk factors
Front Aging Neurosci
2010
2: 3
|
20817278 |
Duce JA et al.:
Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimers disease
Cell
2010
142: 857-867
|
19021541 |
Rogers JT et al.:
Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimers disease
Biochem. Soc. Trans.
2008
36: 1282-1287
|
20631161 |
Brewer GJ et al.:
Copper and ceruloplasmin abnormalities in Alzheimers disease
Am J Alzheimers Dis Other Demen
2010
25: 490-497
|
19166904 |
Cahill CM et al.:
Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases
Biochim. Biophys. Acta
2009
1790: 615-628
|
19631630 |
Yao L et al.:
Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimers disease
Brain Res.
2009
1291: 133-139
|
18400211 |
Cheng CY et al.:
Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats
Brain Res.
2008
1209: 136-150
|
16205720 |
Gaeta A et al.:
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
Br. J. Pharmacol.
2005
146: 1041-1059
|
18687504 |
Jo DG et al.:
Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimers disease
Neurobiol. Aging
2010
31: 917-925
|
18687504 |
Jo DG et al.:
Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimers disease
Neurobiol. Aging
2010
31: 917-925
|
19965584 |
Vedin I et al.:
Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study
J. Lipid Res.
2010
51: 1179-1185
|
17014365 |
Andrews NC et al.:
Iron homeostasis
Annu. Rev. Physiol.
2007
69: 69-85
|
19225519 |
Nikolaev A et al.:
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nature
2009
457: 981-989
|
19898775 |
Wang SM et al.:
Role of hepcidin in murine brain iron metabolism
Cell. Mol. Life Sci.
2010
67: 123-133
|
18585350 |
Dreses-Werringloer U et al.:
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimers disease risk
Cell
2008
133: 1149-1161
|
20619502 |
Liu W et al.:
MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimers-associated pathogenesis in SAMP8 mice
Neurobiol. Aging
2012
33: 522-534
|
19090996 |
Block ML et al.:
NADPH oxidase as a therapeutic target in Alzheimers disease
BMC Neurosci
2008
9: S8
|
20442493 |
Young KJ et al.:
The mitochondrial secret(ase) of Alzheimers disease
J. Alzheimers Dis.
2010
20: S381-S400
|
16551656 |
Manczak M et al.:
Mitochondria are a direct site of A beta accumulation in Alzheimers disease neurons: implications for free radical generation and oxidative damage in disease progression
Hum. Mol. Genet.
2006
15: 1437-1449
|
20463396 |
Di Filippo M et al.:
Mitochondria and the link between neuroinflammation and neurodegeneration
J. Alzheimers Dis.
2010
20: S369-S379
|
20463408 |
Morais VA et al.:
Mitochondria dysfunction and neurodegenerative disorders: cause or consequence
J. Alzheimers Dis.
2010
20: S255-S263
|
15087549 |
Lustbader JW et al.:
ABAD directly links Abeta to mitochondrial toxicity in Alzheimers disease
Science
2004
304: 448-452
|
18757748 |
Hansson Petersen CA et al.:
The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae
Proc. Natl. Acad. Sci. U.S.A.
2008
105
|
15456764 |
Hansson CA et al.:
Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria
J. Biol. Chem.
2004
279
|
20655099 |
Ittner LM et al.:
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimers disease mouse models
Cell
2010
142: 387-397
|
20691893 |
Haass C et al.:
Fyn-tau-amyloid: a toxic triad
Cell
2010
142: 356-358
|
17088888 |
Lin MT et al.:
Alzheimers APP mangles mitochondria
Nat. Med.
2006
12: 1241-1243
|
12196559 |
Stein TD et al.:
Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways
J. Neurosci.
2002
22: 7380-7388
|
12196559 |
Stein TD et al.:
Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways
J. Neurosci.
2002
22: 7380-7388
|
14675736 |
Cardoso SM et al.:
Cytochrome c oxidase is decreased in Alzheimers disease platelets
Neurobiol. Aging
2004
25: 105-110
|
12270688 |
Casley CS et al.:
Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons
Neurobiol. Dis.
2002
10: 258-267
|
19605646 |
Wang X et al.:
Impaired balance of mitochondrial fission and fusion in Alzheimers disease
J. Neurosci.
2009
29: 9090-9103
|
15591653 |
Keil U et al.:
Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure
Pol J Pharmacol
2004
56: 631-634
|
20816785 |
Anekonda TS et al.:
L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimers disease.
Neurobiol. Dis.
2011
41: 62-70
|
21134458 |
Rozkalne A et al.:
Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice
Neurobiol. Dis.
2011
41: 650-654
|
20887789 |
Batlevi Y et al.:
Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging
Neurobiol. Dis.
2011
43: 46-51
|
20888417 |
Massone S et al.:
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease
Neurobiol. Dis.
2011
41: 308-317
|
21081164 |
Rohn TT et al.:
Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimers disease brain
Neurobiol. Dis.
2011
43: 68-78
|
20732422 |
Yamamoto A et al.:
The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration
Neurobiol. Dis.
2011
43: 17-28
|
12270682 |
Janciauskiene S et al.:
Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimers disease
Neurobiol. Dis.
2002
10: 187-200
|
21270867 |
Ledford H et al.:
Alzheimers-disease probe nears approval.
Nature
2011
469: 458
|
20551690 |
Kaiser E et al.:
Cerebrospinal fluid concentrations of functionally important amino acids and metabolic compounds in patients with mild cognitive impairment and Alzheimers disease.
Neurodegener Dis
2010
7: 251-259
|
18037246 |
Padmashri R et al.:
Glutamate transporter blockade affects Ca(2+) responses in astrocytes.
Neuroscience
2008
151: 56-62
|
19897719 |
Rhein V et al.:
Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimers disease mice.
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
19035593 |
Frydman-Marom A et al.:
Cognitive-performance recovery of Alzheimers disease model mice by modulation of early soluble amyloidal assemblies.
Angew. Chem. Int. Ed. Engl.
2009
48: 1981-1986
|
20709030 |
Wang H et al.:
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimers disease targets TGF-beta type II receptor.
Brain Res.
2010
1357: 166-174
|
20937840 |
Cui JG et al.:
Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease
J. Biol. Chem.
2010
285
|
18838197 |
Vargas T et al.:
Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis
Neurobiol. Aging
2010
31: 1569-1581
|
21062284 |
Smith P et al.:
In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs.
J. Neurochem.
2011
116: 240-247
|
18434550 |
Hebert SS et al.:
Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimers disease correlates with increased BACE1/beta-secretase expression
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 6415-6420
|
16599941 |
Wilhelmus MM et al.:
Specific association of small heat shock proteins with the pathological hallmarks of Alzheimers disease brains
Neuropathol. Appl. Neurobiol.
2006
32: 119-130
|
16611012 |
Gomez-Ramos A et al.:
Inhibition of GSK3 dependent tau phosphorylation by metals.
Curr Alzheimer Res
2006
3: 123-127
|
19795195 |
Pickrell AM et al.:
The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation.
J. Bioenerg. Biomembr.
2009
41: 453-456
|
19342591 |
Cho DH et al.:
S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.
Science
2009
324: 102-105
|
19050078 |
Wang X et al.:
Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins.
Proc. Natl. Acad. Sci. U.S.A.
2008
105
|
17715058 |
Fukui H et al.:
Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimers disease
Proc. Natl. Acad. Sci. U.S.A.
2007
104
|
19091971 |
Liu Y et al.:
Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimers disease.
J. Neurosci.
2008
28
|
19118186 |
Sato S et al.:
Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1
J. Neurosci.
2008
28
|
19118186 |
Sato S et al.:
Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1.
J. Neurosci.
2008
28
|
21208686 |
van Beek AH et al.:
Oscillations in cerebral blood flow and cortical oxygenation in Alzheimers disease
Neurobiol. Aging
2012
33: 428
|
19063999 |
Kennelly SP et al.:
Blood pressure and the risk for dementia: a double edged sword
Ageing Res. Rev.
2009
8: 61-70
|
18692159 |
Chung HY et al.:
Molecular inflammation: underpinnings of aging and age-related diseases.
Ageing Res. Rev.
2009
8: 18-30
|
18313368 |
Chung JH et al.:
Molecular mechanism of PPAR in the regulation of age-related inflammation
Ageing Res. Rev.
2008
7: 126-136
|
20170744 |
Vance JE et al.:
Formation and function of apolipoprotein E-containing lipoproteins in the nervous system
Biochim. Biophys. Acta
2010
1801: 806-818
|
20228251 |
Lee M et al.:
Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases.
FASEB J.
2010
24: 2533-2545
|
16025111 |
Snyder EM et al.:
Regulation of NMDA receptor trafficking by amyloid-beta.
Nat. Neurosci.
2005
8: 1051-1058
|
18813209 |
Chiba T et al.:
Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
Mol. Psychiatry
2009
14: 206-222
|
20889807 |
Geldmacher DS et al.:
Alzheimer disease prevention: focus on cardiovascular risk, not amyloid
Cleve Clin J Med
2010
77: 689-704
|
19076444 |
Gibson GE et al.:
Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimers disease
Ann. N. Y. Acad. Sci.
2008
1147: 221-232
|
16472763 |
Clementi ME et al.:
Alzheimers amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35.
Biochem. Biophys. Res. Commun.
2006
342: 206-213
|
20933077 |
Zhang H et al.:
Puerarin protects Alzheimers disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways.
Exp. Gerontol.
2011
46: 30-37
|
21461981 |
Bajic VP et al.:
Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease
Cell. Mol. Biol. Lett.
2011
16: 359-372
|
21421841 |
Jin M et al.:
Soluble amyloid {beta}-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration.
Proc. Natl. Acad. Sci. U.S.A.
2011
108: 5819-5824
|
21349442 |
Bonda DJ et al.:
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations
Lancet Neurol
2011
10: 275-279
|
21121893 |
Monteiro JP et al.:
SIRT1 deacetylase activity and the maintenance of protein homeostasis in response to stress: an overview.
Protein Pept. Lett.
2011
18: 167-173
|
16751189 |
Qin W et al.:
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction.
J. Biol. Chem.
2006
281
|
17517621 |
De Ferrari GV et al.:
Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimers disease.
Proc. Natl. Acad. Sci. U.S.A.
2007
104: 9434-9439
|
21383494 |
Sultana R et al.:
Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimers Disease: Insights into the Role of Oxidative Stress in Alzheimers Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder.
J. Alzheimers Dis.
2011
24: 77-84
|
21187585 |
Schrag M et al.:
Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimers disease.
J. Alzheimers Dis.
2011
24: 137-149
|
21187587 |
Zhou R et al.:
Association between Bone Mineral Density and the Risk of Alzheimers Disease.
J. Alzheimers Dis.
2011
24: 101-108
|
21376707 |
Li W et al.:
Regulation of matrix metalloproteinase 2 by oligomeric amyloid beta protein.
Brain Res.
2011
1387: 141-148
|
21148560 |
Jawhar S et al.:
Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice.
J. Biol. Chem.
2011
286: 4454-4460
|
19863057 |
Buchholz M et al.:
Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement.
J. Med. Chem.
2009
52: 7069-7080
|
20128815 |
Manthey D et al.:
The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities.
Br. J. Pharmacol.
2010
159: 1264-1273
|
21288892 |
Huang KF et al.:
Structures of Human Golgi-resident Glutaminyl Cyclase and Its Complexes with Inhibitors Reveal a Large Loop Movement upon Inhibitor Binding.
J. Biol. Chem.
2011
286
|
18836460 |
Schilling S et al.:
Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimers disease-like pathology.
Nat. Med.
2008
14: 1106-1111
|
19342064 |
Shenk JC et al.:
The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimers disease
J. Neurol. Sci.
2009
283: 199-206
|
20385883 |
Gu Y et al.:
Food combination and Alzheimer disease risk: a protective diet
Arch. Neurol.
2010
67: 699-706
|
20627092 |
Yamada K et al.:
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimers disease.
Brain Res.
2010
1352: 176-186
|
20971085 |
Shi JQ et al.:
Anti-TNF-alpha reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains.
Brain Res.
2011
1368: 239-247
|
18926603 |
Julien C et al.:
High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.
Neurobiol. Aging
2010
31: 1516-1531
|
19604602 |
DOnofrio M et al.:
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice.
Neurobiol. Aging
2011
32: 1007-1022
|
16813604 |
Akomolafe A et al.:
Genetic association between endothelial nitric oxide synthase and Alzheimer disease
Clin. Genet.
2006
70: 49-56
|
21127294 |
Austin SA et al.:
Endothelial nitric oxide modulates expression and processing of amyloid precursor protein.
Circ. Res.
2010
107: 1498-1502
|
19604603 |
Portelius E et al.:
A novel pathway for amyloid precursor protein processing
Neurobiol. Aging
2011
32: 1090-1098
|
19604604 |
Liu RM et al.:
Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimers disease.
Neurobiol. Aging
2011
32: 1079-1089
|
19628305 |
Amadoro G et al.:
Endogenous Abeta causes cell death via early tau hyperphosphorylation.
Neurobiol. Aging
2011
32: 969-990
|
17534003 |
Gliebus G et al.:
The influence of beta-blockers on delayed memory function in people with cognitive impairment.
Am J Alzheimers Dis Other Demen
2007
22: 57-61
|
19805638 |
Takeda S et al.:
Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.
Hypertension
2009
54: 1345-1352
|
21633502 |
Bigalke B et al.:
Adipocytokines and CD34 Progenitor Cells in Alzheimers Disease.
PLoS ONE
2011
6
|
21297254 |
Mateos L et al.:
Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimers disease
J. Alzheimers Dis.
2011
24: 669-679
|
21368380 |
Fiala M et al.:
MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimers disease by vitamin D and curcuminoids
J. Alzheimers Dis.
2011
25: 135-144
|
21157028 |
Gelber RP et al.:
Coffee intake in midlife and risk of dementia and its neuropathologic correlates.
J. Alzheimers Dis.
2011
23: 607-615
|
21321396 |
Carrasquillo MM et al.:
Replication of BIN1 association with Alzheimers disease and evaluation of genetic interactions
J. Alzheimers Dis.
2011
24: 751-758
|
21132329 |
Belbin O et al.:
Investigation of 15 of the top candidate genes for late-onset Alzheimers disease.
Hum. Genet.
2011
129: 273-282
|
21098976 |
Keller L et al.:
The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimers disease risk: a prospective cohort study
J. Alzheimers Dis.
2011
23: 461-469
|
21321400 |
Tiribuzi R et al.:
Lysosomal beta-galactosidase and beta-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimers disease and type 2 diabetes mellitus
J. Alzheimers Dis.
2011
24: 785-797
|
21321389 |
Echeverria V et al.:
Cotinine reduces amyloid-beta aggregation and improves memory in Alzheimers disease mice
J. Alzheimers Dis.
2011
24: 817-835
|
20413858 |
Carlsson CM et al.:
Type 2 diabetes mellitus, dyslipidemia, and Alzheimers disease.
J. Alzheimers Dis.
2010
20: 711-722
|
18376061 |
Carlsson CM et al.:
Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimers disease.
J. Alzheimers Dis.
2008
13: 187-197
|
21536132 |
Butterfield DA et al.:
Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders
Pharmacol. Res.
2011
64: 180-186
|
20847439 |
Murphy MP et al.:
Changes in cognition and amyloid-beta processing with long term cholesterol reduction using atorvastatin in aged dogs.
J. Alzheimers Dis.
2010
22: 135-150
|
21345168 |
Heneka MT et al.:
Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimers disease.
Curr Alzheimer Res
2011
8: 115-131
|
20639188 |
Gulaj E et al.:
Kynurenine and its metabolites in Alzheimers disease patients
Adv Med Sci
2010
55: 204-211
|
17049675 |
Urbanelli L et al.:
Cathepsin D expression is decreased in Alzheimers disease fibroblasts.
Neurobiol. Aging
2008
29: 12-22
|
21416488 |
Green KN et al.:
ST101 induces a novel 17 kDa APP cleavage that precludes Abeta generation in vivo.
Ann. Neurol.
2011
69: 831-844
|
11786245 |
Sly LM et al.:
Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimers disease.
Brain Res. Bull.
2001
56: 581-588
|
21466683 |
Kok EH et al.:
CLU, CR1 and PICALM genes associate with Alzheimers-related senile plaques.
Alzheimers Res Ther
2011
3: 12
|
21391232 |
Chibnik LB et al.:
CR1 is associated with amyloid plaque burden and age-related cognitive decline.
Ann. Neurol.
2011
69: 560-569
|
16515786 |
Pedersen WA et al.:
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Exp. Neurol.
2006
199: 265-273
|
21280074 |
Chu J et al.:
5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo.
Ann. Neurol.
2011
69: 34-46
|
21280075 |
Reitz C et al.:
SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimers disease risk.
Ann. Neurol.
2011
69: 47-64
|
21321391 |
Fragkouli A et al.:
Matrix metalloproteinase-9 participates in NGF-induced alpha-secretase cleavage of amyloid-beta protein precursor in PC12 cells
J. Alzheimers Dis.
2011
24: 705-719
|
21416485 |
Jayadev S et al.:
Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.
Ann. Neurol.
2011
69: 712-720
|
21504563 |
Piette F et al.:
Masitinib as an adjunct therapy for mild-to-moderate Alzheimers disease: a randomised, placebo-controlled phase 2 trial.
Alzheimers Res Ther
2011
3: 16
|
21406112 |
Li B et al.:
Stem cell factor and granulocyte colony-stimulating factor reduce beta-amyloid deposits in the brains of APP/PS1 transgenic mice.
Alzheimers Res Ther
2011
3: 8
|
21193043 |
Barone E et al.:
Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action
Pharmacol. Res.
2011
63: 172-180
|
21335656 |
Perez-Gonzalez R et al.:
Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimers disease.
J. Alzheimers Dis.
2011
24: 17-25
|
21633390 |
Garwood CJ et al.:
Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture.
Cell Death Dis
2011
2: E167
|
21527912 |
Kumar S et al.:
Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimers disease.
EMBO J.
2011
30: 2255-2265
|
21562267 |
Terwel D et al.:
Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis.
J. Neurosci.
2011
31: 7049-7059
|
21817177 |
Yanagisawa K et al.:
[Newly approved drugs for Alzheimer disease: effectiveness and limitation].
Brain Nerve
2011
63: 863-868
|
19694182 |
Wang B et al.:
Schisandrin B protects rat cortical neurons against Abeta1-42-induced neurotoxicity.
Pharmazie
2009
64: 450-454
|
21037121 |
Starkstein SE et al.:
Anosognosia is a significant predictor of apathy in Alzheimers disease.
J Neuropsychiatry Clin Neurosci
2010
22: 378-383
|
20808100 |
Orfei MD et al.:
Anosognosia in mild cognitive impairment and mild Alzheimers disease: frequency and neuropsychological correlates.
Am J Geriatr Psychiatry
2010
18: 1133-1140
|
20555149 |
Sedaghat F et al.:
Brain SPECT findings of anosognosia in Alzheimers disease.
J. Alzheimers Dis.
2010
21: 641-647
|
20188013 |
Leicht H et al.:
Anosognosia in Alzheimers disease: the role of impairment levels in assessment of insight across domains.
J Int Neuropsychol Soc
2010
16: 463-473
|
17361039 |
Jacob CP et al.:
Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimers disease.
J. Alzheimers Dis.
2007
11: 97-116
|
21211392 |
Lei JK et al.:
[Change of serum ACTH and cortisol levels in Alzheimer disease and mild cognition impairment].
Zhonghua Yi Xue Za Zhi
2010
90: 2894-2896
|
20937084 |
Fleisher-Berkovich S et al.:
Distinct modulation of microglial amyloid beta phagocytosis and migration by neuropeptides (i).
J Neuroinflammation
2010
7: 61
|
21387370 |
Himeno E et al.:
Apomorphine treatment in Alzheimer mice promoting amyloid-beta degradation.
Ann. Neurol.
2011
69: 248-256
|
21448224 |
Di Paolo G et al.:
Linking lipids to Alzheimers disease: cholesterol and beyond.
Nat. Rev. Neurosci.
2011
12: 284-296
|
21147981 |
Oliveira TG et al.:
Phospholipase d2 ablation ameliorates Alzheimers disease-linked synaptic dysfunction and cognitive deficits.
J. Neurosci.
2010
30
|
21357679 |
Chapuis J et al.:
Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein
Hum. Mol. Genet.
2011
20: 2026-2036
|
19196476 |
Prinzen C et al.:
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.
BMC Genomics
2009
10: 66
|
21672962 |
Rolyan H et al.:
Telomere shortening reduces Alzheimers disease amyloid pathology in mice.
Brain
2011
134: 2044-2056
|
21389082 |
Casas-Tinto S et al.:
The ER stress factor XBP1s prevents amyloid-beta neurotoxicity.
Hum. Mol. Genet.
2011
20: 2144-2160
|
18276079 |
Clement AB et al.:
Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Neuroscience
2008
152: 459-468
|
17722071 |
Shimmyo Y et al.:
Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases.
J. Neurosci. Res.
2008
86: 368-377
|
20592218 |
Mitterreiter S et al.:
Bepridil and amiodarone simultaneously target the Alzheimers disease beta- and gamma-secretase via distinct mechanisms.
J. Neurosci.
2010
30: 8974-8983
|
18391946 |
Berman DE et al.:
Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
Nat. Neurosci.
2008
11: 547-554
|
19109907 |
OConnor T et al.:
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
Neuron
2008
60: 988-1009
|
20492361 |
Xu J et al.:
Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity
J. Neurochem.
2011
116: 192-204
|
20348102 |
Lammich S et al.:
Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5-untranslated region.
J. Biol. Chem.
2010
285
|
20427278 |
Ullrich S et al.:
The novel membrane protein TMEM59 modulates complex glycosylation, cell surface expression, and secretion of the amyloid precursor protein.
J. Biol. Chem.
2010
285
|
21955788 |
Zhang L et al.:
Identifying Tmem59 related gene regulatory network of mouse neural stem cell from a compendium of expression profiles.
BMC Syst Biol
2011
5: 152
|
21413990 |
Lichtenthaler SF et al.:
Regulated intramembrane proteolysis--lessons from amyloid precursor protein processing.
J. Neurochem.
2011
117: 779-796
|
21695060 |
Hogl S et al.:
Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and gamma-secretase.
PLoS ONE
2011
6
|
20676056 |
Kuhn PH et al.:
ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.
EMBO J.
2010
29: 3020-3032
|
21460840 |
Hollingworth P et al.:
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimers disease
Nat. Genet.
2011
43: 429-435
|
19879754 |
Baumann S et al.:
NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring.
Bioorg. Med. Chem. Lett.
2009
19: 6986-6990
|
21689411 |
Ferris SH et al.:
Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimers disease.
Alzheimers Res Ther
2011
3: 22
|
19552690 |
Lu P et al.:
Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice
Br. J. Pharmacol.
2009
157: 1270-1277
|
12714508 |
Hundhausen C et al.:
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion
Blood
2003
102: 1186-1195
|
21881209 |
Krohn M et al.:
Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice
J. Clin. Invest.
2011
121: 3924-3931
|
21035623 |
Craig-Schapiro R et al.:
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimers disease.
Biol. Psychiatry
2010
68: 903-912
|
16371011 |
Glatz DC et al.:
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimers disease.
J. Neurochem.
2006
96: 635-644
|
21470964 |
Qian W et al.:
Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
Nucleic Acids Res.
2011
39: 6161-6171
|
21281635 |
Jung HJ et al.:
Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Exp. Neurol.
2011
228: 232-241
|
21367856 |
Shi J et al.:
Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease.
J. Biol. Chem.
2011
286
|
21807765 |
Smith PY et al.:
MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Hum. Mol. Genet.
2011
20: 4016-4024
|
20930824 |
author information missing
article information missing
|
16943417 |
Wu JY et al.:
SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy.
Mol. Cell. Biol.
2006
26: 6739-6747
|
15972296 |
Prinzen C et al.:
Genomic structure and functional characterization of the human ADAM10 promoter.
FASEB J.
2005
19: 1522-1524
|
19608551 |
Kim M et al. et al.:
Potential late-onset Alzheimers disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity
Hum. Mol. Genet.
2009
18: 3987-3996
|
19498037 |
Rodriguez-Martin T et al.:
Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
Hum. Mol. Genet.
2009
18: 3266-3273
|
2181826 |
Godfrey DG et al.:
The distribution, relationships and identification of enzymic variants within the subgenus Trypanozoon.
Adv. Parasitol.
1990
29: 1-74
|
16777844 |
Kar A et al.:
RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion.
J. Biol. Chem.
2006
281
|
21333649 |
Qian W et al.:
Splicing factor SC35 promotes tau expression through stabilization of its mRNA.
FEBS Lett.
2011
585: 875-880
|
20615469 |
Chen KL et al.:
Amyloid-beta peptide alteration of tau exon-10 splicing via the GSK3beta-SC35 pathway
Neurobiol. Dis.
2010
40: 378-385
|
19502709 |
Kooistra J et al.:
A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor.
J. Alzheimers Dis.
2009
17: 281-294
|
21365281 |
Gutierrez-Lopez MD et al.:
The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9.
Cell. Mol. Life Sci.
2011
68: 3275-3292
|
20194618 |
Ohe K et al.:
HMGA1a trapping of U1 snRNP at an authentic 5 splice site induces aberrant exon skipping in sporadic Alzheimers disease.
Mol. Cell. Biol.
2010
30: 2220-2228
|
11193153 |
Fahrenholz F et al.:
Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure.
Ann. N. Y. Acad. Sci.
2000
920: 215-222
|
21799908 |
Pietrzak M et al.:
Epigenetic silencing of nucleolar rRNA genes in Alzheimers disease.
PLoS ONE
2011
6
|
21835916 |
Wilkinson K et al.:
A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.
J. Biol. Chem.
2011
286
|
15695522 |
Wang Y et al.:
Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1.
J. Biol. Chem.
2005
280
|
22278060 |
Israel MA et al.:
Probing sporadic and familial Alzheimers disease using induced pluripotent stem cells
Nature
2012
482: 216-220
|
15615629 |
Andreadis A et al.:
Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases.
Biochim. Biophys. Acta
2005
1739: 91-103
|
21114897 |
Radenahmad N et al.:
Young coconut juice, a potential therapeutic agent that could significantly reduce some pathologies associated with Alzheimers disease: novel findings.
Br. J. Nutr.
2011
105: 738-746
|
21492498 |
Barak Y et al.:
Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimers disease: a randomized double-blind pilot study
Int Psychogeriatr
2011
23: 1515-1519
|
15890777 |
Zhou S et al.:
CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimers disease amyloid beta-peptide production.
Proc. Natl. Acad. Sci. U.S.A.
2005
102: 7499-7504
|
21343338 |
Kar A et al.:
RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5 splice site.
Mol. Cell. Biol.
2011
31: 1812-1821
|
21902456 |
Hedskog L et al.:
Strategic role for mitochondria in Alzheimers disease and cancer
Antioxid. Redox Signal.
2012
16: 1476-1491
|
21707856 |
Kato K et al.:
Protein kinase C stabilizes X-linked inhibitor of apoptosis protein (XIAP) through phosphorylation at Ser(87) to suppress apoptotic cell death.
Psychogeriatrics
2011
11: 90-97
|
21054783 |
Hedskog L et al.:
gamma-Secretase complexes containing caspase-cleaved presenilin-1 increase intracellular Abeta(42) /Abeta(40) ratio.
J. Cell. Mol. Med.
2011
15: 2150-2163
|
19389700 |
Quintanilla RA et al.:
Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease
J. Biol. Chem.
2009
284
|
22079237 |
Alldred MJ et al.:
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction
Neurobiol. Dis.
2012
45: 751-762
|
20570249 |
Yang H et al.:
Amelioration of the Alzheimers disease phenotype by absence of 12/15-lipoxygenase
Biol. Psychiatry
2010
68: 922-929
|
21900234 |
Bate C et al.:
Amyloid-beta-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
J. Biol. Chem.
2011
286
|
21715329 |
Xue Y et al.:
Crystal structure of the E2 domain of amyloid precursor protein-like protein 1 in complex with sucrose octasulfate.
J. Biol. Chem.
2011
286
|
22101739 |
Samy AS et al.:
Regulation of IL-1beta-induced cyclooxygenase-2 expression by interactions of Abeta peptide, apolipoprotein E and nitric oxide in human neuroglioma
J. Mol. Neurosci.
2012
47: 533-545
|
21795680 |
Griffiths HH et al.:
Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein.
J. Biol. Chem.
2011
286
|
19671904 |
Scarmeas N et al.:
Physical activity, diet, and risk of Alzheimer disease.
JAMA
2009
302: 627-637
|
20009056 |
Lieb W et al.:
Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
JAMA
2009
302: 2565-2572
|
19887909 |
Kellett KA et al.:
Prion protein and Alzheimer disease.
Prion
2009
3: 190-194
|
20819221 |
Bitel CL et al.:
Increased expression and local accumulation of the prion protein, Alzheimer Abeta peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes.
BMC Physiol.
2010
10: 18
|
22072713 |
Murakami K et al.:
SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease
J. Biol. Chem.
2011
286
|
21694453 |
Novak P et al.:
Tauons and prions: infamous cousins?
J. Alzheimers Dis.
2011
26: 413-430
|
20473510 |
Reiniger L et al.:
Tau, prions and Abeta: the triad of neurodegeneration
Acta Neuropathol.
2011
121: 5-20
|
22100763 |
Kudo W et al.:
Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death.
Hum. Mol. Genet.
2012
21: 1138-1144
|
22028219 |
Jucker M et al.:
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Ann. Neurol.
2011
70: 532-540
|
22017494 |
Rosen RF et al.:
Exogenous seeding of cerebral beta-amyloid deposition in betaAPP-transgenic rats
J. Neurochem.
2012
120: 660-666
|
21699076 |
Szymanski P et al.:
Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimers disease
Pharmazie
2011
66: 399-403
|
20598287 |
Grimmer T et al.:
Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimers disease
Biol. Psychiatry
2010
68: 879-884
|
20400860 |
Khalifa NB et al.:
What is the role of amyloid precursor protein dimerization
Cell Adh Migr
2010
4: 268-272
|
17050537 |
Kuan YH et al.:
PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2
J. Biol. Chem.
2006
281
|
16230627 |
Rodriguez-Martin T et al.:
Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies
Proc. Natl. Acad. Sci. U.S.A.
2005
102
|
22077634 |
Sheng B et al.:
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimers disease
J. Neurochem.
2012
120: 419-429
|
19273754 |
Qin W et al.:
PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia
Arch. Neurol.
2009
66: 352-361
|
21255795 |
Zhang Y et al.:
The -1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimers disease: a meta-analysis
J. Neurol. Sci.
2011
303: 133-138
|
20479757 |
Conejero-Goldberg C et al.:
Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimers disease as based on APOE genotype
Mol. Psychiatry
2011
16: 836-847
|
17998437 |
Li H et al.:
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease
Arch. Neurol.
2008
65: 45-53
|
17684015 |
Huttunen HJ et al.:
HtrA2 regulates beta-amyloid precursor protein (APP) metabolism through endoplasmic reticulum-associated degradation
J. Biol. Chem.
2007
282
|
18292081 |
Kotilinek LA et al.:
Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity
Brain
2008
131: 651-664
|
19943124 |
Rothman SM et al.:
Adverse stress, hippocampal networks, and Alzheimers disease
Neuromolecular Med.
2010
12: 56-70
|
22275252 |
Chu J et al.:
Transcriptional regulation of beta-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments
Ann. Neurol.
2012
71: 57-67
|
18021299 |
Tachida Y et al.:
Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production
J. Neurochem.
2008
104: 1387-1393
|
18587388 |
Yuzwa SA et al.:
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Nat. Chem. Biol.
2008
4: 483-490
|
17940659 |
Dias WB et al.:
O-GlcNAc modification in diabetes and Alzheimers disease
Mol Biosyst
2007
3: 766-772
|
19122823 |
Bajic VP et al.:
Is the time dimension of the cell cycle re-entry in AD regulated by centromere cohesion dynamics
Biosci Hypotheses
2008
1: 156-161
|
15974909 |
Ringman JM et al.:
A potential role of the curry spice curcumin in Alzheimers disease
Curr Alzheimer Res
2005
2: 131-136
|
18815129 |
Ono K et al.:
Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity
J. Biol. Chem.
2008
283
|
18032783 |
Nixon RA et al.:
Autophagy, amyloidogenesis and Alzheimer disease
J. Cell. Sci.
2007
120: 4081-4091
|
21968187 |
Klug W et al.:
Phosphorylation of LRP1 regulates the interaction with Fe65
FEBS Lett.
2011
585: 3229-3235
|
16195917 |
Mikol J et al.:
Extensive cortico-subcortical lesions in Wilsons disease: clinico-pathological study of two cases
Acta Neuropathol.
2005
110: 451-458
|
22264991 |
Chen R et al.:
Elevation of serum TNF-alpha levels in mild and moderate Alzheimer patients with daytime sleepiness
J. Neuroimmunol.
2012
244: 97-102
|
22349686 |
Spalletta G et al.:
Anosognosia and neuropsychiatric symptoms and disorders in mild Alzheimer disease and mild cognitive impairment
J. Alzheimers Dis.
2012
29: 761-772
|
21129451 |
Jardanhazi-Kurutz D et al.:
Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice
Neuroscience
2011
176: 396-407
|
11470313 |
Strausak D et al.:
Copper in disorders with neurological symptoms: Alzheimers, Menkes, and Wilson diseases
Brain Res. Bull.
2001
55: 175-185
|
20493925 |
Song H et al.:
Association between haplotype -88G/25G in A2M with Alzheimers disease
Neurosci. Lett.
2010
479: 143-145
|
9697696 |
Blacker D et al.:
Alpha-2 macroglobulin is genetically associated with Alzheimer disease
Nat. Genet.
1998
19: 357-360
|
21216965 |
Chen WT et al.:
Distinct effects of Zn2+, Cu2+, Fe3+, and Al3+ on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation
J. Biol. Chem.
2011
286: 9646-9656
|
16236446 |
Deary IJ et al.:
Polymorphisms in the gene encoding 11B-hydroxysteroid dehydrogenase type 1 (HSD11B1) and lifetime cognitive change
Neurosci. Lett.
2006
393: 74-77
|
14583441 |
de Quervain DJ et al.:
Glucocorticoid-related genetic susceptibility for Alzheimers disease
Hum. Mol. Genet.
2004
13: 47-52
|
11257240 |
Rasmuson S et al.:
Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimers disease
Biol. Psychiatry
2001
49: 547-552
|
20157240 |
Souza-Talarico JN et al.:
Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimers disease subjects
J. Alzheimers Dis.
2010
19: 839-848
|
22660329 |
Nussbaum JM et al.:
Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta
Nature
2012
485: 651-655
|
22654059 |
Barrett PJ et al.:
The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol
Science
2012
336: 1168-1171
|
18482978 |
Tolia A et al.:
Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase
J. Biol. Chem.
2008
283
|
20871650 |
Shawkatova I et al.:
No association between cytokine gene polymorphism and risk of Alzheimers disease in Slovaks
Acta Neurobiol Exp (Wars)
2010
70: 303-307
|
22178568 |
Fang M et al.:
The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimers disease
Toxicol. Lett.
2012
209: 94-105
|
18096514 |
Lee MR et al.:
Inhibition of APP intracellular domain (AICD) transcriptional activity via covalent conjugation with Nedd8
Biochem. Biophys. Res. Commun.
2008
366: 976-981
|
22506131 |
Borquez DA et al.:
The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimers disease
Int J Alzheimers Dis
2012
2012
|
19282473 |
Stante M et al.:
Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks
Proc. Natl. Acad. Sci. U.S.A.
2009
106: 5093-5098
|
15331662 |
von Rotz RC et al.:
The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor
J. Cell. Sci.
2004
117: 4435-4448
|
22122663 |
Pardossi-Piquard R et al.:
The physiology of the beta-amyloid precursor protein intracellular domain AICD
J. Neurochem.
2012
120: 109-124
|
17093061 |
Muller T et al.:
Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD)
Mol. Biol. Cell
2007
18: 201-210
|
15708439 |
Caccamo A et al.:
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders
Neurobiol. Aging
2005
26: 645-654
|
22563077 |
Maesako M et al.:
Exercise Is More Effective than Diet Control in Preventing High Fat Diet-induced beta-Amyloid Deposition and Memory Deficit in Amyloid Precursor Protein Transgenic Mice
J. Biol. Chem.
2012
287
|
22303443 |
Westin K et al.:
CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimers disease
PLoS ONE
2012
7
|
22805778 |
Hoshi A et al.:
Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease
J. Neuropathol. Exp. Neurol.
2012
71: 750-759
|
22801501 |
Jonsson T et al.:
A mutation in APP protects against Alzheimers disease and age-related cognitive decline
Nature
2012
488: 96-99
|
10742146 |
Lu DC et al.:
A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor
Nat. Med.
2000
6: 397-404
|
14557245 |
Chen Y et al.:
APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimers disease brain
J. Cell Biol.
2003
163: 27-33
|
12533840 |
Dil Kuazi A et al.:
NEDD8 protein is involved in ubiquitinated inclusion bodies
J. Pathol.
2003
199: 259-266
|
18801622 |
Guldiken S et al.:
Subclinical Cushings syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia
Med. Hypotheses
2008
71: 703-705
|
16125145 |
Elgh E et al.:
Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimers disease
Biol. Psychiatry
2006
59: 155-161
|
10722740 |
Chen Y et al.:
The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons
J. Biol. Chem.
2000
275: 8929-8935
|
21880910 |
Li X et al.:
Neuronal production of transthyretin in human and murine Alzheimers disease: is it protective
J. Neurosci.
2011
31
|
15192323 |
Chen YZ et al.:
APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin
Apoptosis
2004
9: 415-422
|
12777371 |
Weggen S et al.:
Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain
J. Biol. Chem.
2003
278
|
20689579 |
Ghosal K et al.:
APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation
PLoS ONE
2010
5
|
21958873 |
Paris D et al.:
Anatabine lowers Alzheimers Abeta production in vitro and in vivo
Eur. J. Pharmacol.
2011
670: 384-391
|
16973241 |
Carter CJ et al.:
Convergence of genes implicated in Alzheimers disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis
Neurochem. Int.
2007
50: 12-38
|
22464332 |
Nakamura K et al.:
Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimers disease
Cell
2012
149: 232-244
|
18587408 |
Faghihi MA et al.:
Expression of a noncoding RNA is elevated in Alzheimers disease and drives rapid feed-forward regulation of beta-secretase
Nat. Med.
2008
14: 723-730
|
22915175 |
Singh-Manoux A et al.:
Obesity phenotypes in midlife and cognition in early old age: the Whitehall II cohort study
Neurology
2012
79: 755-762
|
22796576 |
Eyles DW et al.:
Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease
Front Neuroendocrinol
2013
34: 47-64
|
22591405 |
Qiao DL et al.:
Is vitamin D beneficial to Alzheimer disease? A surprising dilemma
CNS Neurosci Ther
2012
18: 601-603
|
21486290 |
Webster SJ et al.:
The acute effects of dimebolin, a potential Alzheimers disease treatment, on working memory in rhesus monkeys
Br. J. Pharmacol.
2011
164: 970-978
|
22942647 |
Sozio P et al.:
Transdermal donepezil on the treatment of Alzheimers disease
Neuropsychiatr Dis Treat
2012
8: 361-368
|
21502597 |
Rafii MS et al.:
A phase II trial of huperzine A in mild to moderate Alzheimer disease
Neurology
2011
76: 1389-1394
|
22227962 |
Kummer MP et al.:
Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice
J Neuroimmune Pharmacol
2012
7: 165-172
|
22766135 |
Martins LC et al.:
Disease-specific expression of the serotonin-receptor 5-HT(2C) in natural killer cells in Alzheimers dementia
J. Neuroimmunol.
2012
251: 73-79
|
19072283 |
Owen JB et al.:
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimers disease and mild cognitive impairment: implications for progression of AD
J. Proteome Res.
2009
8: 471-482
|
22801742 |
Doecke JD et al.:
Blood-based protein biomarkers for diagnosis of Alzheimer disease
Arch. Neurol.
2012
69: 1318-1325
|
22329649 |
Cai H et al.:
Metabolic dysfunction in Alzheimers disease and related neurodegenerative disorders
Curr Alzheimer Res
2012
9: 5-17
|
16843497 |
Rentzos M et al.:
Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimers disease and frontotemporal dementia
J. Neurol. Sci.
2006
249: 110-114
|
23178247 |
Vom Berg J et al.:
Inhibition of IL-12/IL-23 signaling reduces Alzheimers disease-like pathology and cognitive decline
Nat. Med.
2012
18: 1812-1819
|
11137576 |
Szczepanik AM et al.:
IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line
J. Neuroimmunol.
2001
113: 49-62
|
23157339 |
Arlt S et al.:
Genetic risk factors for depression in Alzheimer`s disease patients
Curr Alzheimer Res
2013
10: 72-81
|
22970774 |
Azizi G et al.:
The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis
Immunopharmacol Immunotoxicol
2012
34: 881-895
|
19776284 |
Reed-Geaghan EG et al.:
CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation
J. Neurosci.
2009
29
|
21071836 |
Murata N et al.:
Silymarin attenuated the amyloid beta plaque burden and improved behavioral abnormalities in an Alzheimers disease mouse model
Biosci. Biotechnol. Biochem.
2010
74: 2299-2306
|
21185897 |
Yin F et al.:
Silibinin: a novel inhibitor of Abeta aggregation
Neurochem. Int.
2011
58: 399-403
|
22610069 |
Lehmann SM et al.:
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
Nat. Neurosci.
2012
15: 827-835
|
19464758 |
Srikanth V et al.:
Advanced glycation endproducts and their receptor RAGE in Alzheimers disease
Neurobiol. Aging
2011
32: 763-777
|
23393093 |
Mori K et al.:
The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS
Science
2013
339: 1335-1338
|
23352322 |
Cacace R et al.:
C9orf72 G4C2 repeat expansions in Alzheimers disease and mild cognitive impairment
Neurobiol. Aging
2013
34: 1712
|
23150934 |
Guerreiro R et al.:
TREM2 variants in Alzheimers disease
N. Engl. J. Med.
2013
368: 117-127
|
19484711 |
Oulhaj A et al.:
Homocysteine as a predictor of cognitive decline in Alzheimers disease
Int J Geriatr Psychiatry
2010
25: 82-90
|
9823829 |
Clarke R et al.:
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
Arch. Neurol.
1998
55: 1449-1455
|
22964832 |
Xi Z et al.:
Investigation of c9orf72 in 4 neurodegenerative disorders
Arch. Neurol.
2012
69: 1583-1590
|
16688597 |
Rota E et al.:
Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimers disease patients
Neurol. Sci.
2006
27: 33-39
|
9147373 |
Xu S et al.:
Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimers disease
Mech. Ageing Dev.
1997
94: 213-222
|
21857683 |
Deng HX et al.:
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia
Nature
2011
477: 211-215
|
20074050 |
Haapasalo A et al.:
Emerging role of Alzheimers disease-associated ubiquilin-1 in protein aggregation
Biochem. Soc. Trans.
2010
38: 150-155
|
21966562 |
Haapasalo A et al.:
Involvement of ubiquilin-1 transcript variants in protein degradation and accumulation
Commun Integr Biol
2011
4: 428-432
|
23162743 |
Ma QL et al.:
PAK in Alzheimer disease, Huntington disease and X-linked mental retardation
Cell Logist
2012
2: 117-125
|
21852239 |
Stieren ES et al.:
Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein
J. Biol. Chem.
2011
286
|
23204143 |
Yarchoan M et al.:
Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias
Brain
2012
135: 3749-3756
|
22745485 |
Kook SY et al.:
Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling
J. Neurosci.
2012
32: 8845-8854
|
23208281 |
Ashe KH et al.:
Prions, prionoids and pathogenic proteins in Alzheimer disease
Prion
2013
7: 55-59
|
21969301 |
Bakalash S et al.:
Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimers disease
Invest. Ophthalmol. Vis. Sci.
2011
52: 9033-9046
|
23667698 |
Takasugi N et al.:
FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-beta Production in Neurons
PLoS ONE
2013
8
|
15923191 |
Tamboli IY et al.:
Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide
J. Biol. Chem.
2005
280
|
20110603 |
Rojo LE et al.:
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimers disease
J. Alzheimers Dis.
2010
19: 573-589
|
10226937 |
Baran H et al.:
Kynurenine metabolism in Alzheimers disease
J Neural Transm
1999
106: 165-181
|
17017544 |
Nemeth H et al.:
Kynurenines, Parkinsons disease and other neurodegenerative disorders: preclinical and clinical studies
J. Neural Transm. Suppl.
2006
70: 285-304
|
21538537 |
De Deyn PP et al.:
Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimers disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study
Int J Geriatr Psychiatry
2012
27: 296-304
|
15465626 |
Walter A et al.:
Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients
Neurobiol. Aging
2004
25: 1299-1303
|
16227558 |
Serot JM et al.:
Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimers disease
J. Neurol. Neurosurg. Psychiatr.
2005
76: 1585-1587
|
23365075 |
Browne TC et al.:
IFN-gamma Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimers disease
J. Immunol.
2013
190: 2241-2251
|
19199127 |
Leoni V et al.:
Oxysterols as markers of neurological disease--a review
Scand. J. Clin. Lab. Invest.
2009
69: 22-25
|
11027840 |
Bretillon L et al.:
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases
Neurosci. Lett.
2000
293: 87-90
|
23666171 |
Leoni V et al.:
Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health
J. Alzheimers Dis.
2013
36: 739-747
|
23285020 |
Hosokawa M et al.:
Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice
PLoS ONE
2012
7
|
23435411 |
Lira-De Leon KI et al.:
Molecular mechanism of tau aggregation induced by anionic and cationic dyes
J. Alzheimers Dis.
2013
35: 319-334
|
23443659 |
Crowe A et al.:
Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation
J. Biol. Chem.
2013
288
|
23653592 |
Xie L et al.:
Methylene blue induces macroautophagy through 5 adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation
Front Cell Neurosci
2013
7: 56
|
22377780 |
Hughes TM et al.:
Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimers disease
J. Alzheimers Dis.
2012
30: 53-61
|
20158567 |
Nilsson P et al.:
Gene therapy in Alzheimers disease - potential for disease modification
J. Cell. Mol. Med.
2010
14: 741-757
|
21383512 |
Mori K et al.:
Effects of Hericium erinaceus on amyloid beta(25-35) peptide-induced learning and memory deficits in mice
Biomed. Res.
2011
32: 67-72
|
18758067 |
Mori K et al.:
Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells
Biol. Pharm. Bull.
2008
31: 1727-1732
|
22078238 |
Costa A et al.:
Galanin and alpha-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimers disease
J. Neuroimmunol.
2011
240-241: 114-120
|
21399480 |
Lauterbach EC et al.:
Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease
Alzheimer Dis Assoc Disord
2012
26: 1-7
|
23935582 |
Mariani S et al.:
Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimers and Parkinsons diseases
Front Aging Neurosci
2013
5: 37
|
17234346 |
Salins P et al.:
Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling
Neurosci. Lett.
2007
412: 211-216
|
22654722 |
Heneka MT et al.:
Impact and Therapeutic Potential of PPARs in Alzheimers Disease
Curr Neuropharmacol
2011
9: 643-650
|
10078972 |
Pradier L et al.:
Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction
Neurobiol. Dis.
1999
6: 43-55
|
15033165 |
Cardona-Gomez P et al.:
Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus
Mol. Cell. Neurosci.
2004
25: 363-373
|
24270855 |
Han J et al.:
OCIAD2 activates gamma-secretase to enhance amyloid beta production by interacting with nicastrin
Cell. Mol. Life Sci.
2014
71: 2561-2576
|
11740561 |
Kamal A et al.:
Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP
Nature
2001
414: 643-648
|
21298039 |
Gatta V et al.:
Microarray analysis on human neuroblastoma cells exposed to aluminum, beta(1-42)-amyloid or the beta(1-42)-amyloid aluminum complex
PLoS ONE
2011
6
|
24780254 |
Laurent C et al.:
Beneficial effects of caffeine in a transgenic model of Alzheimers disease-like tau pathology
Neurobiol. Aging
2014
35: 2079-2090
|
11278378 |
Kihara T et al.:
alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity
J. Biol. Chem.
2001
276
|
10681545 |
Wang HY et al.:
beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimers disease pathology
J. Biol. Chem.
2000
275: 5626-5632
|
24123152 |
Zhang L et al.:
Tyrosine phosphatase STEP61 negatively regulates amyloid beta-mediated ERK/CREB signaling pathways via alpha7 nicotinic acetylcholine receptors
J. Neurosci. Res.
2013
91: 1581-1590
|
23810791 |
Sokolov AN et al.:
Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior
Neurosci Biobehav Rev
2013
37: 2445-2453
|
21982844 |
Williams RJ et al.:
Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease
Free Radic. Biol. Med.
2012
52: 35-45
|
24511465 |
Robin NC et al.:
Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/beta-Catenin Signaling
Stem Cell Reports
2013
2: 9-17
|
16230462 |
Ryan KA et al.:
Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain
J. Cell Biol.
2005
171: 327-335
|
18070361 |
Chen Y et al.:
Amyloid precursor protein modulates beta-catenin degradation
J Neuroinflammation
2007
4: 29
|
18234671 |
Magdesian MH et al.:
Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling
J. Biol. Chem.
2008
283: 9359-9368
|
25878270 |
Kan MJ et al.:
Arginine deprivation and immune suppression in a mouse model of Alzheimers disease
J. Neurosci.
2015
15: 5969-5982
|
25502766 |
Sun Y et al.:
Translational study of Alzheimers disease (AD) biomarkers from brain tissues in AbetaPP/PS1 mice and serum of AD patients
J. Alzheimers Dis.
2015
45: 269-282
|
22406198 |
Kim YH et al.:
Proteomic analysis of plasma from a Tau transgenic mouse
Int. J. Dev. Neurosci.
2012
30: 277-283
|
21912965 |
Boda E et al.:
Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimers disease
J. Mol. Neurosci.
2012
3: 606-615
|
15485486 |
Angulo E et al.:
Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimers disease
J. Neurochem.
2004
3: 547-557
|
18449908 |
Poduslo SE et al.:
Genome screen of late-onset Alzheimers extended pedigrees identifies TRPC4AP by haplotype analysis
Am. J. Med. Genet. B Neuropsychiatr. Genet.
2009
1: 50-55
|
21116278 |
Furney SJ et al.:
Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimers disease
Mol. Psychiatry
2011
16: 1130-1138
|
26458046 |
Mainz A et al.:
The chaperone alphaB-crystallin uses different interfaces to capture an amorphous and an amyloid client
|
26033219 |
Cecarini V et al.:
Effects of Ghrelin on the Proteolytic Pathways of Alzheimers Disease Neuronal Cells
|
25998028 |
Folch J et al.:
The role of leptin in the sporadic form of Alzheimers disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin
Life Sci.
2015
140: 19-28
|
23595620 |
Hokama M et al.:
Altered expression of diabetes-related genes in Alzheimers disease brains: the Hisayama study
Cereb. Cortex
2014
24: 2476-2488
|
26515689 |
Lin CL et al.:
Amyloid-beta suppresses AMP-activated protein kinase (AMPK) signaling and contributes to alpha-synuclein-induced cytotoxicity
Exp. Neurol.
2016
275: 84-98
|
22367557 |
Cai Z et al.:
Roles of AMP-activated protein kinase in Alzheimers disease
Neuromolecular Med.
2012
14: 1-14
|
26250687 |
Goedert M et al.:
NEURODEGENERATION. Alzheimers and Parkinsons diseases: The prion concept in relation to assembled Abeta, tau, and alpha-synuclein
Science
2015
349
|
22746245 |
Nunes MA et al.:
Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimers disease
Curr Alzheimer Res
2013
10: 104-107
|
23246577 |
Lee E et al.:
Effect of conjugated linoleic acid, mu-calpain inhibitor, on pathogenesis of Alzheimers disease
Biochim. Biophys. Acta
2013
1831: 709-718
|
9848094 |
Torp R et al.:
GADD45 is induced in Alzheimers disease, and protects against apoptosis in vitro
Neurobiol. Dis.
1998
5: 245-252
|
28035934 |
author information missing
article information missing
|
28111074 |
Huang YA et al.:
ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion
Cell
2017
168: 427-441.e21
|
25328986 |
Phillips MC et al.:
Apolipoprotein E isoforms and lipoprotein metabolism
IUBMB Life
2014
66: 616-623
|
11408727 |
Dupuy AM et al.:
The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimers disease
Gerontology
2001
47: 213-218
|
25280473 |
Ashbrook DG et al.:
Joint genetic analysis of hippocampal size in mouse and human identifies a novel gene linked to neurodegenerative disease
BMC Genomics
2014
15: 850
|
24456642 |
Couttas TA et al.:
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimers disease pathogenesis
Acta Neuropathol Commun
2014
2: 9
|
10416513 |
Caramelli P et al.:
Increased apolipoprotein B serum concentration in Alzheimers disease
Acta Neurol. Scand.
1999
100: 61-63
|
24470773 |
Mielke MM et al.:
Clinical epidemiology of Alzheimers disease: assessing sex and gender differences
Clin Epidemiol
2014
6: 37-48
|
28240269 |
Suhre K et al. et al.:
Connecting genetic risk to disease end points through the human blood plasma proteome
Nat Commun
2017
8: 14357
|
21841246 |
Mosconi L et al.:
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimers disease
J. Alzheimers Dis.
2011
27: 483-490
|
25633671 |
Hull J et al.:
Regional Increase in the Expression of the BCAT Proteins in Alzheimers Disease Brain: Implications in Glutamate Toxicity
J. Alzheimers Dis.
2015
45: 891-905
|
26983404 |
Gallart-Palau X et al.:
Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimers disease with cerebrovascular disease
Mol Brain
2016
9: 27
|
26969397 |
Riedel BC et al.:
Age, APOE and sex: Triad of risk of Alzheimers disease
J. Steroid Biochem. Mol. Biol.
2016
160: 134-147
|
28107809 |
Kitamura Y et al.:
Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimers disease
Neurol. Res.
2017
39: 231-238
|
21857965 |
Obama T et al.:
Dietary cholesterol reduces plasma triacylglycerol in apolipoprotein E-null mice: suppression of lipin-1 and -2 in the glycerol-3-phosphate pathway
PLoS ONE
2011
6
|
18155511 |
Xu Z et al.:
Long-term phytosterol treatment alters gene expression in the liver of apo E-deficient mice
J. Nutr. Biochem.
2008
19: 545-554
|
17077142 |
Wang JM et al.:
Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo
Proc. Natl. Acad. Sci. U.S.A.
2006
103
|
24444806 |
Panizzon MS et al.:
Interaction of APOE genotype and testosterone on episodic memory in middle-aged men
Neurobiol. Aging
2014
35: 1778
|
21423873 |
Elliott DA et al.:
Apolipoproteins in the brain: implications for neurological and psychiatric disorders
Clin Lipidol
2010
51: 555-573
|
14741101 |
DeMattos RB et al.:
ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo
Neuron
2004
41: 193-202
|
9547226 |
Stone DJ et al.:
Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimers disease
J. Neurosci.
1998
18: 3180-3185
|
22701550 |
Song F et al.:
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals
PLoS One
2012
7
|
18395206 |
Raber J et al.:
AR, apoE, and cognitive function
Horm Behav
2008
53: 706-715
|
0 |
author information missing
article information missing
|
28248224 |
Martins IJ et al.:
The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimers Disease
|
7737971 |
Hamazaki H et al.:
Ca(2+)-dependent binding of human serum amyloid P component to Alzheimers beta-amyloid peptide
J. Biol. Chem.
1995
270
|
12214001 |
Kindy MS et al.:
Apolipoprotein Serum Amyloid A in Alzheimers Disease
J. Alzheimers Dis.
1999
1: 155-167
|
10329371 |
Chauhan VP et al.:
Binding of gelsolin, a secretory protein, to amyloid beta-protein
Biochem. Biophys. Res. Commun.
1999
258: 241-246
|
26980008 |
Ashby EL et al.:
Altered Expression of Human Mitochondrial Branched Chain Aminotransferase in Dementia with Lewy Bodies and Vascular Dementia
Neurochem. Res.
2017
42: 306-319
|
28261376 |
Griffin JW et al.:
Amino Acid Catabolism in Alzheimers Disease Brain: Friend or Foe? }, authors { names std { { name ml Griffin JW, affil str Department of Biomedical Sciences, East Tennessee State University College of Medicine, Johnson City, TN 37614, USA
Oxid Med Cell Longev
2017
2017
|
28298292 |
Chang TY et al.:
Cellular cholesterol homeostasis and Alzheimers disease
J. Lipid Res.
2017
58: 2239-2254
|
27634977 |
Pistollato F et al.:
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Nutr. Rev.
2016
74: 624-634
|
18657226 |
Ryu JK et al.:
A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimers disease brain
J. Cell. Mol. Med.
2009
13: 2911-2925
|
19863188 |
Roher AE et al.:
Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimers disease
Biomarkers
2009
14: 493-501
|
22883744 |
Cudaback E et al.:
Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
J Neuroinflammation
2012
9: 192
|
25938590 |
Fonteh AN et al.:
Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimers disease
PLoS ONE
2015
10
|
28697566 |
Johansson P et al.:
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimers Disease
|
24952994 |
Mielke MM et al.:
Cerebrospinal fluid sphingolipids, beta-amyloid, and tau in adults at risk for Alzheimers disease
Neurobiol. Aging
2014
35: 2486-2494
|
23868911 |
Fonteh AN et al.:
Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimers disease
J. Lipid Res.
2013
54: 2884-2897
|
22521584 |
Kosicek M et al.:
Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimers disease
Neurosci. Lett.
2012
516: 302-305
|
22835784 |
van Echten-Deckert G et al.:
Sphingolipids: critical players in Alzheimers disease
Prog. Lipid Res.
2012
51: 378-393
|
20953867 |
Kosicek M et al.:
Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimers disease patients--a pilot study
Anal Bioanal Chem
2010
398: 2929-2937
|
20452460 |
Haughey NJ et al.:
Roles for dysfunctional sphingolipid metabolism in Alzheimers disease neuropathogenesis
Biochim. Biophys. Acta
2010
1801: 878-886
|
20110596 |
Martin V et al.:
Lipid alterations in lipid rafts from Alzheimers disease human brain cortex
J. Alzheimers Dis.
2010
19: 489-502
|
18547682 |
He X et al.:
Deregulation of sphingolipid metabolism in Alzheimers disease
Neurobiol. Aging
2010
31: 398-408
|
17342407 |
Katsel P et al.:
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimers disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimers disease? }, authors { names std { { name ml Katsel P, affil str Department of Psychiatry, The Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029-6575, USA. pavel.katsel@mssm.edu }, { name ml Li C }, { name ml Haroutunian V } } }, from journal { title { iso-jta Neurochem. Res
Neurochem. Res.
2007
32: 845-856
|
7699335 |
Mucke L et al.:
Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein
J. Exp. Med.
1995
181: 1551-1556
|
14970312 |
Cutler RG et al.:
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimers disease
Proc. Natl. Acad. Sci. U.S.A.
2004
101: 2070-2075
|
14748735 |
Alessenko AV et al.:
Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimers disease
Biochem. Soc. Trans.
2004
32: 144-146
|
12358786 |
Han X et al.:
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimers disease: potential role in disease pathogenesis
J. Neurochem.
2002
82: 809-818
|
19036474 |
Barrier L et al.:
Gender-dependent accumulation of ceramides in the cerebral cortex of the APP(SL)/PS1Ki mouse model of Alzheimers disease
Neurobiol. Aging
2010
31: 1843-1853
|
28341160 |
Toledo JB et al.:
Metabolic network failures in Alzheimers disease-A biochemical road map
|
17888544 |
Bandaru VV et al.:
ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimers but not normal brain
Neurobiol. Aging
2009
30: 591-599
|
24368217 |
Kunzler J et al.:
APOE modulates the effect of estrogen therapy on Abeta accumulation EFAD-Tg mice
Neurosci. Lett.
2014
560: 131-136
|
24486621 |
Panchal M et al.:
Ceramides and sphingomyelinases in senile plaques
Neurobiol. Dis.
2014
65: 193-201
|
17064658 |
Park JH et al.:
Acid ceramidase and human disease
Biochim. Biophys. Acta
2006
1758: 2133-2138
|
26708713 |
Moser VA et al.:
Obesity and sex interact in the regulation of Alzheimers disease
Neurosci Biobehav Rev
2016
67: 102-118
|
24468113 |
Ceccom J et al.:
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimers disease
Acta Neuropathol Commun
2014
2: 12
|
15610181 |
Huang Y et al.:
Elevation of the level and activity of acid ceramidase in Alzheimers disease brain
Eur. J. Neurosci.
2004
20: 3489-3497
|
20409323 |
Lorenzen A et al.:
Rapid and direct transport of cell surface APP to the lysosome defines a novel selective pathway
Mol Brain
2010
3: 11
|
14709545 |
Lee JT et al.:
Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway
J. Cell Biol.
2004
164: 123-131
|
23779114 |
Hanson AJ et al.:
Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial
JAMA Neurol
2013
70: 972-980
|
21125201 |
Doruk H et al.:
The relationship between body mass index and incidental mild cognitive impairment, Alzheimers disease and vascular dementia in elderly
J Nutr Health Aging
2010
14: 834-838
|
26198711 |
Grimm A et al.:
Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-beta or hyperphosphorylated tau protein
Cell. Mol. Life Sci.
2016
73: 201-215
|
18295935 |
Schaeffer V et al.:
Dose-dependent and sequence-sensitive effects of amyloid-beta peptide on neurosteroidogenesis in human neuroblastoma cells
Neurochem. Int.
2008
52: 948-955
|
27163830 |
Kantarci K et al.:
Early Postmenopausal Transdermal 17beta-Estradiol Therapy and Amyloid-beta Deposition
J. Alzheimers Dis.
2016
53: 547-556
|
25443293 |
Dionisio PA et al.:
Amyloid-beta pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset
Neurobiol. Aging
2015
36: 228-240
|
20569235 |
Jazwinski SM et al.:
HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging
Aging Cell
2010
9: 698-708
|
28035926 |
den Hoedt S et al.:
Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels
|
22470521 |
Grimm MO et al.:
Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimers disease pathology with ganglioside metabolism
PLoS ONE
2012
7
|
21543615 |
Takasugi N et al.:
BACE1 activity is modulated by cell-associated sphingosine-1-phosphate
J. Neurosci.
2011
31: 6850-6857
|
28301062 |
Enche Ady CNA et al.:
Metabolomic-guided discovery of Alzheimers disease biomarkers from body fluid
J. Neurosci. Res.
2017
95: 2005-2024
|
15084661 |
Kawarabayashi T et al.:
Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimers disease
J. Neurosci.
2004
24: 3801-3809
|
18096814 |
Williamson R et al.:
Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism
FASEB J.
2008
22: 1552-1559
|
20739292 |
Lefterov I et al.:
Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice
J. Biol. Chem.
2010
285
|
27033548 |
Hong S et al.:
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Science
2016
352: 712-716
|
18048067 |
Walker DG et al.:
Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimers disease
Microvasc. Res.
2008
75: 411-419
|
7575468 |
Munger JS et al.:
Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S
Biochem. J.
1995
311: 299-305
|
11004532 |
Oyama R et al.:
Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimers disease brain by immunoprecipitation
Biochim. Biophys. Acta
2000
1479: 91-102
|
25206748 |
Zhou X et al.:
Lipid rafts participate in aberrant degradative autophagic-lysosomal pathway of amyloid-beta peptide in Alzheimers disease
Neural Regen Res
2014
9: 92-100
|
16480949 |
Chen TY et al.:
The intracellular domain of amyloid precursor protein interacts with flotillin-1, a lipid raft protein
Biochem. Biophys. Res. Commun.
2006
342: 266-272
|
27814578 |
Canerina-Amaro A et al.:
Lipid raft ER signalosome malfunctions in menopause and Alzheimers disease
Front Biosci (Schol Ed)
2017
9: 111-126
|
2207271 |
Colombo MF et al.:
Hydration-dependent conformational states of hemoglobin. Equilibrium and kinetic behavior
Biophys. Chem.
1990
36: 33-39
|
9354781 |
author information missing
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
Nat. Genet.
1997
17: 263-264
|
22737128 |
Hicks DA et al.:
Lipid rafts and Alzheimers disease: protein-lipid interactions and perturbation of signaling
Front Physiol
2012
3: 189
|
24625793 |
Tiwari V et al.:
Pyruvate carboxylase and pentose phosphate fluxes are reduced in AbetaPP-PS1 mouse model of Alzheimers disease: a (1)(3)C NMR study
J. Alzheimers Dis.
2014
41: 387-399
|
18539594 |
Osenkowski P et al.:
Direct and potent regulation of gamma-secretase by its lipid microenvironment
J. Biol. Chem.
2008
283
|
20798852 |
Bjerke M et al.:
Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid
|
20961856 |
Belyaev ND et al.:
The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway
J. Biol. Chem.
2010
285
|
19028695 |
Cheng H et al.:
S-palmitoylation of gamma-secretase subunits nicastrin and APH-1
J. Biol. Chem.
2009
284: 1373-1384
|
29211722 |
Sorrentino V et al.:
Enhancing mitochondrial proteostasis reduces amyloid-beta proteotoxicity
|
26680489 |
Vankova M et al.:
Reduced sulfotransferase SULT2A1 activity in patients with Alzheimers disease
Physiol Res
2015
64: Suppl 2 S265-S273
|
26704533 |
Vankova M et al.:
Preliminary evidence of altered steroidogenesis in women with Alzheimers disease: Have the patients OLDER adrenal zona reticularis? }, authors { names std { { name ml Vankova M, affil str Institute of Endocrinology, Narodni 8, Prague 116 94, Czech Republic. Electronic address: mvankova@endo.cz
J. Steroid Biochem. Mol. Biol.
2016
158: 157-177
|
11427315 |
Schonknecht P et al.:
Reduced cerebrospinal fluid estradiol levels are associated with increased beta-amyloid levels in female patients with Alzheimers disease
Neurosci. Lett.
2001
307: 122-124
|
19186121 |
Davis CH et al.:
Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study
Biophys. J.
2009
96: 785-797
|
16721824 |
Kim SI et al.:
Amyloid beta oligomerization is induced by brain lipid rafts
J. Cell. Biochem.
2006
99: 878-889
|
15718041 |
Pitto M et al.:
Enhanced GM1 ganglioside catabolism in cultured fibroblasts from Alzheimer patients
Neurobiol. Aging
2005
26: 833-838
|
22146133 |
Aly HF et al.:
Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimers disease
Acta Biochim. Pol.
2011
58: 513-520
|
28377712 |
Xia DY et al.:
PGC-1alpha or FNDC5 Is Involved in Modulating the Effects of Abeta1-42 Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, Abeta Deposition and Cognitive Decline of APP/PS1 Tg Mice
Front Aging Neurosci
2017
9: 65
|
26334640 |
Cieslik M et al.:
The Molecular Mechanism of Amyloid beta42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins
PLoS ONE
2015
10
|
29249916 |
Marksteiner J et al.:
Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimers disease
Metabolomics
2018
14: 1
|
11551970 |
Mathews PM et al.:
Alzheimers disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis
J. Biol. Chem.
2002
277: 5299-5307
|
16399207 |
Kar S et al.:
Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimers disease pathology
Neurobiol. Aging
2006
27: 199-210
|
26993302 |
Wang Y et al.:
Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases
Mol. Neurobiol.
2017
54: 2636-2658
|
20050287 |
Martins IJ et al.:
Cholesterol metabolism and transport in the pathogenesis of Alzheimers disease
J. Neurochem.
2009
111: 1275-1308
|
28941727 |
Fernandez-de Retana S et al.:
Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimers disease
Neurobiol. Aging
2017
60: 116-128
|
26923602 |
Ben Halima S et al.:
Specific Inhibition of beta-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
Cell Rep
2016
14: 2127-2141
|
27333034 |
Letronne F et al.:
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimers Disease
EBioMedicine
2016
9: 278-292
|
27396345 |
Becker-Pauly C et al.:
Mice are not Men: ADAM30 Findings Emphasize a Broader Look Towards Murine Alzheimers Disease Models
EBioMedicine
2016
9: 19-20
|
18177262 |
Schechter I et al.:
Kinetic properties of cathepsin D and BACE 1 indicate the need to search for additional beta-secretase candidate(s)
Biol. Chem.
2008
389: 313-320
|
11741391 |
Petit-Turcotte C et al.:
Apolipoprotein C-I expression in the brain in Alzheimers disease
Neurobiol. Dis.
2001
8: 953-963
|
10828089 |
Demeester N et al.:
Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimers disease
J. Lipid Res.
2000
41: 963-974
|
20413849 |
Kim WS et al.:
Increased ATP-binding cassette transporter A1 expression in Alzheimers disease hippocampal neurons
J. Alzheimers Dis.
2010
21: 193-205
|
17361034 |
Strum JC et al.:
Rosiglitazone induces mitochondrial biogenesis in mouse brain
J. Alzheimers Dis.
2007
11: 45-51
|
26117841 |
Abdullah MM et al.:
Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era
Nutr. Rev.
2015
73: 523-543
|
29115990 |
Martiskainen H et al.:
DHCR24 exerts neuroprotection upon inflammation-induced neuronal death
J Neuroinflammation
2017
14: 215
|
26628388 |
Hernandez-Jimenez M et al.:
Seladin-1/DHCR24 Is Neuroprotective by Associating EAAT2 Glutamate Transporter to Lipid Rafts in Experimental Stroke
Stroke
2016
47: 206-213
|
22910610 |
Feher A et al.:
Gender dependent effect of DHCR24 polymorphism on the risk for Alzheimers disease
Neurosci. Lett.
2012
526: 20-23
|
15954227 |
Peri A et al.:
Seladin-1 as a target of estrogen receptor activation in the brain: a new gene for a rather old story? }, authors { names std { { name ml Peri A, affil str Department of Clinical Physiopathology, Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies, University of Florence, Italy. a.peri@dfc.unifi.it }, { name ml Danza G }, { name ml Serio M } } }, from journal { title { iso-jta J. Endocrinol. Invest
J. Endocrinol. Invest.
2005
28: 285-293
|
19597241 |
Drzewinska J et al.:
[Seladin-1/DHCR24: a key protein of cell homeostasis and cholesterol biosynthesis]
Postepy Hig Med Dosw (Online)
2009
63: 318-330
|
18194465 |
Cecchi C et al.:
Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content
J. Cell. Mol. Med.
2008
12: 1990-2002
|
20061018 |
Alberdi E et al.:
Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors
Cell Calcium
2010
47: 264-272
|
25339759 |
Shibuya Y et al.:
Inhibiting ACAT1/SOAT1 in microglia stimulates autophagy-mediated lysosomal proteolysis and increases Abeta1-42 clearance
J. Neurosci.
2014
34
|
29559883 |
Marin R et al.:
Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause
Front Neurosci
2018
12: 128
|
25168729 |
Fernandez-Echevarria C et al.:
Abeta promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimers disease
Neuroscience
2014
278: 354-366
|
28102888 |
Chen LH et al.:
Genetic Polymorphisms in Estrogen Metabolic Pathway Associated with Risks of Alzheimers Disease: Evidence from a Southern Chinese Population
J Am Geriatr Soc
2017
65: 332-339
|
27541017 |
Li Q et al.:
miR-98-5p Acts as a Target for Alzheimers Disease by Regulating Abeta Production Through Modulating SNX6 Expression
J. Mol. Neurosci.
2016
60: 413-420
|
23872114 |
Chua LM et al.:
The Kunitz-protease inhibitor domain in amyloid precursor protein reduces cellular mitochondrial enzymes expression and function
Biochem. Biophys. Res. Commun.
2013
437: 642-647
|
15882808 |
Thakur MK et al.:
Estradiol regulates APP mRNA alternative splicing in the mice brain cortex
Neurosci. Lett.
2005
381: 154-157
|
15357665 |
Feng Z et al.:
Long-term effects of melatonin or 17 beta-estradiol on improving spatial memory performance in cognitively impaired, ovariectomized adult rats
J. Pineal Res.
2004
37: 198-206
|
9223340 |
Xia W et al.:
Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease
Proc. Natl. Acad. Sci. U.S.A.
1997
94: 8208-8213
|
28731435 |
Hong H et al.:
Identification of Circulating miR-125b as a Potential Biomarker of Alzheimers Disease in APP/PS1 Transgenic Mouse
J. Alzheimers Dis.
2017
59: 1449-1458
|
26497032 |
Ren RJ et al.:
Peripheral Blood MicroRNA Expression Profiles in Alzheimers Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism
Mol. Neurobiol.
2016
53: 5772-5781
|
8239286 |
Higgins LS et al.:
Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimers disease-like histopathology
Ann. N. Y. Acad. Sci.
1993
695: 224-227
|
20417581 |
Ishunina TA et al.:
Decreased alternative splicing of estrogen receptor-alpha mRNA in the Alzheimers disease brain
Neurobiol. Aging
2012
33: 286-296.e3
|
29869871 |
DelBove CE et al.:
The Fate of Nascent APP in Hippocampal Neurons: A Live Cell Imaging Study
ACS Chem Neurosci
2018
9: 2225-2232
|
2111579 |
Johnson SA et al.:
Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimers disease
Science
1990
248: 854-857
|
2881207 |
author information missing
The precursor of Alzheimers disease amyloid A4 protein resembles a cell-surface receptor
Nature
1987
325: 733-736
|
23684647 |
Nalivaeva NN et al.:
The amyloid precursor protein: a biochemical enigma in brain development, function and disease
FEBS Lett.
2013
587: 2046-2054
|
25695604 |
Shu R et al. et al.:
APP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation
Cell Death Dis
2015
6: e1651
|
21172309 |
Long JM et al.:
MicroRNA-101 downregulates Alzheimers amyloid-beta precursor protein levels in human cell cultures and is differentially expressed
Biochem. Biophys. Res. Commun.
2011
404: 889-895
|
22733824 |
Long JM et al.:
MicroRNA-153 physiologically inhibits expression of amyloid-beta precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients
J. Biol. Chem.
2012
287
|
11441186 |
Cao X et al.:
A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60
Science
2001
293: 115-120
|
21293490 |
Xu X et al.:
Mediator is a transducer of amyloid-precursor-protein-dependent nuclear signalling
EMBO Rep.
2011
12: 216-222
|
10718932 |
Bowen RL et al.:
An association of elevated serum gonadotropin concentrations and Alzheimer disease?
J. Neuroendocrinol.
2000
12: 351-354
|
11560301 |
Short RA et al.:
Elevated gonadotropin levels in patients with Alzheimer disease
Mayo Clin. Proc.
2001
76: 906-909
|
12391612 |
Bowen RL et al.:
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimers disease pathology
J. Neurosci. Res.
2002
70: 514-518
|
21368841 |
Turner AJ et al.:
Mediator: the missing link in amyloid precursor protein nuclear signalling
EMBO Rep.
2011
12: 180-181
|
15886752 |
Tsolaki M et al.:
Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimers dementia
Hell J Nucl Med
2005
8: 39-42
|
26895791 |
Sajan M et al.:
Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1alpha and Increases in Abeta1-40/42 and Phospho-Tau May Abet Alzheimer Development
Diabetes
2016
65: 1892-1903
|
24832605 |
Wang X et al.:
FoxO mediates APP-induced AICD-dependent cell death
Cell Death Dis
2014
5: e1233
|
19478482 |
Corbo RM et al.:
Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimers disease in women
Dement Geriatr Cogn Disord
2009
27: 513-518
|
21297427 |
Erten-Lyons D et al.:
Microcephaly genes and risk of late-onset Alzheimer disease
Alzheimer Dis Assoc Disord
2011
25: 276-282
|
24567336 |
Akhter R et al.:
The essential role of p53-up-regulated modulator of apoptosis (Puma) and its regulation by FoxO3a transcription factor in beta-amyloid-induced neuron death
J. Biol. Chem.
2014
289
|
12600719 |
Ueberham U et al.:
Cyclin C expression is involved in the pathogenesis of Alzheimers disease
Neurobiol. Aging
2003
24: 427-435
|
26455863 |
Fluteau A et al.:
The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain
Neurosci. Lett.
2015
609: 11-17
|
21354436 |
Herrera JL et al.:
Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity
Steroids
2011
76: 840-844
|
27507672 |
Oikonomidi A et al.:
Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta
J. Neurochem.
2016
139: 324-332
|
8624099 |
Sandbrink R et al.:
APP gene family. Alternative splicing generates functionally related isoforms
Ann. N. Y. Acad. Sci.
1996
777: 281-287
|
21865747 |
Corbo RM et al.:
Influence of variation in the follicle-stimulating hormone receptor gene (FSHR) and age at menopause on the development of Alzheimers disease in women
Dement Geriatr Cogn Disord
2011
32: 63-69
|
28538088 |
Koenig AM et al.:
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study
Alzheimer Dis Assoc Disord
2017
31: 107-113
|
21839813 |
Yenkoyan K et al.:
Neuroprotective action of proline-rich polypeptide-1 in beta-amyloid induced neurodegeneration in rats
Brain Res. Bull.
2011
86: 262-271
|
9202320 |
Keller JN et al.:
Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal
J. Neurochem.
1997
69: 273-284
|
29055815 |
An Y et al. et al.:
Evidence for brain glucose dysregulation in Alzheimers disease
Alzheimers Dement
2018
14: 318-329
|
17023091 |
Hartai Z et al.:
Decreased serum and red blood cell kynurenic acid levels in Alzheimers disease
Neurochem. Int.
2007
50: 308-313
|
23274895 |
Arrieta-Cruz I et al.:
Evidence for a role of proline and hypothalamic astrocytes in the regulation of glucose metabolism in rats
Diabetes
2013
62: 1152-1158
|
26047665 |
Liemburg-Apers DC et al.:
Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism
Arch. Toxicol.
2015
89: 1209-1226
|
19595769 |
Ramirez CM et al.:
VDAC and ERalpha interaction in caveolae from human cortex is altered in Alzheimers disease
Mol. Cell. Neurosci.
2009
42: 172-183
|
20053478 |
Zhao L et al.:
17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimers prevention
Neurobiol. Aging
2011
32: 1949-1963
|
10213152 |
Kamboh MI et al.:
A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimers disease
Neurosci. Lett.
1999
263: 129-132
|
20547867 |
Chen Y et al.:
ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
27103636 |
Sweet RA et al. et al.:
Apolipoprotein E*4 (APOE*4) Genotype Is Associated with Altered Levels of Glutamate Signaling Proteins and Synaptic Coexpression Networks in the Prefrontal Cortex in Mild to Moderate Alzheimer Disease
Mol. Cell Proteomics
2016
15: 2252-2262
|
10801051 |
Trioche P et al.:
Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia
J. Inherit. Metab. Dis.
2000
23: 107-112
|
2935594 |
author information missing
Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntingtons disease and Alzheimer-type dementia
J. Neurol. Sci.
1985
71: 137-143
|
27392855 |
Bangen KJ et al.:
Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimers Disease Pathology
J. Alzheimers Dis.
2016
53: 1553-1562
|
27328687 |
Yamazaki Y et al.:
Apolipoprotein E as a Therapeutic Target in Alzheimers Disease: A Review of Basic Research and Clinical Evidence
CNS Drugs
2016
30: 773-789
|
29946028 |
Prasad H et al.:
Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH
Proc. Natl. Acad. Sci. U.S.A.
2018
115
|
25561733 |
Prasad H et al.:
The Na+/H+ exchanger NHE6 modulates endosomal pH to control processing of amyloid precursor protein in a cell culture model of Alzheimer disease
J. Biol. Chem.
2015
290: 5311-5327
|
30337151 |
MahmoudianDehkordi S et al. et al.:
Altered bile acid profile associates with cognitive impairment in Alzheimers disease-An emerging role for gut microbiome
|
23340677 |
Schousboe A et al.:
Glutamate metabolism in the brain focusing on astrocytes
Adv Neurobiol
2014
11: 13-30
|
27740595 |
Hawkins RA et al.:
How Glutamate Is Managed by the Blood-Brain Barrier
|
29476033 |
Ekblad LL et al.:
Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation
Neurology
2018
90
|
20452985 |
Munter LM et al.:
Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif
J. Biol. Chem.
2010
285
|
26402005 |
Keeney JT et al.:
Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimers Disease Prevention and Early Intervention
J. Alzheimers Dis.
2015
48: 411-424
|
30032423 |
Uddin MS et al.:
APOE and Alzheimers Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimers Pathogenesis
Mol. Neurobiol.
2019
56: 2450-2465
|
30134963 |
Yi D et al.:
Synergistic interaction between APOE and family history of Alzheimers disease on cerebral amyloid deposition and glucose metabolism
Alzheimers Res Ther
2018
10: 84
|
28934977 |
Chhibber A et al.:
ERbeta and ApoE isoforms interact to regulate BDNF-5-HT2A signaling and synaptic function in the female brain
Alzheimers Res Ther
2017
9: 79
|
28272510 |
Johnson LA et al.:
Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome
Sci Rep
2017
7: 43701
|
28434655 |
Zhao N et al.:
Apolipoprotein E, Receptors, and Modulation of Alzheimers Disease
Biol. Psychiatry
2018
83: 347-357
|
29967007 |
Wu L et al.:
Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimers Disease Risk Reduction and Early Intervention
J. Neurosci.
2018
38: 6665-6681
|
14966149 |
Mosconi L et al.:
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimers disease
J. Neurol. Neurosurg. Psychiatry
2004
75: 370-376
|
30337152 |
Nho K et al. et al.:
Altered bile acid profile in mild cognitive impairment and Alzheimers disease: Relationship to neuroimaging and CSF biomarkers
Alzheimers Dement
2019
15: 232-244
|
30441866 |
Giau VV et al.:
Gut Microbiota and Their Neuroinflammatory Implications in Alzheimers Disease
|
30182854 |
Junges VM et al.:
Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimers Disease
Curr Alzheimer Res
2018
15: 1179-1190
|
27604604 |
Kohler CA et al.:
The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimers Disease
Curr. Pharm. Des.
2016
22: 6152-6166
|
28937600 |
Del Rio D et al.:
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
|
30138667 |
de J R De-Paula V et al.:
Relevance of gutmicrobiota in cognition, behaviour and Alzheimers disease
Pharmacol. Res.
2018
136: 29-34
|
27255810 |
Ciavardelli D et al.:
Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimers disease subjects
Neurobiol. Aging
2016
43: 1-12
|
27566465 |
Hu X et al.:
Alzheimers disease and gut microbiota
Sci China Life Sci
2016
59: 1006-1023
|
22392034 |
Wang CC et al.:
The role of PGC-1 and Apoepsilon4 in insomnia
Psychiatr. Genet.
2012
22: 82-87
|
19749434 |
Cimini A et al.:
Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimers disease: a role for peroxisomes
J. Alzheimers Dis.
2009
18: 935-952
|
29758946 |
Zhuang ZQ et al. et al.:
Gut Microbiota is Altered in Patients with Alzheimers Disease
J. Alzheimers Dis.
2018
63: 1337-1346
|
28461186 |
Fan YY et al.:
APOE epsilon4 allele elevates the expressions of inflammatory factors and promotes Alzheimers disease progression: A comparative study based on Han and She populations in the Wenzhou area
Brain Res. Bull.
2017
132: 39-43
|
24990149 |
Guedes JR et al.:
Early miR-155 upregulation contributes to neuroinflammation in Alzheimers disease triple transgenic mouse model
Hum. Mol. Genet.
2014
23: 6286-6301
|
21377451 |
Zhou J et al.:
Paeonol increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimers disease
Brain Res.
2011
1388: 141-147
|
29627302 |
Zhao H et al.:
Inhibitive Effect of Resveratrol on the Inflammation in Cultured Astrocytes and Microglia Induced by Abeta1-42
Neuroscience
2018
379: 390-404
|
24145446 |
Theendakara V et al. et al.:
Neuroprotective Sirtuin ratio reversed by ApoE4
Proc. Natl. Acad. Sci. U.S.A.
2013
110
|
29575030 |
Bauerl C et al.:
Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimers disease during lifespan
Lett. Appl. Microbiol.
2018
66: 464-471
|
29051531 |
Vogt NM et al.:
Gut microbiome alterations in Alzheimers disease
Sci Rep
2017
7: 13537
|
19631758 |
Reiman EM et al.:
Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimers disease and normal aging
Neuroimage
2010
49: 169-176
|
28982335 |
Metaxas A et al.:
Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APPswe/PSEN1dE9 Mice
Curr Alzheimer Res
2018
15: 420-428
|
18322398 |
Counts SE et al.:
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimers disease
Neurodegener Dis
2008
5: 228-231
|
26592823 |
Zhang B et al.:
MiR-16 regulates cell death in Alzheimers disease by targeting amyloid precursor protein
Eur Rev Med Pharmacol Sci
2015
19: 4020-4027
|
26449188 |
Yun HM et al.:
Serotonin 6 receptor controls Alzheimers disease and depression
Oncotarget
2015
6
|
29703883 |
Kitzlerova E et al.:
Interactions Among Polymorphisms of Susceptibility Loci for Alzheimers Disease or Depressive Disorder
Med. Sci. Monit.
2018
24: 2599-2619
|
21926624 |
Enache D et al.:
Depression in dementia: epidemiology, mechanisms, and treatment
Curr Opin Psychiatry
2011
24: 461-472
|
12052537 |
Emilsson L et al.:
Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimers disease patients
Neurosci. Lett.
2002
326: 56-60
|
12098640 |
Takehashi M et al.:
Association of monoamine oxidase A gene polymorphism with Alzheimers disease and Lewy body variant
Neurosci. Lett.
2002
327: 79-82
|
17692293 |
Wu YH et al.:
A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimers disease patients
Brain Res.
2007
1167: 13-19
|
30692905 |
Forny-Germano L et al.:
The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimers Disease
Front Neurosci
2019
12: 1027
|
29929471 |
Chang YS et al.:
Higher levels of thyroxine may predict a favorable response to donepezil treatment in patients with Alzheimer disease: a prospective, case-control study
BMC Neurosci
2018
19: 36
|
11155096 |
Kalmijn S et al.:
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
Clin. Endocrinol. (Oxf)
2000
53: 733-737
|
28124751 |
Farbood Y et al.:
Peripheral and central administration of T3 improved the histological changes, memory and the dentate gyrus electrophysiological activity in an animal model of Alzheimers disease
Metab Brain Dis
2017
32: 693-701
|
29481662 |
McAninch EA et al.:
A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans
J. Clin. Endocrinol. Metab.
2018
103: 1818-1826
|
17105838 |
de Jong FJ et al.:
The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe
J. Clin. Endocrinol. Metab.
2007
92: 636-640
|
25735998 |
Wang T et al.:
TNF-alpha G308A polymorphism and the susceptibility to Alzheimers disease: an updated meta-analysis
Arch. Med. Res.
2015
46: 24-30.e1
|
28294066 |
Shukla M et al.:
Mechanisms of Melatonin in Alleviating Alzheimers Disease
Curr Neuropharmacol
2017
15: 1010-1031
|
29774516 |
Fu X et al.:
Periodic Variation of AAK1 in an Abeta1-42-Induced Mouse Model of Alzheimers Disease
J. Mol. Neurosci.
2018
65: 179-189
|
29376091 |
Kjeldsen EW et al.:
ABCA7 and risk of dementia and vascular disease in the Danish population
Ann Clin Transl Neurol
2017
5: 41-51
|
25594074 |
Rohn TT et al.:
Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?
|
20946940 |
Patel A et al.:
Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimers disease in subjects with Down syndrome
Neurosci. Lett.
2011
487: 144-148
|
21098978 |
Sherva R et al.:
Identification of novel candidate genes for Alzheimers disease by autozygosity mapping using genome wide SNP data
J Alzheimers Dis
2011
23: 349-359
|
30898171 |
Smith AR et al.:
Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimers disease
Clin Epigenetics
2019
11: 52
|
17687027 |
Romito-DiGiacomo RR et al.:
Effects of Alzheimers disease on different cortical layers: the role of intrinsic differences in Abeta susceptibility
J. Neurosci.
2007
27: 8496-8504
|
31618972 |
Psemeneckiene G et al.:
Polymorphisms of Proinflammatory Cytokines in Relation to APOE Epsilon 4 and Risk of Alzheimers Disease in the Lithuanian Population
|
24671632 |
Chin D et al.:
Adenosine triphosphate concentrations are higher in the brain of APOE3- compared to APOE4-targeted replacement mice and can be modulated by curcumin
Genes Nutr
2014
9: 397
|
26564908 |
Tambini MD et al.:
ApoE4 upregulates the activity of mitochondria-associated ER membranes
EMBO Rep.
2016
17: 27-36
|
22730380 |
Cash JG et al.:
Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress
J. Biol. Chem.
2012
287
|
28333036 |
Abdullah L et al.:
APOE epsilon4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimers Disease
Aging (Albany NY)
2017
9: 964-985
|
30804776 |
Fernandez CG et al.:
The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimers Disease
Front Aging Neurosci
2019
11: 14
|
26993346 |
Schott JM et al. et al.:
Genetic risk factors for the posterior cortical atrophy variant of Alzheimers disease
Alzheimers Dement
2016
12: 862-871
|
26374899 |
Atagi Y et al. et al.:
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
J. Biol. Chem.
2015
290
|
24386905 |
Tai LM et al.:
Soluble apoE/Abeta complex: mechanism and therapeutic target for APOE4-induced AD risk
Mol Neurodegener
2014
9: 2
|
30127720 |
Konishi H et al.:
Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases
Front Cell Neurosci
2018
12: 206
|
28164773 |
Shackleton B et al.:
Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimers Disease
Curr Alzheimer Res
2017
14: 578-585
|
30836275 |
Manzine PR et al.:
ADAM10 in Alzheimers disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
Biomed. Pharmacother.
2019
113
|
31980586 |
Meilandt WJ et al. et al.:
Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Abeta42:Abeta40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimers mouse model
|
28930663 |
Krasemann S et al. et al.:
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Immunity
2017
47: 566-581.e9
|
31130847 |
Muth C et al.:
Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro
Front Cell Neurosci
2019
13: 181
|
30038567 |
Zhou Y et al.:
TREM2-Dependent Effects on Microglia in Alzheimers Disease
Front Aging Neurosci
2018
10: 202
|
27239545 |
Guedes JR et al.:
MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimers disease
Alzheimers Dement (Amst)
2015
3: 7-17
|
25593125 |
Li X et al.:
Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia
FASEB J.
2015
29: 1754-1762
|
27636840 |
Musunuri S et al.:
Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimers Disease Brain
J. Alzheimers Dis.
2016
54: 1671-1686
|
31640095 |
Wong MWK et al.:
APOE Genotype Differentially Modulates Plasma Lipids in Healthy Older Individuals, with Relevance to Brain Health
J. Alzheimers Dis.
2019
72: 703-716
|
27087442 |
Zhou M et al. et al.:
APOE4 Induces Site-Specific Tau Phosphorylation Through Calpain-CDK5 Signaling Pathway in EFAD-Tg Mice
Curr Alzheimer Res
2016
13: 1048-1055
|
28959956 |
Shi Y et al. et al.:
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Nature
2017
549: 523-527
|
30314521 |
Sierksma A et al.:
Deregulation of neuronal miRNAs induced by amyloid-beta or TAU pathology
Mol Neurodegener
2018
13: 54
|
32123170 |
Arnold M et al. et al.:
Sex and APOE epsilon4 genotype modify the Alzheimers disease serum metabolome
Nat Commun
2020
11: 1148
|
27457486 |
Dose J et al.:
APOE genotype and stress response - a mini review
Lipids Health Dis
2016
15: 121
|
29340569 |
Apostolova LG et al. et al.:
Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis
JAMA Neurol
2018
75: 328-341
|
31848472 |
Luo J et al.:
Mechanisms and regulation of cholesterol homeostasis
|
30590907 |
Lee S et al.:
The Interface Between ER and Mitochondria: Molecular Compositions and Functions
Mol. Cells
2018
41: 1000-1007
|
27235807 |
Area-Gomez E et al.:
Mitochondria-associated ER membranes and Alzheimer disease
Curr. Opin. Genet. Dev.
2016
38: 90-96
|
26639975 |
Malishkevich A et al.:
Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimers Disease Biomarkers
J. Alzheimers Dis.
2016
50: 249-260
|
22832961 |
Kamboh MI et al. et al.:
Genome-wide association study of Alzheimers disease
Transl Psychiatry
2012
2: e117
|
21786198 |
Chakroborty S et al.:
Early calcium dysregulation in Alzheimers disease: setting the stage for synaptic dysfunction
Sci China Life Sci
2011
54: 752-762
|
30883359 |
Orr AL et al.:
Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function
J. Alzheimers Dis.
2019
68: 991-1011
|
31052389 |
Suidan GL et al.:
Targeting Apolipoprotein E for Alzheimers Disease: An Industry Perspective
|
11447277 |
Huang Y et al.:
Apolipoprotein E fragments present in Alzheimers disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons
Proc. Natl. Acad. Sci. U.S.A.
2001
98: 8838-8843
|
16344479 |
Chang S et al.:
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
Proc. Natl. Acad. Sci. U.S.A.
2005
102
|
23867607 |
Rohn TT et al.:
Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimers disease
Int J Mol Sci
2013
14
|
19695092 |
Nakamura T et al.:
Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells
Mol Neurodegener
2009
4: 35
|
12939405 |
Harris FM et al. et al.:
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimers disease-like neurodegeneration and behavioral deficits in transgenic mice
Proc. Natl. Acad. Sci. U.S.A.
2003
100
|
30028014 |
Chernick D et al.:
High-density lipoprotein mimetic peptide 4F mitigates amyloid-beta-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia
J. Neurochem.
2018
147: 647-662
|
30444064 |
Stopnicki B et al.:
Helper CD4 T cells expressing granzyme B cause glial fibrillary acidic protein fragmentation in astrocytes in an MHCII-independent manner
Glia
2019
67: 582-593
|
8819138 |
Haug LS et al.:
Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimers disease cerebral cortex: selectivity of changes and possible correlation to pathological severity
Neurodegeneration
1996
5: 169-176
|
29253316 |
Egorova PA et al.:
Inositol 1,4,5-trisphosphate receptors and neurodegenerative disorders
FEBS J.
2018
285: 3547-3565
|
18478527 |
Wojda U et al.:
Calcium ions in neuronal degeneration
IUBMB Life
2008
60: 575-590
|
26372964 |
Zhu L et al.:
Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimers disease pathogenesis
Proc. Natl. Acad. Sci. U.S.A.
2015
112
|
27277824 |
Mahley RW et al.:
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
J. Mol. Med.
2016
94: 739-746
|
31306119 |
Simonovitch S et al.:
The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo
J. Alzheimers Dis.
2019
70: 861-875
|
1663746 |
Mattson MP et al.:
Effects of elevated intracellular calcium levels on the cytoskeleton and tau in cultured human cortical neurons
Mol. Chem. Neuropathol.
1991
15: 117-142
|
26213471 |
Giau VV et al.:
Role of apolipoprotein E in neurodegenerative diseases
Neuropsychiatr Dis Treat
2015
11: 1723-1737
|
28424375 |
Ventura-Clapier R et al.:
Mitochondria: a central target for sex differences in pathologies
Clin. Sci.
2017
131: 803-822
|
19075583 |
Muller T et al.:
Disease state, age, sex, and post-mortem time-dependent expression of proteins in AD vs. control frontal cortex brain samples
Curr Alzheimer Res
2008
5: 562-571
|
20157261 |
Mueller C et al.:
The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimers disease
J. Alzheimers Dis.
2010
19: 1081-1091
|
30890171 |
Safieh M et al.:
ApoE4: an emerging therapeutic target for Alzheimers disease
BMC Med
2019
17: 64
|
16369530 |
Rovelet-Lecrux A et al. et al.:
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy
Nat. Genet.
2006
38: 24-26
|
30507579 |
Reed MJ et al.:
Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimers Disease
J. Alzheimers Dis.
2019
67: 91-102
|
11053967 |
Savaskan E et al.:
Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimers disease
Eur. Neurol.
2000
44: 172-180
|
17564960 |
Liu F et al. et al.:
A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population
Am. J. Hum. Genet.
2007
81: 17-31
|
20858966 |
Gahete MD et al.:
Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimers disease patients
J. Alzheimers Dis.
2010
22: 819-828
|
21681798 |
Hata S et al. et al.:
Alternative processing of gamma-secretase substrates in common forms of mild cognitive impairment and Alzheimers disease: evidence for gamma-secretase dysfunction
Ann. Neurol.
2011
69: 1026-1031
|
26384575 |
Feher A et al.:
Genetic analysis of the RELN gene: Gender specific association with Alzheimers disease
Psychiatry Res
2015
230: 716-718
|
28821390 |
Ramakrishnan V et al.:
PSEN1 gene polymorphisms in Caucasian Alzheimers disease: A meta-analysis
Clin. Chim. Acta
2017
473: 65-70
|
29885764 |
Wachinger C et al.:
A Longitudinal Imaging Genetics Study of Neuroanatomical Asymmetry in Alzheimers Disease
Biol. Psychiatry
2018
84: 522-530
|
31068785 |
Brooks LRK et al.:
Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimers Disease
Front Neurosci
2019
13: 392
|
32160551 |
Yasukawa T et al.:
NRBP1-Containing CRL2/CRL4A Regulates Amyloid beta Production by Targeting BRI2 and BRI3 for Degradation
Cell Rep
2020
30: 3478-3491.e6
|
30480246 |
Dolfe L et al. et al.:
The Bri2 and Bri3 BRICHOS Domains Interact Differently with Abeta42 and Alzheimer Amyloid Plaques
J Alzheimers Dis Rep
2018
2: 27-39
|
19874264 |
Zhong N et al.:
Understanding the basis for the association of apoE4 with Alzheimers disease: opening the door for therapeutic approaches
Curr Alzheimer Res
2009
6: 415-418
|
15312168 |
Irizarry MC et al.:
Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein
J. Neurochem.
2004
90: 1132-1143
|
9067471 |
Ishii K et al. et al.:
Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimers disease
Brain Res.
1997
748: 250-252
|
8602762 |
Gearing M et al.:
Abeta-peptide length and apolipoprotein E genotype in Alzheimers disease
Ann. Neurol.
1996
39: 395-399
|
27884212 |
Kehoe PG et al.:
Angiotensin-converting enzyme 2 is reduced in Alzheimers disease in association with increasing amyloid-beta and tau pathology
Alzheimers Res Ther
2016
8: 50
|
29196815 |
Mroczko B et al.:
Amyloid beta oligomers (AbetaOs) in Alzheimers disease
J Neural Transm (Vienna)
2018
125: 177-191
|
30541599 |
Kant S et al.:
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimers disease
Fluids Barriers CNS
2018
15: 34
|
29755342 |
Lejri I et al.:
Mitochondria, Estrogen and Female Brain Aging
Front Aging Neurosci
2018
10: 124
|
25720398 |
Le Page A et al.:
NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimers Disease Patients
J. Alzheimers Dis.
2015
46: 93-107
|
15225622 |
Yamamoto N et al.:
Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain
FEBS Lett.
2004
569: 135-139
|
29272008 |
Xu D et al.:
Apolipoprotein E 4 triggers multiple pathway-mediated Ca2+ overload, causes CaMK II phosphorylation abnormity and aggravates oxidative stress caused cerebral cortical neuron damage
Eur Rev Med Pharmacol Sci
2017
21: 5717-5728
|
27358062 |
Ayers KL et al.:
A loss of function variant in CASP7 protects against Alzheimers disease in homozygous APOE epsilon4 allele carriers
BMC Genomics
2016
17: Suppl 2 445
|
28985224 |
Rehker J et al. et al.:
Caspase-8, association with Alzheimers Disease and functional analysis of rare variants
PLoS ONE
2017
12
|
30850702 |
Mouchard A et al.:
ApoE-fragment/Abeta heteromers in the brain of patients with Alzheimers disease
Sci Rep
2019
9: 3989
|
18845536 |
Roychaudhuri R et al.:
Amyloid beta-protein assembly and Alzheimer disease
J. Biol. Chem.
2009
284: 4749-4753
|
23620513 |
Verghese PB et al.:
ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions
Proc. Natl. Acad. Sci. U.S.A.
2013
110
|
27470930 |
Salameh TS et al.:
Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimers disease
Exp. Biol. Med. (Maywood)
2016
241: 1676-1683
|
30814349 |
Smith CJ et al.:
Putative Survival Advantages in Young Apolipoprotein varepsilon4 Carriers are Associated with Increased Neural Stress
J. Alzheimers Dis.
2019
68: 885-923
|
15220465 |
Corbo RM et al.:
Apolipoprotein E polymorphism and fertility: a study in pre-industrial populations
Mol. Hum. Reprod.
2004
10: 617-620
|
8698352 |
Gerdes LU et al.:
Are men carrying the apolipoprotein epsilon 4- or epsilon 2 allele less fertile than epsilon 3 epsilon 3 genotypes?
Hum. Genet.
1996
98: 239-242
|
28683096 |
van Exel E et al.:
Effect of APOE epsilon4 allele on survival and fertility in an adverse environment
PLoS ONE
2017
12
|
25282659 |
Gaynor JW et al. et al.:
Validation of association of the apolipoprotein E epsilon2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants
J. Thorac. Cardiovasc. Surg.
2014
148: 2560-2566
|
28335828 |
Yassine HN et al.:
DHA brain uptake and APOE4 status: a PET study with [1-(11)C]-DHA
Alzheimers Res Ther
2017
9: 23
|
21659554 |
Huebbe P et al.:
APOE epsilon4 is associated with higher vitamin D levels in targeted replacement mice and humans
FASEB J.
2011
25: 3262-3270
|
28284953 |
Stening E et al.:
Specific patterns of whole-brain structural covariance of the anterior and posterior hippocampus in young APOE epsilon4 carriers
Behav. Brain Res.
2017
326: 256-264
|
21606569 |
Alexopoulos P et al.:
Hippocampal volume differences between healthy young apolipoprotein E epsilon2 and epsilon4 carriers
J. Alzheimers Dis.
2011
26: 207-210
|
21215387 |
Taylor AE et al.:
IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children
Biol. Psychiatry
2011
70: 152-158
|
8475230 |
Keltikangas-Jarvinen L et al.:
Dependence between apolipoprotein E phenotypes and temperament in children, adolescents, and young adults
Psychosom Med
1993
55: 155-163
|
19605830 |
Caselli RJ et al. et al.:
Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect
N. Engl. J. Med.
2009
361: 255-263
|
17395708 |
Brown CM et al.:
Androgen-mediated immune function is altered by the apolipoprotein E gene
Endocrinology
2007
148: 3383-3390
|
24444806 |
Panizzon MS et al. et al.:
Interaction of APOE genotype and testosterone on episodic memory in middle-aged men
Neurobiol. Aging
2014
35: 1778.e1-1778.e8
|
26791201 |
Theendakara V et al.:
Direct Transcriptional Effects of Apolipoprotein E
J. Neurosci.
2016
36: 685-700
|
12077215 |
Raber J et al.:
Androgens protect against apolipoprotein E4-induced cognitive deficits
J. Neurosci.
2002
22: 5204-5209
|
28533891 |
Love JE et al.:
Nuclear uptake of an amino-terminal fragment of apolipoprotein E4 promotes cell death and localizes within microglia of the Alzheimers disease brain
Int J Physiol Pathophysiol Pharmacol
2017
9: 40-57
|
29264400 |
Rohn TT et al.:
Nuclear Localization of Apolipoprotein E4: A New Trick for an Old Protein
|
11305869 |
Cho HS et al.:
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation
J. Neuropathol. Exp. Neurol.
2001
60: 342-349
|
7715296 |
Wisniewski T et al.:
Is Alzheimers disease an apolipoprotein E amyloidosis?
Lancet
1995
345: 956-958
|
21368138 |
Bien-Ly N et al.:
C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-beta (Abeta) and acts in concert with Abeta to elicit neuronal and behavioral deficits in mice
Proc. Natl. Acad. Sci. U.S.A.
2011
108: 4236-4241
|
26402072 |
Duits FH et al.:
Matrix Metalloproteinases in Alzheimers Disease and Concurrent Cerebral Microbleeds
J. Alzheimers Dis.
2015
48: 711-720
|
25050378 |
Wang XX et al.:
Matrix metalloproteinases and their multiple roles in Alzheimers disease
Biomed Res Int
2014
2014
|
22445724 |
Dafnis I et al.:
An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines
Neuroscience
2012
210: 21-32
|
16787929 |
Yan P et al. et al.:
Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ
J. Biol. Chem.
2006
281
|
20847401 |
Subramanian S et al.:
CCR6: a biomarker for Alzheimers-like disease in a triple transgenic mouse model
J. Alzheimers Dis.
2010
22: 619-629
|
12689599 |
Lorenzl S et al.:
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimers disease
Neurochem. Int.
2003
43: 191-196
|
19235898 |
Hernandez-Guillamon M et al.:
Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by beta-amyloid 25-35 fragment
J. Neurosci. Res.
2009
87: 2115-2125
|
28094792 |
Urfer-Buchwalder A et al.:
Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimers Disease
Sci Rep
2017
7: 40668
|
22077634 |
Sheng B et al.:
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimers disease
J. Neurochem.
2012
120: 419-429
|
28720530 |
Theendakara V et al.:
Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimers disease
Mol. Cell. Neurosci.
2017
83: 83-91
|
11796747 |
Casley CS et al.:
Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities
J. Neurochem.
2002
80: 91-100
|
32152337 |
Area-Gomez E et al. et al.:
APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice
Sci Rep
2020
10: 4277
|
29311783 |
Nuriel T et al.:
The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo
Front Neurosci
2017
11: 702
|
10822435 |
Yaffe K et al.:
Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction
Neurology
2000
54: 1949-1954
|
9278514 |
Paech K et al.:
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
Science
1997
277: 1508-1510
|
22962256 |
Jayaraman A et al.:
17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain
Endocrinology
2012
153: 5467-5479
|
15590928 |
Zhao L et al.:
Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimers disease intervention
J. Neurosci.
2004
24
|
25745640 |
Gottschalk WK et al.:
The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging
|
22514691 |
Cha MY et al.:
Mitochondria-specific accumulation of amyloid beta induces mitochondrial dysfunction leading to apoptotic cell death
PLoS ONE
2012
7
|
27636849 |
Sainaghi PP et al.:
Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimers Disease
J. Alzheimers Dis.
2017
55: 59-65
|
29433734 |
Santo EE et al.:
FOXO in Neural Cells and Diseases of the Nervous System
Curr. Top. Dev. Biol.
2018
127: 105-118
|
31808750 |
Yin J et al.:
Apolipoprotein E regulates mitochondrial function through the PGC-1alpha-sirtuin 3 pathway
Aging (Albany NY)
2019
11
|
19076441 |
Mosconi L et al.:
Brain glucose hypometabolism and oxidative stress in preclinical Alzheimers disease
Ann. N. Y. Acad. Sci.
2008
1147: 180-195
|
9596412 |
Montine KS et al.:
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype
J. Neuropathol. Exp. Neurol.
1998
57: 415-425
|
27583919 |
Zheng J et al.:
The CYP19A1 rs3751592 variant confers susceptibility to Alzheimer disease in the Chinese Han population
Medicine (Baltimore)
2016
95: e4742
|
20819998 |
Panizzon MS et al. et al.:
Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men
Neurology
2010
75: 874-880
|
18439297 |
Haasl RJ et al.:
A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimers disease in males carrying an apolipoprotein E epsilon4 allele
BMC Med. Genet.
2008
9: 37
|
19339974 |
Bu G et al.:
Apolipoprotein E and its receptors in Alzheimers disease: pathways, pathogenesis and therapy
Nat. Rev. Neurosci.
2009
10: 333-344
|
32521573 |
Han C et al.:
New mechanism of nerve injury in Alzheimers disease: beta-amyloid-induced neuronal pyroptosis
|
29028155 |
Brinkmalm G et al.:
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimers Disease
|
32460813 |
Konijnenberg E et al. et al.:
APOE epsilon4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimers disease
Alzheimers Res Ther
2020
12: 65
|
27128370 |
Perkins M et al. et al.:
Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E varepsilon4 Carriers
J. Alzheimers Dis.
2016
53: 95-106
|
32973177 |
Valla J et al.:
Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimers susceptibility gene
J. Alzheimers Dis.
2010
22: 307-313
|
23639788 |
Djogo N et al.:
Adhesion molecule L1 binds to amyloid beta and reduces Alzheimers disease pathology in mice
Neurobiol. Dis.
2013
56: 104-115
|
10571241 |
Hiesberger T et al.:
Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation
Neuron
1999
24: 481-489
|
15014128 |
Brecht WJ et al.:
Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice
J. Neurosci.
2004
24: 2527-2534
|
32587511 |
Yassine HN et al.:
APOE Alleles and Diet in Brain Aging and Alzheimers Disease
Front Aging Neurosci
2020
12: 150
|
31738402 |
Seo DO et al.:
Gut Microbiota: From the Forgotten Organ to a Potential Key Player in the Pathology of Alzheimers Disease
J Gerontol A Biol Sci Med Sci
2020
75: 1232-1241
|
30958695 |
Tran TTT et al.:
APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimers disease pathophysiology
FASEB J
2019
33: 8221-8231
|
30336580 |
Griffin BA et al.:
APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates
|
23921897 |
Schonfeld P et al.:
Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain
J Cereb Blood Flow Metab
2013
33: 1493-1499
|
25488255 |
Wang SP et al.:
Metabolism as a tool for understanding human brain evolution: lipid energy metabolism as an example
J Hum Evol
2014
77: 41-49
|
22353463 |
Galea E et al.:
Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
Biochim Biophys Acta
2012
1822: 1475-1488
|
32444841 |
Wang Y et al.:
Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimers Risk in Female Brain
Sci Rep
2020
10: 8528
|
11449190 |
Hogervorst E et al.:
Serum total testosterone is lower in men with Alzheimers disease
Neuro Endocrinol Lett
2001
22: 163-168
|
28655134 |
Asih PR et al.:
Multiple Mechanisms Linking Type 2 Diabetes and Alzheimers Disease: Testosterone as a Modifier
J Alzheimers Dis
2017
59: 445-466
|
32560743 |
Sundermann EE et al.:
Sex differences in Alzheimers-related Tau biomarkers and a mediating effect of testosterone
Biol Sex Differ
2020
11: 33
|
15750215 |
Steen E et al.:
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimers disease--is this type 3 diabetes?
J Alzheimers Dis
2005
7: 63-80
|
28438892 |
Camandola S et al.:
Brain metabolism in health, aging, and neurodegeneration
EMBO J
2017
36: 1474-1492
|
26669800 |
Shibuya Y et al.:
ACAT1/SOAT1 as a therapeutic target for Alzheimers disease
Future Med Chem
2015
7: 2451-2467
|
15269217 |
Wahrle SE et al.:
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
J Biol Chem
2004
279
|
15269218 |
Hirsch-Reinshagen V et al.:
Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain
J Biol Chem
2004
279
|
19326444 |
Minagawa H et al.:
Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture
J Neurosci Res
2009
87: 2498-2508
|
31813629 |
Bonfili L et al.:
Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimers disease
Neurobiol Aging
2020
87: 35-43
|
32512571 |
author information missing
Involvement of testosterone signaling in the integrity of the neurovascular unit in the male: review of evidence, contradictions and hypothesis
|
9390772 |
Mooradian AD et al.:
GLUT-1 expression in the cerebra of patients with Alzheimers disease
Neurobiol Aging
1997
18: 469-474
|
31665905 |
Yamazaki Y et al.:
ApoE (Apolipoprotein E) in Brain Pericytes Regulates Endothelial Function in an Isoform-Dependent Manner by Modulating Basement Membrane Components
Arterioscler Thromb Vasc Biol
2020
40: 128-144
|
32376954 |
Montagne A et al. et al.:
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Nature
2020
581: 71-76
|
32350425 |
author information missing
Risk factor for Alzheimers disease breaks the blood-brain barrier
Nature
2020
581: 31-32
|
24708805 |
Sajja RK et al.:
Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line
Fluids Barriers CNS
2014
11: 8
|
32789766 |
Koepsell H et al.:
Glucose transporters in brain in health and disease
Pflugers Arch
2020
472: 1299-1343
|
29797185 |
Raikwar SP et al.:
Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimers Disease?
Mol Neurobiol
2019
56: 833-843
|
18174027 |
Liu Y et al.:
Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
FEBS Lett
2008
582: 359-364
|
27372644 |
Salomon-Zimri S et al.:
Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment
J Alzheimers Dis
2016
53: 1443-1458
|
29401605 |
Wijesekara N et al.:
Tau ablation in mice leads to pancreatic beta cell dysfunction and glucose intolerance
FASEB J
2018
32: 3166-3173
|
28902142 |
Yamazaki Y et al.:
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimers Disease
|
26195256 |
Tarasoff-Conway JM et al. et al.:
Clearance systems in the brain-implications for Alzheimer disease
Nat Rev Neurol
2015
11: 457-470
|
25921624 |
Yin F et al.:
The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity
Neurobiol Aging
2015
36: 2282-2295
|
24244584 |
Ding F et al.:
Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimers mouse brain: implication for bioenergetic intervention
PLoS One
2013
8
|
28984596 |
Palmieri G et al.:
Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimers Disease: A Sign of Defective Proteostasis?
J Alzheimers Dis
2017
60: 1097-1106
|
19627603 |
Yamin R et al.:
Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
Mol Neurodegener
2009
4: 33
|
24688718 |
Wakabayashi S et al.:
The essential biology of the endoplasmic reticulum stress response for structural and computational biologists
Comput Struct Biotechnol J
2013
6
|
20947216 |
Gleichmann M et al.:
Molecular changes in brain aging and Alzheimers disease are mirrored in experimentally silenced cortical neuron networks
Neurobiol Aging
2012
33: 205.e1-205.18
|
31382130 |
Wohua Z et al.:
Glutaredoxin 2 (GRX2) deficiency exacerbates high fat diet (HFD)-induced insulin resistance, inflammation and mitochondrial dysfunction in brain injury: A mechanism involving GSK-3beta
Biomed Pharmacother
2019
118
|
27154981 |
Yin F et al.:
Energy metabolism and inflammation in brain aging and Alzheimers disease
Free Radic Biol Med
2016
100: 108-122
|
31231219 |
Zuena AR et al.:
Chemokines in Alzheimers Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Front Pharmacol
2019
10: 622
|
19204726 |
Chapuis J et al. et al.:
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimers disease
Mol Psychiatry
2009
14: 1004-1016
|
27091974 |
Fu AK et al.:
IL-33 ameliorates Alzheimers disease-like pathology and cognitive decline
Proc Natl Acad Sci U S A
2016
113
|
24413615 |
Xiong Z et al.:
Alzheimers disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain
J Alzheimers Dis
2014
40: 297-308
|
18571100 |
Pollio G et al. et al.:
Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Abeta toxicity
Neurobiol Dis
2008
31: 145-158
|
12834896 |
Buddle M et al.:
Microtubule-associated protein 2 (MAP2) associates with the NMDA receptor and is spatially redistributed within rat hippocampal neurons after oxygen-glucose deprivation
Brain Res
2003
978: 38-50
|
17018137 |
Webber KM et al.:
Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease
Mol Neurodegener
2006
1: 14
|
22406427 |
Villanueva EB et al.:
Secreted phospholipase A(2) group IIA is a neurotoxin released by stimulated human glial cells
Mol Cell Neurosci
2012
49: 430-438
|
17764962 |
Parachikova A et al.:
Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease
Neurobiol Dis
2007
28: 143-153
|
30447377 |
Ye X et al.:
Association of CSF CD40 levels and synaptic degeneration across the Alzheimers disease spectrum
Neurosci Lett
2019
694: 41-45
|
27321472 |
Sun X et al.:
APOE epsilon4 carriers may undergo synaptic damage conferring risk of Alzheimers disease
Alzheimers Dement
2016
12: 1159-1166
|
23954108 |
Ebbert MT et al.:
Population-based analysis of Alzheimers disease risk alleles implicates genetic interactions
Biol Psychiatry
2014
75: 732-737
|
10574372 |
Tanahashi H et al.:
Genomic organization of the human X11L2 gene (APBA3), a third member of the X11 protein family interacting with Alzheimers beta-amyloid precursor protein
Neuroreport
1999
10: 2575-2578
|
19118172 |
Ho A et al.:
Deletion of Mint proteins decreases amyloid production in transgenic mouse models of Alzheimers disease
J Neurosci
2008
28
|
29962946 |
Brandon JA et al.:
APOE and Alzheimers Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction
Front Aging Neurosci
2018
10: 180
|
29523845 |
Annese A et al.:
Whole transcriptome profiling of Late-Onset Alzheimers Disease patients provides insights into the molecular changes involved in the disease
Sci Rep
2018
8: 4282
|
27816213 |
Pichler S et al.:
The miRNome of Alzheimers disease: consistent downregulation of the miR-132/212 cluster
Neurobiol Aging
2017
50: 167.e1-167.e10
|
32075102 |
Pajuelo Reguera D et al.:
Cytochrome c Oxidase Subunit 4 Isoform Exchange Results in Modulation of Oxygen Affinity
|
16943564 |
Devi L et al.:
Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimers disease brain is associated with mitochondrial dysfunction
J Neurosci
2006
26: 9057-9068
|
33086624 |
Murakami M et al.:
Updating Phospholipase A2 Biology
|
17965832 |
Wang Y et al.:
Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions
Cell Mol Life Sci
2008
65: 237-252
|
30394676 |
Sun LL et al.:
Molecular differences in Alzheimers disease between male and female patients determined by integrative network analysis
J Cell Mol Med
2019
23: 47-58
|
27983596 |
Preciados M et al.:
Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases
|
15932949 |
Reiman EM et al.:
Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism
Proc Natl Acad Sci U S A
2005
102: 8299-8302
|
31127273 |
Choi I et al.:
SIRT1 in Astrocytes Regulates Glucose Metabolism and Reproductive Function
Endocrinology
2019
160: 1547-1560
|
28768174 |
Goyal MS et al.:
Loss of Brain Aerobic Glycolysis in Normal Human Aging
Cell Metab
2017
26: 353-360.e3
|
16449386 |
Cai D et al.:
Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation
Proc Natl Acad Sci U S A
2006
103: 1941-1946
|
16449385 |
Cai D et al.:
Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimers disease-linked presenilin-1 mutant neurons
Proc Natl Acad Sci U S A
2006
103: 1936-1940
|
19276086 |
Liu Y et al.:
Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1
J Biol Chem
2009
284
|
30918495 |
Camacho J et al.:
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
Front Neurol
2019
10: 187
|
31738162 |
Herring SK et al.:
Brain clusterin protein isoforms and mitochondrial localization
|
26682220 |
Ma C et al.:
Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men
Biomed Res Int
2015
2015
|
24731980 |
Bai Z et al. et al.:
Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities
Alzheimer Dis Assoc Disord
2014
28: 226-233
|
20395015 |
Wikgren M et al.:
APOE epsilon4 is associated with longer telomeres, and longer telomeres among epsilon4 carriers predicts worse episodic memory
Neurobiol Aging
2012
33: 335-344
|
33891334 |
Pontifex MG et al.:
APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE-TR mice
FASEB J
2021
35
|
30540774 |
Mosconi L et al.:
Increased Alzheimers risk during the menopause transition: A 3-year longitudinal brain imaging study
PLoS One
2018
13
|
22016362 |
Takata Y et al.:
Association between ApoE phenotypes and telomere erosion in Alzheimers disease
J Gerontol A Biol Sci Med Sci
2012
67: 330-335
|
31890852 |
Mahoney ER et al.:
Telomere length associations with cognition depend on Alzheimers disease biomarkers
Alzheimers Dement (N Y)
2019
5: 883-890
|
17785354 |
Rao P et al.:
Angiotensin II regulates adipocyte apolipoprotein E expression
J Clin Endocrinol Metab
2007
92: 4366-4372
|
22825311 |
Honig LS et al.:
Association of shorter leukocyte telomere repeat length with dementia and mortality
Arch Neurol
2012
69: 1332-1339
|
24241262 |
author information missing
Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimers disease
J Health Care Poor Underserved
2013
24: 70-78
|
21686130 |
Culpan D et al.:
Tumour necrosis factor-alpha (TNF-alpha) and miRNA expression in frontal and temporal neocortex in Alzheimers disease and the effect of TNF-alpha on miRNA expression in vitro
Int J Mol Epidemiol Genet
2011
2: 156-162
|
28894825 |
Thomson RS et al.:
Hearing loss as a risk factor for dementia: A systematic review
Laryngoscope Investig Otolaryngol
2017
2: 69-79
|
31984308 |
An YA et al. et al.:
Dysregulation of Amyloid Precursor Protein Impairs Adipose Tissue Mitochondrial Function and Promotes Obesity
Nat Metab
2019
1: 1243-1257
|
32630431 |
Chaudhari K et al.:
ApoE Genotype-Dependent Response to Antioxidant and Exercise Interventions on Brain Function
|
18179727 |
Jofre-Monseny L et al.:
Influence of apolipoprotein E genotype and dietary alpha-tocopherol on redox status and C-reactive protein levels in apolipoprotein E3 and E4 targeted replacement mice
Br J Nutr
2008
100: 44-53
|
10490274 |
Ramassamy C et al.:
Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimers disease is related to the apolipoprotein E genotype
Free Radic Biol Med
1999
27: 544-553
|
28035917 |
Persson T et al.:
Apolipoprotein E4 Elicits Lysosomal Cathepsin D Release, Decreased Thioredoxin-1 Levels, and Apoptosis
J Alzheimers Dis
2017
56: 601-617
|
26924205 |
Wang Y et al.:
Lost region in amyloid precursor protein (APP) through TALEN-mediated genome editing alters mitochondrial morphology
Sci Rep
2016
6: 22244
|
25335802 |
Alata W et al.:
Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood-brain barrier function in mice
J Cereb Blood Flow Metab
2015
35: 86-94
|
30232327 |
Koizumi K et al. et al.:
Apoepsilon4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function
Nat Commun
2018
9: 3816
|
8179300 |
Simpson IA et al.:
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimers disease
Ann Neurol
1994
35: 546-551
|
12325053 |
Hogervorst E et al.:
Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimers disease in men
Int J Geriatr Psychiatry
2002
17: 938-940
|
10573435 |
Barrett-Connor E et al.:
Cognitive function and endogenous sex hormones in older women
J Am Geriatr Soc
1999
47: 1289-1293
|
22596268 |
Hedskog L et al.:
Biochemical studies of poly-T variants in the Alzheimers disease associated TOMM40 gene
J Alzheimers Dis
2012
31: 527-536
|
2769254 |
Kalaria RN et al.:
Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease
J Neurochem
1989
53: 1083-1088
|
7815078 |
Harr SD et al.:
Functional alterations in Alzheimers disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone
J Neuropathol Exp Neurol
1995
54: 38-41
|
2514687 |
Tanaka S et al.:
Tissue-specific expression of three types of beta-protein precursor mRNA: enhancement of protease inhibitor-harboring types in Alzheimers disease brain
Biochem Biophys Res Commun
1989
165: 1406-1414
|
14992810 |
Preece P et al.:
Amyloid precursor protein mRNA levels in Alzheimers disease brain
Brain Res Mol Brain Res
2004
122: 1-9
|
22089642 |
Bekris LM et al.:
Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE
J Hum Genet
2012
57: 18-25
|
34157306 |
author information missing
article information missing
|
32471464 |
author information missing
article information missing
|
32296178 |
author information missing
article information missing
|
27604972 |
author information missing
article information missing
|
21705112 |
author information missing
article information missing
|
29353455 |
author information missing
article information missing
|
26590417 |
author information missing
article information missing
|
20847408 |
author information missing
article information missing
|
32973177 |
author information missing
article information missing
|
29423459 |
author information missing
article information missing
|
25869786 |
author information missing
article information missing
|
15033273 |
author information missing
article information missing
|
31760549 |
author information missing
article information missing
|
30394676 |
author information missing
article information missing
|
33340485 |
author information missing
article information missing
|
33580390 |
author information missing
article information missing
|
12214001 |
author information missing
article information missing
|
34489623 |
author information missing
article information missing
|
33410232 |
author information missing
article information missing
|
33723589 |
author information missing
article information missing
|
32070225 |
author information missing
article information missing
|
32161412 |
author information missing
article information missing
|
32397599 |
author information missing
article information missing
|
24067654 |
author information missing
article information missing
|
33027662 |
author information missing
article information missing
|
31738978 |
author information missing
article information missing
|
10462693 |
author information missing
article information missing
|
21316350 |
author information missing
article information missing
|
18657529 |
author information missing
article information missing
|
31677348 |
author information missing
article information missing
|
31164996 |
author information missing
article information missing
|
33500712 |
author information missing
article information missing
|
15358178 |
author information missing
article information missing
|
15627653 |
author information missing
article information missing
|
34064758 |
author information missing
article information missing
|
17868329 |
author information missing
article information missing
|
22863908 |
author information missing
article information missing
|
23792692 |
author information missing
article information missing
|
33676568 |
author information missing
article information missing
|
31711277 |
author information missing
article information missing
|
28096339 |
author information missing
article information missing
|
31257151 |
author information missing
article information missing
|
24276092 |
author information missing
article information missing
|
31641056 |
author information missing
article information missing
|
34616039 |
author information missing
article information missing
|
34647685 |
author information missing
article information missing
|
33180216 |
author information missing
article information missing
|
35163221 |
author information missing
article information missing
|
35669462 |
author information missing
article information missing
|
24149440 |
author information missing
article information missing
|
35291561 |
author information missing
article information missing
|
32044129 |
author information missing
article information missing
|
26844268 |
author information missing
article information missing
|
32866617 |
author information missing
article information missing
|
32709881 |
author information missing
article information missing
|
11359882 |
author information missing
article information missing
|
32917959 |
author information missing
article information missing
|
31130380 |
author information missing
article information missing
|
35346689 |
author information missing
article information missing
|
35088039 |
author information missing
article information missing
|
34439479 |
author information missing
article information missing
|
32338825 |
author information missing
article information missing
|
26686055 |
author information missing
article information missing
|
33400183 |
author information missing
article information missing
|
33378713 |
author information missing
article information missing
|
31951107 |
author information missing
article information missing
|
32210766 |
author information missing
article information missing
|
21594711 |
author information missing
article information missing
|
34465385 |
author information missing
article information missing
|
33958804 |
author information missing
article information missing
|
35644025 |
author information missing
article information missing
|
22046147 |
author information missing
article information missing
|
19368807 |
author information missing
article information missing
|
11804574 |
author information missing
article information missing
|
8480510 |
author information missing
article information missing
|
16996687 |
author information missing
article information missing
|
21244353 |
author information missing
article information missing
|
8987775 |
author information missing
article information missing
|
23408593 |
author information missing
article information missing
|
9547230 |
author information missing
article information missing
|
10359075 |
author information missing
article information missing
|
24594013 |
author information missing
article information missing
|
34639003 |
author information missing
article information missing
|
28458525 |
author information missing
article information missing
|
20644562 |
author information missing
article information missing
|
31601022 |
author information missing
article information missing
|
30385318 |
author information missing
article information missing
|
3585324 |
author information missing
article information missing
|
16574032 |
author information missing
article information missing
|
8421706 |
author information missing
article information missing
|
21799757 |
author information missing
article information missing
|
34943074 |
author information missing
article information missing
|
23679855 |
author information missing
article information missing
|
24275950 |
author information missing
article information missing
|
34044147 |
author information missing
article information missing
|
34749800 |
author information missing
article information missing
|
26405162 |
author information missing
article information missing
|
27254664 |
author information missing
article information missing
|
19176370 |
Catalano A et al.:
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells
Cancer Res.
2009
69: 1485-1493
|
19176370 |
Catalano A et al.:
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells.
Cancer Res.
2009
69: 1485-1493
|
19176370 |
Catalano A et al.:
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells
Cancer Res.
2009
69: 1485-1493
|
19325129 |
Schwarz Q et al.:
Neuropilin 1 signaling guides neural crest cells to coordinate pathway choice with cell specification.
Proc. Natl. Acad. Sci. U.S.A.
2009
106: 6164-6169
|
9331345 |
Taniguchi M et al.:
Disruption of semaphorin III/D gene causes severe abnormality in peripheral nerve projection
Neuron
1997
19: 519-530
|
18708346 |
Bae D et al.:
Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2
J. Biol. Chem.
2008
283
|
18708346 |
Bae D et al.:
Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2.
J. Biol. Chem.
2008
283
|
18664627 |
Kawamura H et al.:
Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.
Blood
2008
112: 3638-3649
|
16966330 |
Lamalice L et al.:
Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF.
J. Biol. Chem.
2006
281
|
14724572 |
Lamalice L et al.:
Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
Oncogene
2004
23: 434-445
|
17569671 |
Guttmann-Raviv N et al.:
Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
J. Biol. Chem.
2007
282
|
18056484 |
Moretti S et al.:
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts.
Blood
2008
111: 2290-2299
|
9215629 |
Yang X et al.:
Daxx, a novel Fas-binding protein that activates JNK and apoptosis
Cell
1997
89: 1067-1076
|
16330548 |
Kurschat P et al.:
Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration.
J. Biol. Chem.
2006
281: 2721-2729
|
17369826 |
Semenova MM et al.:
Rho mediates calcium-dependent activation of p38alpha and subsequent excitotoxic cell death
Nat. Neurosci.
2007
10: 436-443
|
19251628 |
Vance C et al. et al.:
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6
Science
2009
323: 1208-1211
|
18309045 |
Sreedharan J et al.:
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.
Science
2008
319: 1668-1672
|
17023659 |
Neumann M et al. et al.:
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Science
2006
314: 130-133
|
17469116 |
Mackenzie IR et al. et al.:
Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
Ann. Neurol.
2007
61: 427-434
|
8446170 |
Rosen DR et al.:
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
Nature
1993
362: 59-62
|
10196546 |
Takahashi T et al.:
Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors.
Nat. Neurosci.
1998
1: 487-493
|
10520994 |
Takahashi T et al.:
Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors
Cell
1999
99: 59-69
|
16495486 |
Chadborn NH et al.:
PTEN couples Sema3A signalling to growth cone collapse
J. Cell. Sci.
2006
119: 951-957
|
16495486 |
Chadborn NH et al.:
PTEN couples Sema3A signalling to growth cone collapse.
J. Cell. Sci.
2006
119: 951-957
|
11956225 |
Eickholt BJ et al.:
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling.
J. Cell Biol.
2002
157: 211-217
|
18180379 |
Acevedo LM et al.:
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor.
Blood
2008
111: 2674-2680
|
18180379 |
Acevedo LM et al.:
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
Blood
2008
111: 2674-2680
|
18327764 |
Gallo G et al.:
Semaphorin 3A inhibits ERM protein phosphorylation in growth cone filopodia through inactivation of PI3K
Dev Neurobiol
2008
68: 926-933
|
9236236 |
Jin Z et al.:
Rac1 mediates collapsin-1-induced growth cone collapse.
J. Neurosci.
1997
17: 6256-6263
|
18272814 |
Narazaki M et al.:
Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A
Blood
2008
111: 4126-4136
|
15378658 |
Weydt P et al.:
Increased cytotoxic potential of microglia from ALS-transgenic mice
Glia
2004
48: 179-182
|
19672969 |
Zhao W et al.:
Extracellular mutant SOD1 induces microglial-mediated motoneuron injury
Glia
2010
58: 231-243
|
18519638 |
Nishitoh H et al.:
ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1
Genes Dev
2008
22: 1451-1464
|
12847526 |
Lambrechts D et al.:
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.
Nat. Genet.
2003
34: 383-394
|
11381259 |
Oosthuyse B et al.:
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.
Nat. Genet.
2001
28: 131-138
|
18519638 |
Nishitoh H et al.:
ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1
Genes Dev.
2008
22: 1451-1464
|
18519638 |
Nishitoh H et al.:
ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1
Genes Dev.
2008
22: 1451-1464
|
19762508 |
Hetz C et al.:
XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy
Genes Dev.
2009
23: 2294-2306
|
19762508 |
Hetz C et al.:
XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy.
Genes Dev.
2009
23: 2294-2306
|
15568021 |
Storkebaum E et al.:
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
Nat. Neurosci.
2005
8: 85-92
|
19183264 |
Suzuki H et al.:
ALS-linked P56S-VAPB, an aggregated loss-of-function mutant of VAPB, predisposes motor neurons to ER stress-related death by inducing aggregation of co-expressed wild-type VAPB
J. Neurochem.
2009
108: 973-985
|
18233996 |
Oh YK et al.:
Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells
J. Neurochem.
2008
104: 993-1005
|
19330001 |
Saxena S et al.:
A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice
Nat. Neurosci.
2009
12: 627-636
|
19330001 |
Saxena S et al.:
A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice.
Nat. Neurosci.
2009
12: 627-636
|
18077368 |
Kieran D et al.:
Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice.
Proc. Natl. Acad. Sci. U.S.A.
2007
104
|
18077368 |
Kieran D et al.:
Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice
Proc. Natl. Acad. Sci. U.S.A.
2007
104
|
18413601 |
Taoufik E et al.:
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 6185-6190
|
18413601 |
Taoufik E et al.:
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 6185-6190
|
7507336 |
Cheng B et al.:
Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
Neuron
1994
12: 139-153
|
11029549 |
Jin KL et al.:
Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain.
Neuroscience
2000
99: 577-585
|
16847061 |
Atkin JD et al.:
Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1
J. Biol. Chem.
2006
281
|
16847061 |
Atkin JD et al.:
Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1
J. Biol. Chem.
2006
281
|
16847061 |
Atkin JD et al.:
Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1.
J. Biol. Chem.
2006
281
|
19661182 |
Ying Z et al.:
Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation.
Hum. Mol. Genet.
2009
18: 4268-4281
|
19661182 |
Ying Z et al.:
Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation
Hum. Mol. Genet.
2009
18: 4268-4281
|
9618543 |
Rosenstein JM et al.:
Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo.
Proc. Natl. Acad. Sci. U.S.A.
1998
95: 7086-7091
|
19661182 |
Ying Z et al.:
Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation
Hum. Mol. Genet.
2009
18: 4268-4281
|
9618543 |
Rosenstein JM et al.:
Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo
Proc. Natl. Acad. Sci. U.S.A.
1998
95: 7086-7091
|
18566591 |
Jeyabalan A et al.:
Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia
Am. J. Hypertens.
2008
21: 943-947
|
19889996 |
Yang YS et al.:
Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis.
J. Neurosci.
2009
29
|
17360578 |
Warner-Schmidt JL et al.:
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Proc. Natl. Acad. Sci. U.S.A.
2007
104: 4647-4652
|
17360578 |
Warner-Schmidt JL et al.:
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants.
Proc. Natl. Acad. Sci. U.S.A.
2007
104: 4647-4652
|
18263603 |
Gkogkas C et al.:
VAPB interacts with and modulates the activity of ATF6
Hum. Mol. Genet.
2008
17: 1517-1526
|
18263603 |
Gkogkas C et al.:
VAPB interacts with and modulates the activity of ATF6
Hum. Mol. Genet.
2008
17: 1517-1526
|
16891305 |
Kanekura K et al.:
Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8)
J. Biol. Chem.
2006
281
|
16192378 |
McCloskey DP et al.:
Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures
J. Neurosci.
2005
25: 8889-8897
|
19109488 |
Kieran D et al.:
Control of motoneuron survival by angiogenin
J. Neurosci.
2008
28
|
19109488 |
Kieran D et al.:
Control of motoneuron survival by angiogenin
J. Neurosci.
2008
28
|
18065154 |
Nicoletti JN et al.:
Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus
Neuroscience
2008
151: 232-241
|
18065154 |
Nicoletti JN et al.:
Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.
Neuroscience
2008
151: 232-241
|
19444281 |
Sebastia J et al.:
Angiogenin protects motoneurons against hypoxic injury.
Cell Death Differ.
2009
16: 1238-1247
|
19444281 |
Sebastia J et al.:
Angiogenin protects motoneurons against hypoxic injury
Cell Death Differ.
2009
16: 1238-1247
|
19444281 |
Sebastia J et al.:
Angiogenin protects motoneurons against hypoxic injury
Cell Death Differ.
2009
16: 1238-1247
|
15258583 |
Cao L et al.:
VEGF links hippocampal activity with neurogenesis, learning and memory
Nat. Genet.
2004
36: 827-835
|
15258583 |
Cao L et al.:
VEGF links hippocampal activity with neurogenesis, learning and memory.
Nat. Genet.
2004
36: 827-835
|
16581901 |
Raoul C et al.:
Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL
Proc. Natl. Acad. Sci. U.S.A.
2006
103: 6007-6012
|
16964394 |
Yoshino Y et al.:
Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells.
Int. J. Oncol.
2006
29: 981-987
|
12354397 |
Raoul C et al.:
Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.
Neuron
2002
35: 1067-1083
|
15207859 |
Ackerley S et al.:
p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis
Mol. Cell. Neurosci.
2004
26: 354-364
|
15207859 |
Ackerley S et al.:
p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis.
Mol. Cell. Neurosci.
2004
26: 354-364
|
15207859 |
Ackerley S et al.:
p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis
Mol. Cell. Neurosci.
2004
26: 354-364
|
16000635 |
Martin LJ et al.:
Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation
J. Neurosci.
2005
25: 6449-6459
|
16000635 |
Martin LJ et al.:
Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation
J. Neurosci.
2005
25: 6449-6459
|
12812752 |
Tortarolo M et al.:
Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression
Mol. Cell. Neurosci.
2003
23: 180-192
|
17630988 |
Petri S et al.:
The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis
J. Neurochem.
2007
102: 991-1000
|
19091752 |
Liu Y et al.:
Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2
J. Biol. Chem.
2009
284: 3691-3699
|
16510725 |
Kiaei M et al.:
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis
J. Neurosci.
2006
26: 2467-2473
|
16510725 |
Kiaei M et al.:
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
J. Neurosci.
2006
26: 2467-2473
|
19734218 |
D'Ambrosi N et al.:
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis
J. Immunol.
2009
183: 4648-4656
|
16512913 |
Yiangou Y et al.:
COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.
BMC Neurol
2006
6: 12
|
16619237 |
Almer G et al.:
Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis
Ann. Neurol.
2006
59: 980-983
|
19477238 |
Mir M et al.:
Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants
Neuroscience
2009
162: 959-971
|
18219391 |
Harraz MM et al.:
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model
J. Clin. Invest.
2008
118: 659-670
|
18219391 |
Harraz MM et al.:
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model
J. Clin. Invest.
2008
118: 659-670
|
17853944 |
Marden JJ et al.:
Redox modifier genes in amyotrophic lateral sclerosis in mice
J. Clin. Invest.
2007
117: 2913-2919
|
17389365 |
Son M et al.:
Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology
Proc. Natl. Acad. Sci. U.S.A.
2007
104: 6072-6077
|
19765191 |
Gal J et al.:
Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism
J. Neurochem.
2009
111: 1062-1073
|
19765191 |
Gal J et al.:
Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism
J. Neurochem.
2009
111: 1062-1073
|
19793721 |
Ferguson CJ et al.:
Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2.
Hum. Mol. Genet.
2009
18: 4868-4878
|
19793721 |
Ferguson CJ et al.:
Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2
Hum. Mol. Genet.
2009
18: 4868-4878
|
19944744 |
Wang X et al.:
Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system
Neurosci. Lett.
2010
469: 112-116
|
18250315 |
Fornai F et al.:
Lithium delays progression of amyotrophic lateral sclerosis
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 2052-2057
|
18250315 |
Fornai F et al.:
Lithium delays progression of amyotrophic lateral sclerosis.
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 2052-2057
|
18337307 |
Proescher JB et al.:
Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS
Hum. Mol. Genet.
2008
17: 1728-1737
|
19656261 |
Tokuda E et al.:
Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis
J. Neurochem.
2009
111: 181-191
|
19765193 |
Boylan K et al.:
Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker
J. Neurochem.
2009
111: 1182-1191
|
19765193 |
Boylan K et al.:
Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.
J. Neurochem.
2009
111: 1182-1191
|
18003833 |
Yamashita N et al.:
Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1.
J. Neurosci.
2007
27
|
14762105 |
Shea TB et al.:
Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons
J. Cell. Sci.
2004
117: 933-941
|
18519042 |
Manser C et al.:
Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.
FEBS Lett.
2008
582: 2303-2308
|
18519042 |
Manser C et al.:
Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport
FEBS Lett.
2008
582: 2303-2308
|
19717447 |
Zhu X et al.:
MSC p43 required for axonal development in motor neurons.
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
10893265 |
Ackerley S et al.:
Glutamate slows axonal transport of neurofilaments in transfected neurons.
J. Cell Biol.
2000
150: 165-176
|
11082065 |
El-Husseini AE et al.:
PSD-95 involvement in maturation of excitatory synapses.
Science
2000
290: 1364-1368
|
17344389 |
Su KY et al.:
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory
J. Neurosci.
2007
27: 2513-2524
|
17344389 |
Su KY et al.:
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory.
J. Neurosci.
2007
27: 2513-2524
|
15372378 |
Nishimura AL et al.:
A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis
Am. J. Hum. Genet.
2004
75: 822-831
|
20008544 |
Fasana E et al.:
A VAPB mutant linked to amyotrophic lateral sclerosis generates a novel form of organized smooth endoplasmic reticulum
FASEB J.
2010
24: 1419-1430
|
16945901 |
Ferri A et al.:
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials
Proc. Natl. Acad. Sci. U.S.A.
2006
103
|
9853749 |
Migaud M et al.:
Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein
Nature
1998
396: 433-439
|
19344252 |
Cozzolino M et al.:
Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity.
Antioxid. Redox Signal.
2009
11: 1547-1558
|
20007902 |
Williams AH et al.:
MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice
Science
2009
326: 1549-1554
|
18715867 |
Kawamata H et al.:
Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria
J. Biol. Chem.
2008
283
|
20007902 |
Williams AH et al.:
MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.
Science
2009
326: 1549-1554
|
17099709 |
Kaneko S et al.:
A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord.
Nat. Med.
2006
12: 1380-1389
|
16478527 |
Damiano M et al.:
Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice
J. Neurochem.
2006
96: 1349-1361
|
9705358 |
Giraudo E et al.:
Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells.
J. Biol. Chem.
1998
273
|
12649282 |
Duval M et al.:
Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.
J. Biol. Chem.
2003
278
|
19041930 |
Tolosa L et al.:
Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition.
Neuroscience
2009
158: 1348-1355
|
18182045 |
Tolosa L et al.:
Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.
J. Neurochem.
2008
105: 1080-1090
|
15233914 |
Pasinelli P et al.:
Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria.
Neuron
2004
43: 19-30
|
17855507 |
Duval M et al.:
Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase.
Mol. Biol. Cell
2007
18: 4659-4668
|
15233914 |
Pasinelli P et al.:
Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria
Neuron
2004
43: 19-30
|
16710367 |
Crosio C et al.:
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis
Cell Death Differ.
2006
13: 2150-2153
|
16710367 |
Crosio C et al.:
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis
Cell Death Differ.
2006
13: 2150-2153
|
19545440 |
Jaiswal MK et al.:
Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.
BMC Neurosci
2009
10: 64
|
16928866 |
Gould TW et al.:
Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.
J. Neurosci.
2006
26: 8774-8786
|
19046404 |
Soo KY et al.:
Recruitment of mitochondria into apoptotic signaling correlates with the presence of inclusions formed by amyotrophic lateral sclerosis-associated SOD1 mutations
J. Neurochem.
2009
108: 578-590
|
17394546 |
Ezzi SA et al.:
Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation
J. Neurochem.
2007
102: 170-178
|
17394546 |
Ezzi SA et al.:
Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation
J. Neurochem.
2007
102: 170-178
|
17394546 |
Ezzi SA et al.:
Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation.
J. Neurochem.
2007
102: 170-178
|
19638399 |
Kupershmidt L et al.:
Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis
FASEB J.
2009
23: 3766-3779
|
19523650 |
Fang L et al.:
Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
J. Neurol. Sci.
2009
285: 62-66
|
17362932 |
Kiaei M et al.:
Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
Exp. Neurol.
2007
205: 74-81
|
20097566 |
Soon CP et al.:
Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice
Neuromuscul. Disord.
2010
20: 260-266
|
15358145 |
Choi JS et al.:
Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes
Biochem. Biophys. Res. Commun.
2004
321: 574-583
|
15358145 |
Choi JS et al.:
Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes
Biochem. Biophys. Res. Commun.
2004
321: 574-583
|
15198682 |
Urushitani M et al.:
CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70
J. Neurochem.
2004
90: 231-244
|
19610091 |
Sone J et al.:
Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis
J. Neurosci. Res.
2010
88: 123-135
|
15201339 |
Nguyen DT et al.:
Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress
Mol. Biol. Cell
2004
15: 4248-4260
|
15201339 |
Nguyen DT et al.:
Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress.
Mol. Biol. Cell
2004
15: 4248-4260
|
12145308 |
Niwa J et al.:
Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity
J. Biol. Chem.
2002
277
|
12145308 |
Niwa J et al.:
Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity.
J. Biol. Chem.
2002
277
|
17666395 |
Niwa J et al.:
Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1.
J. Biol. Chem.
2007
282
|
14684739 |
Miyazaki K et al.:
NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1
J. Biol. Chem.
2004
279
|
14684739 |
Miyazaki K et al.:
NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1.
J. Biol. Chem.
2004
279
|
19179380 |
Lee J et al.:
Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis
FASEB J.
2009
23: 1739-1749
|
17925878 |
Yamagishi S et al.:
An in vitro model for Lewy body-like hyaline inclusion/astrocytic hyaline inclusion: induction by ER stress with an ALS-linked SOD1 mutation
PLoS ONE
2007
2: E1030
|
20223753 |
Wong M et al.:
Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice
Hum. Mol. Genet.
2010
19: 2284-2302
|
18706911 |
Pierce A et al.:
GAPDH is conformationally and functionally altered in association with oxidative stress in mouse models of amyotrophic lateral sclerosis
J. Mol. Biol.
2008
382: 1195-1210
|
16043017 |
Poon HF et al.:
Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis
Free Radic. Biol. Med.
2005
39: 453-462
|
17584954 |
Muller FL et al.:
Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.
Am. J. Physiol. Regul. Integr. Comp. Physiol.
2007
293
|
17584954 |
Muller FL et al.:
Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production
Am. J. Physiol. Regul. Integr. Comp. Physiol.
2007
293
|
20007371 |
Gros-Louis F et al.:
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
20007371 |
Gros-Louis F et al.:
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
20198480 |
Kraemer BC et al.:
Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis.
Acta Neuropathol.
2010
119: 409-419
|
19379745 |
Feiguin F et al.:
Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior.
FEBS Lett.
2009
583: 1586-1592
|
19816510 |
Wang M et al.:
Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis
Cell Death Differ.
2010
17: 488-498
|
20188146 |
Tudor EL et al.:
Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology
Neuroscience
2010
167: 774-785
|
16835242 |
Latreille M et al.:
Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress
J. Biol. Chem.
2006
281
|
16835242 |
Latreille M et al.:
Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress
J. Biol. Chem.
2006
281
|
16835242 |
Latreille M et al.:
Nck in a complex containing the catalytic subunit of protein phosphatase 1 regulates eukaryotic initiation factor 2alpha signaling and cell survival to endoplasmic reticulum stress.
J. Biol. Chem.
2006
281
|
19383787 |
Zhang YJ et al.:
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.
Proc. Natl. Acad. Sci. U.S.A.
2009
106: 7607-7612
|
19805353 |
Iwawaki T et al.:
Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability.
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
19805353 |
Iwawaki T et al.:
Function of IRE1 alpha in the placenta is essential for placental development and embryonic viability
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
20379728 |
Braak H et al.:
Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord
Acta Neuropathol.
2010
120: 67-74
|
20043239 |
Shiina Y et al.:
TDP-43 dimerizes in human cells in culture
Cell. Mol. Neurobiol.
2010
30: 641-652
|
20071528 |
Barmada SJ et al.:
Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis
J. Neurosci.
2010
30: 639-649
|
19251627 |
Kwiatkowski TJ Jr et al.:
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Science
2009
323: 1205-1208
|
18923022 |
Poesen K et al.:
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.
J. Neurosci.
2008
28
|
18923022 |
Poesen K et al.:
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration
J. Neurosci.
2008
28
|
18923022 |
Poesen K et al.:
Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration
J. Neurosci.
2008
28
|
17652584 |
Lu L et al.:
Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression
J. Neurosci.
2007
27: 7929-7938
|
17652584 |
Lu L et al.:
Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.
J. Neurosci.
2007
27: 7929-7938
|
19196430 |
Li X et al.:
Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3-untranslated region.
J. Neurochem.
2009
108: 1032-1044
|
19622636 |
Uemura A et al.:
Unconventional splicing of XBP1 mRNA occurs in the cytoplasm during the mammalian unfolded protein response.
J. Cell. Sci.
2009
122: 2877-2886
|
17403682 |
Zhang F et al.:
Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.
J. Biol. Chem.
2007
282
|
17403682 |
Zhang F et al.:
Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex
J. Biol. Chem.
2007
282
|
18515363 |
Strom AL et al.:
Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation
J. Biol. Chem.
2008
283
|
18719118 |
Ilieva HS et al.:
Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death
Proc. Natl. Acad. Sci. U.S.A.
2008
105
|
18719118 |
Ilieva HS et al.:
Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death
Proc. Natl. Acad. Sci. U.S.A.
2008
105
|
18178312 |
Gomes E et al.:
p38 MAPK as a negative regulator of VEGF/VEGFR2 signaling pathway in serum deprived human SK-N-SH neuroblastoma cells
Neurosci. Lett.
2008
431: 95-100
|
11445557 |
Chen R et al.:
Regulation of Akt/PKB activation by tyrosine phosphorylation.
J. Biol. Chem.
2001
276
|
20020442 |
Price J et al.:
Akt-1 mediates survival of chondrocytes from endoplasmic reticulum-induced stress.
J. Cell. Physiol.
2010
222: 502-508
|
15911875 |
Kieran D et al.:
A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice
J. Cell Biol.
2005
169: 561-567
|
12730604 |
Hafezparast M et al.:
Mutations in dynein link motor neuron degeneration to defects in retrograde transport
Science
2003
300: 808-812
|
20428114 |
Maruyama H et al. et al.:
Mutations of optineurin in amyotrophic lateral sclerosis
Nature
2010
465: 223-226
|
20428114 |
Maruyama H et al.:
Mutations of optineurin in amyotrophic lateral sclerosis.
Nature
2010
465: 223-226
|
19657041 |
Perlson E et al.:
A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration
J. Neurosci.
2009
29: 9903-9917
|
15339911 |
Hu P et al.:
Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death
J. Biol. Chem.
2004
279
|
15339911 |
Hu P et al.:
Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death.
J. Biol. Chem.
2004
279
|
12654515 |
Li B et al.:
VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death
Brain Res. Mol. Brain Res.
2003
111: 155-164
|
17991856 |
Lin JH et al.:
IRE1 signaling affects cell fate during the unfolded protein response.
Science
2007
318: 944-949
|
18305234 |
Laird FM et al.:
Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking
J. Neurosci.
2008
28: 1997-2005
|
18094236 |
Lai C et al.:
The G59S mutation in p150(glued) causes dysfunction of dynactin in mice
J. Neurosci.
2007
27
|
18701194 |
Anagnostou G et al.:
Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord.
Neurobiol. Aging
2010
31: 969-985
|
18555774 |
Tsuda H et al.:
The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.
Cell
2008
133: 963-977
|
18344992 |
Zhong Z et al.:
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Nat. Neurosci.
2008
11: 420-422
|
18030339 |
Garbuzova-Davis S et al.:
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS
PLoS ONE
2007
2: E1205
|
19841542 |
Zhong Z et al.:
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells
J. Clin. Invest.
2009
119: 3437-3449
|
19841542 |
Zhong Z et al.:
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells
J. Clin. Invest.
2009
119: 3437-3449
|
18250315 |
Fornai F et al. et al.:
Lithium delays progression of amyotrophic lateral sclerosis
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 2052-2057
|
16236328 |
Shao L et al.:
Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells.
Life Sci.
2006
78: 1317-1323
|
15980862 |
Ravikumar B et al.:
Dynein mutations impair autophagic clearance of aggregate-prone proteins.
Nat. Genet.
2005
37: 771-776
|
14960605 |
Nguyen MD et al.:
Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis
J. Neurosci.
2004
24: 1340-1349
|
15056289 |
Pehar M et al.:
Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis
J. Neurochem.
2004
89: 464-473
|
20138122 |
Milane A et al.:
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis
Neurosci. Lett.
2010
472: 166-170
|
11754077 |
Cassina P et al.:
Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis
J. Neurosci. Res.
2002
67: 21-29
|
19733563 |
Neymotin A et al.:
Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis
Exp. Neurol.
2009
220: 191-197
|
20616880 |
Huang C et al.:
Sustained expression of TDP-43 and FUS in motor neurons in rodents lifetime
Int. J. Biol. Sci.
2010
6: 396-406
|
20606625 |
Dormann D et al.:
ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import
EMBO J.
2010
29: 2841-2857
|
20606625 |
Dormann D et al.:
ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import
EMBO J.
2010
29: 2841-2857
|
17481916 |
Strong MJ et al.:
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Mol. Cell. Neurosci.
2007
35: 320-327
|
17481916 |
Strong MJ et al.:
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Mol. Cell. Neurosci.
2007
35: 320-327
|
20517935 |
Deng HX et al.:
FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis
Ann. Neurol.
2010
67: 739-748
|
18305110 |
Winton MJ et al.:
Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation
J. Biol. Chem.
2008
283
|
20570967 |
Crippa V et al.:
The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)
Hum. Mol. Genet.
2010
19: 3440-3456
|
20570967 |
Crippa V et al. et al.:
The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS)
Hum. Mol. Genet.
2010
19: 3440-3456
|
20624952 |
Ling SC et al.:
ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
19815002 |
Volkening K et al.:
Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)
Brain Res.
2009
1305: 168-182
|
20138212 |
Caragounis A et al.:
Zinc induces depletion and aggregation of endogenous TDP-43
Free Radic. Biol. Med.
2010
48: 1152-1161
|
16877542 |
Wu DC et al.:
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice
Proc. Natl. Acad. Sci. U.S.A.
2006
103
|
20219021 |
Rentzos M et al.:
Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation
Acta Neurol. Scand.
2010
122: 425-429
|
19752764 |
Sargsyan SA et al.:
Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1
Neuroreport
2009
20: 1450-1455
|
17852013 |
Rentzos M et al.:
RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis
Amyotroph Lateral Scler
2007
8: 283-287
|
18997009 |
Chiu IM et al.:
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS
Proc. Natl. Acad. Sci. U.S.A.
2008
105
|
20071543 |
Duplan L et al.:
Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death
J. Neurosci.
2010
30: 785-796
|
20071543 |
Duplan L et al.:
Collapsin response mediator protein 4a (CRMP4a) is upregulated in motoneurons of mutant SOD1 mice and can trigger motoneuron axonal degeneration and cell death
J. Neurosci.
2010
30: 785-796
|
19323997 |
Yang Y et al.:
Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1
Neuron
2009
61: 880-894
|
19323997 |
Yang Y et al.:
Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1
Neuron
2009
61: 880-894
|
11818550 |
Howland DS et al.:
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
Proc. Natl. Acad. Sci. U.S.A.
2002
99: 1604-1609
|
19074031 |
Vargas MR et al.:
Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis
J. Neurosci.
2008
28
|
14755726 |
Henkel JS et al.:
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue
Ann. Neurol.
2004
55: 221-235
|
19429692 |
D'Ambrogio A et al.:
Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo
Nucleic Acids Res.
2009
37: 4116-4126
|
19910924 |
Fiesel FC et al.:
Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6
EMBO J.
2010
29: 209-221
|
19910924 |
Fiesel FC et al.:
Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6
EMBO J.
2010
29: 209-221
|
20361056 |
Zhou H et al.:
Transgenic rat model of neurodegeneration caused by mutation in the TDP gene
PLoS Genet.
2010
6
|
17555556 |
Xiao Q et al.:
Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia
J. Neurochem.
2007
102: 2008-2019
|
19888600 |
Chen K et al.:
Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice
Brain Struct Funct
2010
214: 219-234
|
19236470 |
Kuhle J et al.:
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis
Eur. J. Neurol.
2009
16: 771-774
|
19236470 |
Kuhle J et al.:
Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis
Eur. J. Neurol.
2009
16: 771-774
|
19005069 |
Cheret C et al.:
Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase.
J. Neurosci.
2008
28
|
18598679 |
Li B et al.:
The NADPH oxidase is involved in lipopolysaccharide-mediated motor neuron injury.
Brain Res.
2008
1226: 199-208
|
19307024 |
Mantovani S et al.:
Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process
J. Neuroimmunol.
2009
210: 73-79
|
20544912 |
Mitchell RM et al.:
Plasma biomarkers associated with ALS and their relationship to iron homeostasis
Muscle Nerve
2010
42: 95-103
|
18825663 |
Liang X et al.:
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
Ann. Neurol.
2008
64: 304-314
|
18825663 |
Liang X et al.:
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
Ann. Neurol.
2008
64: 304-314
|
19539030 |
Casafont I et al.:
TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons
J. Struct. Biol.
2009
167: 235-241
|
20740007 |
Elden AC et al. et al.:
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Nature
2010
466: 1069-1075
|
20579074 |
Huang EJ et al.:
Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions
Brain Pathol.
2010
20: 1069-1076
|
20544928 |
Rademakers R et al.:
Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis
Muscle Nerve
2010
42: 170-176
|
20154090 |
Hanson KA et al.:
Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS)
J. Biol. Chem.
2010
285
|
19112176 |
Kim SH et al.:
Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1
J. Biol. Chem.
2009
284: 8083-8092
|
19887443 |
Nishimoto Y et al.:
Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.
J. Biol. Chem.
2010
285: 608-619
|
17898224 |
Zhang YJ et al.:
Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43
J. Neurosci.
2007
27
|
20600671 |
Duan W et al.:
Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell
Neuroscience
2010
169: 1621-1629
|
20133711 |
Wils H et al.:
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Proc. Natl. Acad. Sci. U.S.A.
2010
107: 3858-3863
|
18546284 |
Hasegawa M et al.:
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Ann. Neurol.
2008
64: 60-70
|
18546284 |
Hasegawa M et al.:
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Ann. Neurol.
2008
64: 60-70
|
20303959 |
Guo Y et al.:
Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice
FEBS Lett.
2010
584: 1615-1622
|
19223871 |
Tatom JB et al.:
Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrigs disease in rats via TDP-43 overexpression
Mol. Ther.
2009
17: 607-613
|
19833869 |
Wegorzewska I et al.:
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Proc. Natl. Acad. Sci. U.S.A.
2009
106
|
20660762 |
Chiang PM et al.:
Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
16369483 |
Urushitani M et al.:
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis
Nat. Neurosci.
2006
9: 108-118
|
16369483 |
Urushitani M et al.:
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis
Nat. Neurosci.
2006
9: 108-118
|
20829229 |
Ferri A et al.:
Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity
Hum. Mol. Genet.
2010
19: 4529-4542
|
20202083 |
Yamashita S et al.:
DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity
J. Neurochem.
2010
113: 860-870
|
20202083 |
Yamashita S et al.:
DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity
J. Neurochem.
2010
113: 860-870
|
19889637 |
Zhou J et al.:
Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis
J. Biol. Chem.
2010
285: 705-712
|
20460269 |
Pedrini S et al.:
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2
Hum. Mol. Genet.
2010
19: 2974-2986
|
20460269 |
Pedrini S et al.:
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2
Hum. Mol. Genet.
2010
19: 2974-2986
|
17510659 |
Hetz C et al.:
The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis
Cell Death Differ.
2007
14: 1386-1389
|
17510659 |
Hetz C et al.:
The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis
Cell Death Differ.
2007
14: 1386-1389
|
19100675 |
Abutin RM et al.:
Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells
Exp. Hematol.
2009
37: 151-158
|
20456006 |
Tovar-Y-Romo LB et al.:
VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK
J. Neurochem.
2010
115: 1090-1101
|
19741096 |
Yonashiro R et al.:
Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation
Mol. Biol. Cell
2009
20: 4524-4530
|
10650002 |
Urano F et al.:
Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1
Science
2000
287: 664-666
|
17178835 |
Jiang SX et al.:
Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo
Mol. Cell. Biol.
2007
27: 1696-1705
|
20890041 |
Reyes NA et al.:
Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis
J. Clin. Invest.
2010
120: 3673-3679
|
18160256 |
Nawa M et al.:
A novel Akt/PKB-interacting protein promotes cell adhesion and inhibits familial amyotrophic lateral sclerosis-linked mutant SOD1-induced neuronal death via inhibition of PP2A-mediated dephosphorylation of Akt/PKB
Cell. Signal.
2008
20: 493-505
|
18086918 |
Kang J et al.:
MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis
J. Cell Biol.
2007
179: 1219-1230
|
17725983 |
De Vos KJ et al.:
Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content
Hum. Mol. Genet.
2007
16: 2720-2728
|
12390515 |
Jung C et al.:
Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis
J. Neurochem.
2002
83: 535-545
|
15634778 |
Kirkinezos IG et al.:
Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice
J. Neurosci.
2005
25: 164-172
|
19240958 |
Lin J et al.:
Specific electron transport chain abnormalities in amyotrophic lateral sclerosis
J. Neurol.
2009
256: 774-782
|
12050154 |
Mattiazzi M et al.:
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice
J. Biol. Chem.
2002
277
|
16903849 |
Raimondi A et al.:
Cell culture models to investigate the selective vulnerability of motoneuronal mitochondria to familial ALS-linked G93ASOD1
Eur. J. Neurosci.
2006
24: 387-399
|
15758154 |
Vijayvergiya C et al.:
Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice
J. Neurosci.
2005
25: 2463-2470
|
18703498 |
Kawamata H et al.:
Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria
Hum. Mol. Genet.
2008
17: 3303-3317
|
19320055 |
Son M et al.:
Redox susceptibility of SOD1 mutants is associated with the differential response to CCS over-expression in vivo
Neurobiol. Dis.
2009
34: 155-162
|
17620987 |
Jiang YM et al.:
Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis
J. Neuropathol. Exp. Neurol.
2007
66: 617-627
|
21078990 |
Li Q et al.:
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
21078990 |
Li Q et al.:
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
20797535 |
Israelson A et al.:
Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS
Neuron
2010
67: 575-587
|
20797535 |
Israelson A et al.:
Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS
Neuron
2010
67: 575-587
|
18296640 |
Vande Velde C et al.:
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 4022-4027
|
19779023 |
Magrane J et al.:
Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities
Hum. Mol. Genet.
2009
18: 4552-4564
|
19272377 |
Martin LJ et al.:
The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice
Exp. Neurol.
2009
218: 333-346
|
19174508 |
Nguyen KT et al.:
The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals
Proc. Natl. Acad. Sci. U.S.A.
2009
106: 2007-2011
|
19404401 |
Dupuis L et al.:
Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons
PLoS ONE
2009
4: E5390
|
19158288 |
Jeong SY et al.:
Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis
J. Neurosci.
2009
29: 610-619
|
17394531 |
Zimmerman MC et al.:
Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels
J. Neurochem.
2007
102: 609-618
|
16702190 |
Wood-Allum CA et al.:
Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen
Brain
2006
129: 1693-1709
|
20127819 |
Morimoto N et al.:
Induction of parkinsonism-related proteins in the spinal motor neurons of transgenic mouse carrying a mutant SOD1 gene
J. Neurosci. Res.
2010
88: 1804-1811
|
18712292 |
Lev N et al.:
DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS.
J. Mol. Neurosci.
2009
38: 94-102
|
17434459 |
Eve DJ et al.:
Transcription factor p53 in degenerating spinal cords.
Brain Res.
2007
1150: 174-181
|
17099894 |
Martin LJ et al.:
Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
J. Comp. Neurol.
2007
500: 20-46
|
19805546 |
Lu L et al.:
Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor.
J. Biol. Chem.
2009
284
|
17434152 |
Murakami T et al.:
Early decrease of mitochondrial DNA repair enzymes in spinal motor neurons of presymptomatic transgenic mice carrying a mutant SOD1 gene.
Brain Res.
2007
1150: 182-189
|
19900586 |
Loizzo S et al.:
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model.
Mitochondrion
2010
10: 108-114
|
19379740 |
Bradley LJ et al.:
Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues.
Exp. Neurol.
2009
218: 92-97
|
18417691 |
Cassina P et al.:
Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants.
J. Neurosci.
2008
28: 4115-4122
|
21059924 |
Bilsland LG et al.:
Deficits in axonal transport precede ALS symptoms in vivo.
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
20606625 |
Dormann D et al.:
ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
EMBO J.
2010
29: 2841-2857
|
25374358 |
Smith BN et al.:
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS
Neuron
2014
84: 324-331
|
28989002 |
Sanfilippo C et al.:
CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients
Mol. Cell. Neurosci.
2017
85: 162-169
|
20079427 |
Halter B et al.:
Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis
Free Radic. Biol. Med.
2010
48: 915-923
|
23300739 |
Figueroa-Romero C et al.:
Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis
PLoS ONE
2012
7
|
31784536 |
Yuva-Aydemir Y et al.:
Transcription elongation factor AFF2/FMR2 regulates expression of expanded GGGGCC repeat-containing C9ORF72 allele in ALS/FTD
Nat Commun
2019
10: 5466
|
17244347 |
Lederer CW et al.:
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
BMC Genomics
2007
8: 26
|
17671248 |
Dunckley T et al. et al.:
Whole-genome analysis of sporadic amyotrophic lateral sclerosis
N. Engl. J. Med.
2007
357: 775-788
|
24918638 |
Venkova K et al.:
Semaphorin 3A signaling through neuropilin-1 is an early trigger for distal axonopathy in the SOD1G93A mouse model of amyotrophic lateral sclerosis
J. Neuropathol. Exp. Neurol.
2014
73: 702-713
|
26704906 |
Figueroa-Romero C et al.:
Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms
Mol. Cell. Neurosci.
2016
71: 34-45
|
28283675 |
Andres-Benito P et al.:
Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration
Aging (Albany NY)
2017
9: 823-851
|
22922411 |
Van Hoecke A et al. et al.:
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Nat. Med.
2012
18: 1418-1422
|
26687981 |
Lewandowski SA et al.:
Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration
Acta Neuropathol.
2016
131: 453-464
|
27812125 |
Won YH et al.:
Elucidation of Relevant Neuroinflammation Mechanisms Using Gene Expression Profiling in Patients with Amyotrophic Lateral Sclerosis
PLoS ONE
2016
11
|
16807408 |
Parkinson N et al.:
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
Neurology
2006
67: 1074-1077
|
23022214 |
author information missing
article information missing
|
11803234 |
Croonenberghs J et al.:
Activation of the inflammatory response system in autism.
Neuropsychobiology
2002
45: 1-6
|
19157572 |
Li X et al.:
Elevated immune response in the brain of autistic patients.
J. Neuroimmunol.
2009
207: 111-116
|
10693155 |
Croonenberghs J et al.:
Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder
Neuropsychopharmacology
2000
22: 275-283
|
10693155 |
Croonenberghs J et al.:
Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder.
Neuropsychopharmacology
2000
22: 275-283
|
21573053 |
Naik US et al.:
A study of nuclear transcription factor-kappa B in childhood autism.
PLoS ONE
2011
6
|
21521652 |
Al-ayadhi LY et al.:
Increased serum osteopontin levels in autistic children: relation to the disease severity
Brain Behav. Immun.
2011
25: 1393-1398
|
20705131 |
Ashwood P et al.:
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
Brain Behav. Immun.
2011
25: 40-45
|
12039413 |
Torres AR et al.:
The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder
Hum. Immunol.
2002
63: 311-316
|
21346746 |
Penzes P et al.:
Dendritic spine pathology in neuropsychiatric disorders
Nat. Neurosci.
2011
14: 285-293
|
23596459 |
Gilling M et al.:
Dysfunction of the Heteromeric KV7.3/KV7.5 Potassium Channel is Associated with Autism Spectrum Disorders
Front Genet
2013
4: 54
|
19289393 |
Ben-Shachar S et al.:
Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders
J. Med. Genet.
2009
46: 382-388
|
24776741 |
McCarthy SE et al.:
De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability
|
24752249 |
Breitenkamp AF et al.:
Rare mutations of CACNB2 found in autism spectrum disease-affected families alter calcium channel function
PLoS ONE
2014
9
|
25707359 |
Chen N et al.:
Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes
Biochim. Biophys. Acta
2015
7: 827-833
|
25271084 |
Mullegama SV et al.:
MBD5 haploinsufficiency is associated with sleep disturbance and disrupts circadian pathways common to Smith-Magenis and fragile X syndromes
Eur. J. Hum. Genet.
2015
23: 781-789
|
28720891 |
Al-Mubarak B et al. et al.:
Whole exome sequencing reveals inherited and de novo variants in autism spectrum disorder: a trio study from Saudi families
Sci Rep
2017
7: 5679
|
26749308 |
Turner TN et al. et al.:
Genome Sequencing of Autism-Affected Families Reveals Disruption of Putative Noncoding Regulatory DNA
Am. J. Hum. Genet.
2016
98: 58-74
|
25774383 |
Cartier E et al. et al.:
Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors
EBioMedicine
2015
2: 135-146
|
18593506 |
Nakamura K et al. et al.:
Genetic and expression analyses reveal elevated expression of syntaxin 1A ( STX1A) in high functioning autism
Int. J. Neuropsychopharmacol.
2008
11: 1073-1084
|
22495309 |
O'Roak BJ et al. et al.:
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
Nature
2012
485: 246-250
|
30873608 |
Castronovo P et al.:
Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review
|
23995680 |
King IF et al. et al.:
Topoisomerases facilitate transcription of long genes linked to autism
Nature
2013
501: 58-62
|
23495017 |
Dabell MP et al. et al.:
Investigation of NRXN1 deletions: clinical and molecular characterization
Am. J. Med. Genet. A
2013
161A: 717-731
|
27965028 |
Sajid U et al.:
Two De Novo Mutations in an Autistic Child Who Had Previously Undergone Transplantation for Dilated Cardiomyopathy: The Importance of Keeping an Open Mind
Can J Cardiol
2017
33: 292.e5-292.e7
|
18057082 |
et al.:
A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha
J. Med. Genet.
2008
45: 239-243
|
24360806 |
He Z et al. et al.:
Rare-variant extensions of the transmission disequilibrium test: application to autism exome sequence data
Am. J. Hum. Genet.
2014
94: 33-46
|
25363760 |
De Rubeis S et al. et al.:
Synaptic, transcriptional and chromatin genes disrupted in autism
Nature
2014
515: 209-215
|
28263302 |
C Yuen RK et al. et al.:
Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
Nat. Neurosci.
2017
20: 602-611
|
22542183 |
Iossifov I et al. et al.:
De novo gene disruptions in children on the autistic spectrum
Neuron
2012
74: 285-299
|
25363768 |
Iossifov I et al. et al.:
The contribution of de novo coding mutations to autism spectrum disorder
Nature
2014
515: 216-221
|
29021403 |
Hamilton MJ et al. et al.:
Heterozygous mutations affecting the protein kinase domain of CDK13 cause a syndromic form of developmental delay and intellectual disability
J. Med. Genet.
2018
55: 28-38
|
23275889 |
Prasad A et al. et al.:
A discovery resource of rare copy number variations in individuals with autism spectrum disorder
G3 (Bethesda)
3 (B
2: 1665-1685
|
22495311 |
Neale BM et al. et al.:
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Nature
2012
485: 242-245
|
28584692 |
Shroff G et al.:
Human Embryonic Stem Cells in the Treatment of Autism: A Case Series
Innov Clin Neurosci
2017
14: 12-16
|
22843504 |
Anney R et al. et al.:
Individual common variants exert weak effects on the risk for autism spectrum disorders
Hum. Mol. Genet.
2012
21: 4781-4792
|
29346770 |
Takata A et al. et al.:
Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder
Cell Rep
2018
22: 734-747
|
22965006 |
Skafidas E et al.:
Predicting the diagnosis of autism spectrum disorder using gene pathway analysis
Mol. Psychiatry
2014
19: 504-510
|
18252227 |
Marshall CR et al. et al.:
Structural variation of chromosomes in autism spectrum disorder
Am. J. Hum. Genet.
2008
82: 477-488
|
11706102 |
Purcell AE et al.:
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
Neurology
2001
57: 1618-1628
|
21614001 |
Voineagu I et al.:
Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Nature
2011
474: 380-384
|
26783092 |
Feng J et al.:
Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder
Nutr Neurosci
2017
20: 284-290
|
29505902 |
O'Connell KS et al.:
The genetic architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism spectrum disorder
Mol. Cell. Neurosci.
2018
88: 300-307
|
11357950 |
Nelson KB et al.:
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation
Ann. Neurol.
2001
49: 597-606
|
21358714 |
Gai X et al. et al.:
Rare structural variation of synapse and neurotransmission genes in autism
Mol. Psychiatry
2012
17: 402-411
|
24007566 |
Stamova BS et al.:
Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
Mol Autism
2013
4: 30
|
31277925 |
Nakagawa N et al. et al.:
Memo1-Mediated Tiling of Radial Glial Cells Facilitates Cerebral Cortical Development
Neuron
2019
103: 836-852.e5
|
31327155 |
Miryounesi M et al.:
ELMO Domain Containing 1 (ELMOD1) Gene Mutation Is Associated with Mental Retardation and Autism Spectrum Disorder
J. Mol. Neurosci.
2019
69: 312-315
|
29428674 |
Quartier A et al.:
Genes and Pathways Regulated by Androgens in Human Neural Cells, Potential Candidates for the Male Excess in Autism Spectrum Disorder
Biol. Psychiatry
2018
84: 239-252
|
23279911 |
Boudry-Labis E et al. et al.:
A novel microdeletion syndrome at 9q21.13 characterised by mental retardation, speech delay, epilepsy and characteristic facial features
Eur J Med Genet
2013
56: 163-170
|
28251352 |
Zhang J et al. et al.:
Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features
Hum. Genet.
2017
136: 377-386
|
23838881 |
Talebizadeh Z et al.:
A proof-of-concept study: exon-level expression profiling and alternative splicing in autism using lymphoblastoid cell lines
Psychiatr. Genet.
2014
24: 1-9
|
20308993 |
Vorstman JA et al. et al.:
A double hit implicates DIAPH3 as an autism risk gene
Mol. Psychiatry
2011
16: 442-451
|
26398136 |
Kuo PH et al. et al.:
Genome-Wide Association Study for Autism Spectrum Disorder in Taiwanese Han Population
PLoS ONE
2015
10
|
23756379 |
Poelmans G et al.:
AKAPs integrate genetic findings for autism spectrum disorders
Transl Psychiatry
2013
3: e270
|
27479844 |
Krishnan A et al.:
Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder
Nat. Neurosci.
2016
19: 1454-1462
|
28628100 |
Geisheker MR et al. et al.:
Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains
Nat. Neurosci.
2017
20: 1043-1051
|
29147782 |
Chiocchetti AG et al. et al.:
Common functional variants of the glutamatergic system in Autism spectrum disorder with high and low intellectual abilities
J Neural Transm (Vienna)
2018
125: 259-271
|
27545675 |
Bain JM et al. et al.:
Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females
Am. J. Hum. Genet.
2016
99: 728-734
|
20452682 |
Mostafa GA et al.:
The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children
J. Neuroimmunol.
2010
223: 115-119
|
22589251 |
Harper KM et al.:
Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain
Hum. Mol. Genet.
2012
21: 3489-3499
|
31923461 |
Loomis C et al.:
Identification of MAGUK scaffold proteins as intracellular binding partners of synaptic adhesion protein Slitrk2
Mol. Cell. Neurosci.
2020
103
|
20479760 |
Piton A et al. et al.:
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia
Mol. Psychiatry
2011
16: 867-880
|
25360606 |
Jones RM et al.:
MACROD2 gene associated with autistic-like traits in a general population sample
Psychiatr. Genet.
2014
24: 241-248
|
21981781 |
Talkowski ME et al. et al.:
Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder
Am. J. Hum. Genet.
2011
89: 551-563
|
27428651 |
Shemesh Y et al. et al.:
Ucn3 and CRF-R2 in the medial amygdala regulate complex social dynamics
Nat. Neurosci.
2016
19: 1489-1496
|
26314684 |
Liu X et al. et al.:
Genome-wide Association Study of Autism Spectrum Disorder in the East Asian Populations
Autism Res
2016
9: 340-349
|
31094488 |
Torrico B et al.:
Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes }, authors { names std { { name ml Torrico B, affil str From the Departament de Genetica, Microbiologia i Estadistica, Universitat de Barcelona, Spain (Torrico, Vivo-Luque, Fernandez-Castillo, Cormand, Toma); the Institute of Biomedicine, University of Barcelona, Barcelona, Spain (Torrico, Fernandez-Castillo, Cormand, Toma); the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain (Torrico, Fernandez-Castillo, Cormand, Toma); the Institut de Recerca Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain (Torrico, Fernandez-Castillo, Cormand); the Neuroscience Research Australia, Sydney, NSW, Australia (Shaw, Fullerton, Toma); the School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia (Shaw, Fullerton, Toma); the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Institute of Science and Technology, Barcelona, Spain (Mosca, Aloy); the Child and Adolescent Mental Health Unit, Hospital Universitari Mutua de Terrassa, Spain (Hervas); the Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain (Aloy); and the Centro Nacional de Analisis Genomico (CNAG), Barcelona, Spain (Bayes)
J Psychiatry Neurosci
2019
44: 350-359
|
31018497 |
Carrasco M et al.:
Alterations of Mitochondrial Biology in the Oral Mucosa of Chilean Children with Autism Spectrum Disorder (ASD)
|
25418537 |
O'Roak BJ et al. et al.:
Recurrent de novo mutations implicate novel genes underlying simplex autism risk
Nat Commun
2014
5: 5595
|
30394313 |
Wang M et al.:
Alteration of gut microbiota-associated epitopes in children with autism spectrum disorders
Brain Behav. Immun.
2019
75: 192-199
|
29114925 |
Ishizuka K et al. et al.:
Possible involvement of a cell adhesion molecule, Migfilin, in brain development and pathogenesis of autism spectrum disorders
J. Neurosci. Res.
2018
96: 789-802
|
28262759 |
Goto M et al.:
Role of a circadian-relevant gene NR1D1 in brain development: possible involvement in the pathophysiology of autism spectrum disorders
Sci Rep
2017
7: 43945
|
24520327 |
Choi J et al.:
Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum
PLoS ONE
2014
9
|
31323913 |
Rafi SK et al.:
High Functioning Autism with Missense Mutations in Synaptotagmin-Like Protein 4 (SYTL4) and Transmembrane Protein 187 (TMEM187) Genes: SYTL4- Protein Modeling, Protein-Protein Interaction, Expression Profiling and MicroRNA Studies
|
24493018 |
Chiocchetti AG et al.:
Glutamatergic candidate genes in autism spectrum disorder: an overview
J Neural Transm (Vienna)
2014
121: 1081-1106
|
28540026 |
author information missing
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia
Mol Autism
2017
8: 21
|
24158444 |
Chu BW et al.:
The E3 ubiquitin ligase UBE3C enhances proteasome processivity by ubiquitinating partially proteolyzed substrates
J Biol Chem
2013
288
|
35221709 |
author information missing
article information missing
|
15805158 |
author information missing
article information missing
|
11074872 |
Guidotti A et al.:
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study
Arch. Gen. Psychiatry
2000
57: 1061-1069
|
17270400 |
Veldic M et al.:
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder
Schizophr. Res.
2007
91: 51-61
|
19059449 |
Torres KC et al.:
The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
Prog. Neuropsychopharmacol. Biol. Psychiatry
2009
33: 214-219
|
20368704 |
Williams HJ et al.:
Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder
Mol. Psychiatry
2011
16: 429-441
|
16924267 |
Severinsen JE et al.:
Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder.
Mol. Psychiatry
2006
11: 1126-1138
|
16484223 |
Assmann EM et al.:
FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region
J. Biol. Chem.
2006
281: 9869-9881
|
20569643 |
Hope S et al.:
Osteoprotegerin levels in patients with severe mental disorders
J Psychiatry Neurosci
2010
35: 304-310
|
19754466 |
OBrien WT et al.:
Validating GSK3 as an in vivo target of lithium action.
Biochem. Soc. Trans.
2009
37: 1133-1138
|
21176028 |
Beech RD et al.:
Increased peripheral blood expression of electron transport chain genes in bipolar depression.
Bipolar Disord
2010
12: 813-824
|
20566748 |
Cataldo AM et al.:
Abnormalities in mitochondrial structure in cells from patients with bipolar disorder.
Am. J. Pathol.
2010
177: 575-585
|
17485607 |
Naydenov AV et al.:
Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress.
Arch. Gen. Psychiatry
2007
64: 555-564
|
20368511 |
Andreazza AC et al.:
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder
Arch. Gen. Psychiatry
2010
67: 360-368
|
1728159 |
Dubovsky SL et al.:
Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients.
Am J Psychiatry
1992
149: 118-120
|
15737668 |
Munakata K et al.:
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
Biol. Psychiatry
2005
57: 525-532
|
14993118 |
Konradi C et al.:
Molecular evidence for mitochondrial dysfunction in bipolar disorder
Arch. Gen. Psychiatry
2004
61: 300-308
|
16696827 |
MacDonald ML et al.:
Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder.
Bipolar Disord
2006
8: 255-264
|
18191109 |
Shao L et al.:
Shared gene expression alterations in schizophrenia and bipolar disorder
Biol. Psychiatry
2008
64: 89-97
|
19350560 |
Kahler AK et al.:
Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples.
Am. J. Med. Genet. B Neuropsychiatr. Genet.
2010
153B: 86-96
|
22428012 |
Li J et al.:
Lithium impacts on the amplitude and period of the molecular circadian clockwork
PLoS ONE
2012
7
|
22384149 |
McCarthy MJ et al.:
A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response
PLoS ONE
2012
7
|
11723175 |
Bezchlibnyk YB et al.:
Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex
J. Neurochem.
2001
79: 826-834
|
23231880 |
Manu P et al.:
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
Schizophr. Res.
2013
143: 358-362
|
20591414 |
Mukherjee S et al.:
Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior
Biol. Psychiatry
2010
68: 503-511
|
17259569 |
Varma MK et al.:
Life-threatening hyperglycemia and acidosis related to olanzapine: a case report and review of the literature
J Intensive Care Med
2007
22: 52-55
|
11673795 |
Kirov G et al.:
Screening ABCG1, the human homologue of the Drosophila white gene, for polymorphisms and association with bipolar affective disorder
Mol. Psychiatry
2001
6: 671-677
|
21961650 |
Squassina A et al.:
Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder
Pharmacogenomics
2011
12: 1559-1569
|
20679588 |
Erk S et al.:
Brain function in carriers of a genome-wide supported bipolar disorder variant
Arch. Gen. Psychiatry
2010
67: 803-811
|
22831755 |
Meier S et al.:
Neuregulin 3 is associated with attention deficits in schizophrenia and bipolar disorder
Int. J. Neuropsychopharmacol.
2013
16: 549-556
|
21927946 |
Yamada K et al.:
Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population
Hum. Genet.
2012
131: 443-451
|
22017219 |
Backlund L et al.:
Cognitive manic symptoms associated with the P2RX7 gene in bipolar disorder
Bipolar Disord
2011
13: 500-508
|
21738484 |
Smith EN et al.:
Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes
PLoS Genet.
2011
7
|
23437964 |
Gonzalez S et al.:
Suggestive evidence for association between L-type voltage-gated calcium channel (CACNA1C) gene haplotypes and bipolar disorder in Latinos: a family-based association study
Bipolar Disord
2013
15: 206-214
|
24114586 |
Weston-Green K et al.:
Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor
CNS Drugs
2013
27: 1069-1080
|
22472876 |
Ripke S et al.:
A mega-analysis of genome-wide association studies for major depressive disorder
Mol. Psychiatry
2013
18: 497-511
|
24461634 |
Finseth PI et al.:
Association analysis between suicidal behaviour and candidate genes of bipolar disorder and schizophrenia
J Affect Disord
2014
163: 110-114
|
23974872 |
Ripke S et al.:
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Nat. Genet.
2013
45: 1150-1159
|
23880959 |
Wolf C et al.:
CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia
Eur Arch Psychiatry Clin Neurosci
2014
264: 93-102
|
15563509 |
Iwamoto K et al.:
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis
Hum. Mol. Genet.
2005
14: 241-253
|
23070075 |
Green EK et al.:
Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample
Mol. Psychiatry
2013
18: 1302-1307
|
17486107 |
Baum AE et al.:
A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder
Mol. Psychiatry
2008
13: 197-207
|
15722956 |
Pickard BS et al.:
Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18
Psychiatr. Genet.
2005
15: 37-44
|
16733521 |
Borsotto M et al.:
PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder
Pharmacogenomics J.
2007
7: 123-132
|
17678634 |
Cannon DM et al.:
Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder
Biol. Psychiatry
2007
62: 870-877
|
31170425 |
Noroozi R et al.:
Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder
Neurochem. Int.
2019
129
|
24348429 |
Kerner B et al.:
Rare Genomic Variants Link Bipolar Disorder with Anxiety Disorders to CREB-Regulated Intracellular Signaling Pathways
Front Psychiatry
2013
4: 154
|
12140780 |
Vawter MP et al.:
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
Mol. Psychiatry
2002
7: 571-578
|
19166596 |
Kripke DF et al.:
Circadian polymorphisms associated with affective disorders
J Circadian Rhythms
2009
7: 2
|
24039173 |
McGrath LM et al.:
Genetic predictors of risk and resilience in psychiatric disorders: a cross-disorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia
Am. J. Med. Genet. B Neuropsychiatr. Genet.
2013
162B: 779-788
|
26848839 |
Davis KN et al.:
GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders
PLoS ONE
2016
11
|
27350034 |
Pacifico R et al.:
Transcriptome sequencing implicates dorsal striatum-specific gene network, immune response and energy metabolism pathways in bipolar disorder
Mol. Psychiatry
2017
22: 441-449
|
24718920 |
Nurnberger JI Jr et al.:
Identification of pathways for bipolar disorder: a meta-analysis
JAMA Psychiatry
2014
71: 657-664
|
29628500 |
Lee SE et al.:
nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders
Exp. Mol. Med.
2018
50: 2
|
27890468 |
van Hulzen KJE et al. et al.:
Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis
Biol. Psychiatry
2017
82: 634-641
|
21382426 |
Iwamoto K et al.:
Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders
Neurosci. Res.
2011
70: 238-242
|
20357757 |
Polter A et al.:
Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances
Neuropsychopharmacology
2010
35: 1761-1774
|
30149091 |
Corponi F et al.:
Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder
Prog. Neuropsychopharmacol. Biol. Psychiatry
2019
89: 23-29
|
30905121 |
Oral E et al.:
Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels
Clin Psychopharmacol Neurosci
2019
17: 211-221
|
21621268 |
Magno LA et al.:
Genetic variations in FOXO3A are associated with Bipolar Disorder without confering vulnerability for suicidal behavior
J Affect Disord
2011
133: 633-637
|
28463235 |
Scaini G et al.:
Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients
Transl Psychiatry
2017
7: e1111
|
32754070 |
Reponen EJ et al. et al.:
Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
Front Psychiatry
2020
11: 672
|
17258816 |
Lee BD et al. et al.:
Malic enzyme 2 and susceptibility to psychosis and mania
Psychiatry Res
2007
150: 1-11
|
18357389 |
Lee SJ et al.:
Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways
Oncol. Rep.
2008
19: 1007-1013
|
21601006 |
Yoganathan TN et al.:
Integrin-linked kinase (ILK): a hot therapeutic target
Biochem. Pharmacol.
2000
60: 1115-1119
|
30121007 |
Chakravarthi BVSK et al. et al.:
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression
Neoplasia
2018
20: 894-904
|
27189278 |
Kim WT et al. et al.:
Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls
Yonsei Med. J.
2016
57: 865-871
|
32094233 |
Lokeshwar VB et al. et al.:
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer
|
23866964 |
Dong LH et al.:
Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma
J Hematol Oncol
2013
6: 53
|
20028864 |
Brown KA et al.:
Obesity and breast cancer: progress to understanding the relationship
Cancer Res.
2010
70: 4-7
|
19509226 |
Brown KA et al.:
Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women
Cancer Res.
2009
69: 5392-5399
|
15766664 |
Kim RH et al.:
DJ-1, a novel regulator of the tumor suppressor PTEN.
Cancer Cell
2005
7: 263-273
|
11705844 |
Le Naour F et al.:
Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.
Clin. Cancer Res.
2001
7: 3328-3335
|
20971498 |
Berthier A et al.:
PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells
Hum. Pathol.
2011
42: 75-87
|
16850246 |
Greenlee H et al.:
Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer
Breast Cancer Res. Treat.
2007
102: 111-117
|
1935184 |
Lessner MW et al.:
A student nurses experience in an ICU.
Crit Care Nurse
1991
11: 12
|
16361546 |
Cobleigh MA et al.:
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes
Clin. Cancer Res.
2005
11: 8623-8631
|
11410592 |
Castro-Rivera E et al.:
Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements.
J. Biol. Chem.
2001
276
|
15870704 |
Lewandowski SA et al.:
Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity.
Oncogene
2005
24: 4789-4798
|
16328059 |
Li SY et al.:
Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
Oncol. Rep.
2006
15: 221-225
|
17519015 |
De Luca A et al.:
Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter.
BMC Mol. Biol.
2007
8: 39
|
17510434 |
Lin Z et al.:
Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Cancer Res.
2007
67: 5017-5024
|
8195246 |
Krishnan V et al.:
Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells.
J. Biol. Chem.
1994
269
|
9626663 |
Sun G et al.:
Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex.
Mol. Endocrinol.
1998
12: 882-890
|
12432273 |
Weinstein-Oppenheimer CR et al.:
The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line.
Cancer Biol. Ther.
2002
1: 256-262
|
10733592 |
Perillo B et al.:
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence.
Mol. Cell. Biol.
2000
20: 2890-2901
|
24495551 |
Mehta D et al.:
Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling
|
21655990 |
Hadad S et al.:
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.
Breast Cancer Res. Treat.
2011
128: 783-794
|
18714348 |
Martin KJ et al.:
Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.
PLoS ONE
2008
3: E2994
|
21120602 |
Paruthiyil S et al.:
Estrogen receptor beta causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2
Breast Cancer Res. Treat.
2011
129: 777-784
|
17268063 |
Iso T et al.:
Modulation of the expression of bloom helicase by estrogenic agents.
Biol. Pharm. Bull.
2007
30: 266-271
|
19477925 |
Pedram A et al.:
Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair.
Mol. Biol. Cell
2009
20: 3374-3389
|
17942748 |
Boverhof DR et al.:
Inhibition of estrogen-mediated uterine gene expression responses by dioxin
Mol. Pharmacol.
2008
73: 82-93
|
18949048 |
Wang C et al.:
Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells.
PLoS ONE
2008
3: E3523
|
16010982 |
Vani G et al.:
Effect of histone H1 on estrogen receptor status of human breast cancer MCF 7 cells.
Mol. Cell. Biochem.
2005
272: 151-155
|
19221498 |
Alimova IN et al.:
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
Cell Cycle
2009
8: 909-915
|
14506733 |
Kawai H et al.:
Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha
Int. J. Cancer
2003
107: 353-358
|
17062558 |
Zakikhani M et al.:
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.
Cancer Res.
2006
66
|
21185374 |
Englert NA et al.:
Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells.
J. Steroid Biochem. Mol. Biol.
2011
123: 140-150
|
12612058 |
Hodges LC et al.:
Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells.
Mol. Cancer Res.
2003
1: 300-311
|
14605097 |
Wang DY et al.:
Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1.
Mol. Endocrinol.
2004
18: 402-411
|
16962797 |
Lee SU et al.:
Protein profiling and transcript expression levels of heat shock proteins in 17beta-estradiol-treated human MCF-7 breast cancer cells.
Cell Biol. Int.
2006
30: 983-991
|
17392432 |
Eakin CM et al.:
Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase.
Proc. Natl. Acad. Sci. U.S.A.
2007
104: 5794-5799
|
19887602 |
Ueki T et al.:
Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
Cancer Res.
2009
69: 8752-8760
|
20501845 |
Zhao C et al.:
Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1.
Cancer Res.
2010
70: 5174-5183
|
19434490 |
Treeck O et al.:
Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Breast Cancer Res. Treat.
2010
120: 557-565
|
17428314 |
Lin CY et al.:
Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer
Breast Cancer Res.
2007
9: R25
|
10766163 |
Liu G et al.:
Estrogen receptor protects p53 from deactivation by human double minute-2.
Cancer Res.
2000
60: 1810-1814
|
15328371 |
Wang W et al.:
TAFII70 isoform-specific growth suppression correlates with its ability to complex with the GADD45a protein
Mol. Cancer Res.
2004
2: 442-452
|
17407970 |
Su T et al.:
Dip1 inhibits growth and gene transcription in MCF-7 breast cancer cells
J. Exp. Ther. Oncol.
2007
6: 117-127
|
10220405 |
Yarden RI et al.:
BRCA1 interacts with components of the histone deacetylase complex
Proc. Natl. Acad. Sci. U.S.A.
1999
96: 4983-4988
|
23288347 |
Yamada A et al.:
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival
Breast Cancer Res. Treat.
2013
137: 773-782
|
12878187 |
Gauthier ML et al.:
Protein kinase Calpha negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor
Biochem. Biophys. Res. Commun.
2003
307: 839-846
|
22279420 |
Mohibi S et al.:
Mouse models of estrogen receptor-positive breast cancer
J Carcinog
2011
10: 35
|
19754359 |
van der Veeken J et al.:
Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy
Curr Cancer Drug Targets
2009
9: 748-760
|
18996184 |
Gaikwad NW et al.:
Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
Free Radic. Biol. Med.
2009
46: 253-262
|
22386952 |
Pruthi S et al.:
Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk
J. Steroid Biochem. Mol. Biol.
2012
132: 73-79
|
16675129 |
Cavalieri E et al.:
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention
Biochim. Biophys. Acta
2006
1766: 63-78
|
25110054 |
Do MT et al.:
Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression
Toxicol. Appl. Pharmacol.
2014
280: 138-148
|
19995559 |
Vinothini G et al.:
Correlation of xenobiotic-metabolizing enzymes, oxidative stress and NFkappaB signaling with histological grade and menopausal status in patients with adenocarcinoma of the breast
Clin. Chim. Acta
2010
411: 368-374
|
23576571 |
Rodriguez M et al.:
CYP1A1 regulates breast cancer proliferation and survival
Mol. Cancer Res.
2013
11: 780-792
|
23733406 |
Goode GD et al.:
Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line
Int. J. Cancer
2013
133: 2769-2780
|
14647449 |
Stoner M et al.:
Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins
Oncogene
2004
5: 1052-1063
|
23172368 |
Sotgia F et al.:
Mitochondria fuel breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells
Cell Cycle
2012
11: 4390-4401
|
24212942 |
Gupta N et al.:
beta-Catenin Is a Positive Regulator of Estrogen Receptor-alpha Function in Breast Cancer Cells
Cancers (Basel)
2011
3: 2990-3001
|
20838384 |
Kalra J et al.:
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
Oncogene
2010
29: 6343-6356
|
16785428 |
Bose R et al.:
Phosphoproteomic analysis of Her2/neu signaling and inhibition
Proc. Natl. Acad. Sci. U.S.A.
2006
103: 9773-9778
|
21402692 |
Mitra R et al.:
CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+/-)-14,15-epoxyeicosatrienoic acid (EET)
J. Biol. Chem.
2011
286
|
21054339 |
Kim HG et al.:
Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation
Br. J. Pharmacol.
2011
162: 1096-1108
|
21925487 |
Rudd LP et al.:
Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1)
Chem. Biol. Interact.
2011
194: 113-119
|
24667650 |
Sengupta D et al.:
ERRbeta signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells
Br. J. Cancer
2014
110: 2144-2158
|
10608854 |
Li Z et al.:
IQGAP1 and calmodulin modulate E-cadherin function
J. Biol. Chem.
1999
274
|
25801958 |
Citro S et al.:
PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression
J Mol Cell Biol
2015
7: 132-142
|
21737670 |
Nakagawa M et al.:
Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer
Anticancer Res.
2011
31: 2389-2393
|
17875716 |
Miao ZH et al.:
Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses
Cancer Res.
2007
67: 8752-8761
|
20615467 |
Maeda T et al.:
Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer
J. Steroid Biochem. Mol. Biol.
2010
122: 180-185
|
24754247 |
Gozalpour E et al.:
Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3
Mol. Pharm.
2014
11: 1844-1855
|
19682730 |
Gupta PB et al.:
Identification of selective inhibitors of cancer stem cells by high-throughput screening
Cell
2009
138: 645-659
|
23730416 |
Hayman TJ et al.:
Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell Radiosensitivity
Transl Oncol
2013
3: 355-362
|
24831777 |
Banerjee N et al.:
Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues
Breast Cancer Res. Treat.
2014
145: 647-661
|
26378621 |
Zhang W et al.:
Tris(2-chloroethyl)phosphate-induced cell growth arrest via attenuation of SIRT1-independent PI3K/Akt/mTOR pathway
J Appl Toxicol
2016
36: 914-924
|
21339306 |
Tiraby C et al.:
Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth
Cancer Res.
2011
71: 2518-2528
|
21566910 |
Vandewalle B et al.:
Effect of calcium on e-cadherin expression in breast-tumor cells
Int. J. Oncol.
1994
4: 181-185
|
18521741 |
Lanzino M et al.:
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells
Breast Cancer Res. Treat.
2009
115: 297-306
|
22025613 |
Dong C et al.:
Regulation of alpha(2B)-adrenergic receptor-mediated extracellular signal-regulated kinase 1/2 (ERK1/2) activation by ADP-ribosylation factor 1
J. Biol. Chem.
2011
286
|
11072781 |
Jeng MH et al.:
Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells
Breast Cancer Res. Treat.
2000
62: 167-175
|
20353938 |
Ingermann AR et al.:
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer
J. Biol. Chem.
2010
285
|
24304688 |
McGuirk S et al.:
PGC-1alpha supports glutamine metabolism in breast cancer
Cancer Metab
2013
1: 22
|
14500345 |
Oesterreich S et al.:
Estrogen-mediated down-regulation of E-cadherin in breast cancer cells
Cancer Res.
2003
63: 5203-5208
|
19943104 |
Jin W et al.:
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
Breast Cancer Res. Treat.
2010
123: 359-373
|
26621032 |
Holt SH et al.:
Activation of apoptosis in NAF-1-deficient human epithelial breast cancer cells
J. Cell. Sci.
2016
129: 155-165
|
23959881 |
Sohn YS et al.:
NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth
Proc. Natl. Acad. Sci. U.S.A.
2013
110
|
11525591 |
et al.:
|
23233354 |
Buffa L et al.:
Molecular mechanism of WW-domain binding protein-2 coactivation function in estrogen receptor signaling
IUBMB Life
2013
65: 76-84
|
21429623 |
Ordonez C et al.:
Gender differences in apolipoprotein D expression during aging and in Alzheimer disease
Neurobiol. Aging
2012
33: 433.e11-433.e20
|
28219369 |
McKinnon CM et al.:
The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B
BMC Cancer
2017
17: 145
|
26887652 |
Gruel N et al.:
LIN7A is a major determinant of cell-polarity defects in breast carcinomas
Breast Cancer Res.
2016
18: 23
|
19901966 |
El-Tanani MK et al.:
Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression
Oncogene
2010
29: 752-762
|
20696928 |
Clendening JW et al.:
Dysregulation of the mevalonate pathway promotes transformation
Proc. Natl. Acad. Sci. U.S.A.
2010
107
|
29655782 |
Miko E et al. et al.:
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness
Biochim Biophys Acta Bioenerg
2018
1859: 958-974
|
23505378 |
Di Leva G et al. et al.:
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status
PLoS Genet.
2013
9
|
30038517 |
Xia E et al.:
Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway
Cancer Manag Res
2018
10: 1575-1583
|
12734209 |
Lam DD et al. et al.:
Leptin does not directly affect CNS serotonin neurons to influence appetite
Cell Metab.
2011
13: 584-591
|
28830874 |
O'Brien KM et al.:
Single-Nucleotide Polymorphisms in Vitamin D-Related Genes May Modify Vitamin D-Breast Cancer Associations
Cancer Epidemiol. Biomarkers Prev.
2017
26: 1761-1771
|
24008983 |
Xu X et al.:
Differential 12-O-Tetradecanoylphorbol-13-acetate-induced activation of rat mammary carcinoma susceptibility Fbxo10 variant promoters via a PKC-AP1 pathway
Mol. Carcinog.
2015
54: 134-147
|
28989055 |
Shu T et al.:
Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment
Cancer Lett.
2017
411: 65-73
|
26795347 |
Bacci M et al.:
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
Cancer Res.
2016
76: 1615-1626
|
24374807 |
Marastoni S et al.:
EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration
J Pathol
2014
232: 391-404
|
29968965 |
Li K et al.:
Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3beta/beta-catenin signaling pathway in breast cancer
Cancer Med
2018
7: 3875-3888
|
25436706 |
author information missing
Expression of thyroid-stimulating hormone receptor, octamer-binding transcription factor 4, and intracisternal A particle-promoted polypeptide in human breast cancer tissues
Horm Mol Biol Clin Investig
2012
9: 173-178
|
30335891 |
Kia V et al.:
Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells
J. Cell. Biochem.
2019
120: 5666-5676
|
28235484 |
Zhang L et al.:
Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function
Biochem. Biophys. Res. Commun.
2017
486: 224-231
|
23001506 |
Godoy P et al.:
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response
Breast Cancer
2014
21: 491-499
|
26640146 |
Park UH et al.:
ASXL2 promotes proliferation of breast cancer cells by linking ERalpha to histone methylation
Oncogene
2016
35: 3742-3752
|
23776679 |
Hwang MS et al.:
miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer
PLoS ONE
2013
8
|
31313837 |
Kang GJ et al.:
SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin
J. Cell. Physiol.
2020
235: 1543-1555
|
21602890 |
Park JH et al.:
Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1alpha mediated by the PTEN/PI3K/Akt pathway
Oncogene
2011
30: 4578-4589
|
31843902 |
Greene KS et al. et al.:
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis
|
26389696 |
Okada M et al.:
Liganded ERalpha Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation
Mol Endocrinol
2015
29: 1646-1657
|
30360534 |
author information missing
article information missing
|
19946270 |
Veeriah S et al.:
Somatic mutations of the Parkinsons disease-associated gene PARK2 in glioblastoma and other human malignancies
Nat. Genet.
2010
42: 77-82
|
9842892 |
Piguet PF et al.:
TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53
Eur. J. Immunol.
1998
28: 3499-3505
|
21602532 |
Cheng I et al.:
Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies.
Gut
2011
60: 1703-1711
|
18172327 |
Gunter MJ et al.:
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.
Cancer Res.
2008
68: 329-337
|
21674030 |
Okyar A et al.:
Strain- and sex-dependent circadian changes in abcc2 transporter expression: implications for irinotecan chronotolerance in mouse ileum
PLoS ONE
2011
6
|
21931543 |
Ballesta A et al.:
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery
PLoS Comput. Biol.
2011
7
|
17591803 |
Koda M et al.:
Expression of the obesity hormone leptin and its receptor correlates with hypoxia-inducible factor-1 alpha in human colorectal cancer
Ann. Oncol.
2007
18: VI116-VI119
|
26124005 |
Wang Z et al.:
Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-kappaB signaling and suppressing cAMP-responsive element transcriptional activity
|
25165391 |
Zhu X et al.:
Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study
J. Nutr.
2014
144: 1734-1741
|
11470825 |
Palmer HG et al.:
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling
J. Cell Biol.
2001
154: 369-387
|
21514270 |
Kouchi Z et al.:
Phosphatidylinositol 5-phosphate 4-kinase type II beta is required for vitamin D receptor-dependent E-cadherin expression in SW480 cells
Biochem. Biophys. Res. Commun.
2011
408: 523-529
|
25559195 |
Takeda H et al.:
Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression
Nat. Genet.
2015
47: 142-150
|
25427913 |
Singh S et al.:
Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers
Adv. Exp. Med. Biol.
2015
815: 281-294
|
26579434 |
Ridlon JM et al.:
The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
Acta Pharm Sin B
2015
5: 99-105
|
19051325 |
Shaffer JM et al.:
Promoter methylation blocks FES protein-tyrosine kinase gene expression in colorectal cancer
Genes Chromosomes Cancer
2009
48: 272-284
|
23945926 |
Setaffy L et al.:
Large serrated polyp with KRAS mutation in inflammatory bowel disease: a nondysplastic dysplasia-associated lesion or mass (DALM)? }, authors { names std { { name ml Setaffy L, affil str Institute of Pathology, Medical University, Graz, Austria
Endoscopy
2013
45: E235-E236
|
22921465 |
Gillespie E et al.:
Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer
J Crohns Colitis
2013
7: 403-411
|
28454420 |
Yu B et al.:
Study of the expression and function of ACY1 in patients with colorectal cancer
Oncol Lett
2017
13: 2459-2464
|
25907800 |
Deng Z et al.:
Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis
Nat Commun
2015
6: 6956
|
10906131 |
Hinoi T et al.:
Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin
J. Biol. Chem.
2000
275
|
28051067 |
Jiao S et al.:
VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
Nat Commun
2017
8: 14058
|
28098873 |
Hu CE et al.:
TRIM37 promotes epithelialmesenchymal transition in colorectal cancer
Mol Med Rep
2017
15: 1057-1062
|
30252597 |
Chen C et al.:
FOXD4 induces tumor progression in colorectal cancer by regulation of the SNAI3/CDH1 axis
|
31802911 |
Dong W et al.:
CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway
Onco Targets Ther
2019
12: 9041-9051
|
31730769 |
Holowatyj AN et al.:
Distinct Molecular Phenotype of Sporadic Colorectal Cancers Among Young Patients Based on Multiomics Analysis
Gastroenterology
2020
158: 1155-1158.e2
|
18216263 |
Wunderlich FT et al.:
Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis
Proc. Natl. Acad. Sci. U.S.A.
2008
105: 1297-1302
|
18932288 |
Lee CF et al.:
Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma
World J. Gastroenterol.
2008
14: 6072-6077
|
12764143 |
Mottet D et al.:
Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells
J. Biol. Chem.
2003
278
|
9442036 |
Cha HH et al.:
Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells
J. Biol. Chem.
1998
273: 1998-2007
|
11741912 |
Adilakshmi T et al.:
Ribosomal protein S25 mRNA partners with MTF-1 and La to provide a p53-mediated mechanism for survival or death
J. Biol. Chem.
2002
277: 4147-4151
|
15611046 |
McMahon S et al.:
Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins
J. Biol. Chem.
2005
280: 6561-6569
|
25796501 |
Wang W et al.:
Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma
Med. Oncol.
2015
32: 131
|
24448241 |
Noh JH et al.:
HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT
Cancer Res.
2014
74: 1728-1738
|
20099302 |
Soll C et al.:
Serotonin promotes tumor growth in human hepatocellular cancer
Hepatology
2010
51: 1244-1254
|
26052399 |
Ampuero J et al.:
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
World J Hepatol
2015
7: 1105-1111
|
20351271 |
Suzuki S et al.:
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
Proc. Natl. Acad. Sci. U.S.A.
2010
107: 7461-7466
|
24797434 |
Liu J et al.:
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma
Oncotarget
2014
5: 2635-2647
|
25915584 |
author information missing
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
J. Clin. Invest.
2015
125: 2293-2306
|
25844758 |
author information missing
article information missing
|
29246230 |
Li M et al.:
Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling
Cell Commun. Signal
2017
15: 52
|
29088718 |
Liu P et al.:
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
Oncotarget
2017
8
|
26311740 |
He C et al.:
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
Oncotarget
2015
6
|
30836988 |
Peng R et al. et al.:
Overexpression of RNF38 facilitates TGF-beta signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
J. Exp. Clin. Cancer Res.
2019
38: 113
|
31105839 |
Kong D et al.:
EYA1 promotes cell migration and tumor metastasis in hepatocellular carcinoma
Am J Transl Res
2019
11: 2328-2338
|
29151969 |
Huang XQ et al.:
Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma
J Cancer
2017
8: 3812-3827
|
30332648 |
Chan LH et al. et al.:
PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation
Cell Rep
2018
25: 690-701.e8
|
27608898 |
Cao F et al.:
PHACTR4 regulates proliferation, migration and invasion of human hepatocellular carcinoma by inhibiting IL-6/Stat3 pathway
Eur Rev Med Pharmacol Sci
2016
20: 3392-3399
|
25474138 |
Cui Y et al.:
AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-kappaB signaling pathway in hepatocellular carcinoma
Oncotarget
2014
5
|
30561826 |
Lee D et al. et al.:
Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma
Hepatology
2019
69: 1768-1786
|
24425307 |
Jiang JH et al. et al.:
Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing
Hepatology
2014
59: 2216-2227
|
32019286 |
author information missing
article information missing
|
35070304 |
author information missing
article information missing
|
25607821 |
author information missing
article information missing
|
20176206 |
Mauchley D et al.:
Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2)
J. Thorac. Cardiovasc. Surg.
2010
139: 591-599
|
29909415 |
Iguchi T et al. et al.:
Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma
Oncology
2018
95: 179-187
|
19946270 |
Veeriah S et al.:
Somatic mutations of the Parkinsons disease-associated gene PARK2 in glioblastoma and other human malignancies.
Nat. Genet.
2010
42: 77-82
|
23408368 |
Fan S et al.:
Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma
Med. Oncol.
2013
30: 384
|
12584187 |
Berdiev BK et al.:
Acid-sensing ion channels in malignant gliomas
J. Biol. Chem.
2003
278
|
20368557 |
Liu Y et al.:
Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival
J. Clin. Oncol.
2010
28: 2467-2474
|
24582898 |
Li W et al.:
MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression
Neurosci. Lett.
2014
566: 82-87
|
25898313 |
Daniele S et al.:
Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
Sci Rep
2015
5: 9956
|
25867026 |
Sesen J et al.:
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response
PLoS ONE
2015
10
|
25222834 |
Cuperlovic-Culf M et al.:
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
Metabolites
2014
4: 807-830
|
23625692 |
Sami A et al.:
Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
Tumour Biol.
2013
34: 1991-2002
|
15578701 |
Camphausen K et al.:
Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid
Int. J. Cancer
2005
114: 380-386
|
21362133 |
Shabason JE et al.:
Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic
J. Cell. Mol. Med.
2011
15: 2735-2744
|
24418474 |
Choi EJ et al.:
Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases
BMC Cancer
2014
14: 17
|
20372862 |
Zhao N et al.:
Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation
Oncol. Rep.
2010
23: 1443-1447
|
19827268 |
Jiang H et al.:
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells
J. Exp. Ther. Oncol.
2009
8: 25-33
|
18772890 |
author information missing
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Nature
2008
455: 1061-1068
|
15143086 |
Chakravarti A et al.:
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
J. Clin. Oncol.
2004
22: 1926-1933
|
24096582 |
Szeliga M et al.:
Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells
Tumour Biol.
2014
35: 1855-1862
|
24276018 |
Martin-Rufian M et al.:
Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells
J. Mol. Med.
2014
92: 277-290
|
25284789 |
Takai H et al.:
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex
Cell Rep
2014
9: 48-60
|
28534507 |
Zhu C et al.:
CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma
Oncogene
2017
36: 5356-5368
|
22992974 |
Zadran S et al.:
ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme
Tumour Biol.
2012
33: 2411-2421
|
30552850 |
Wang Y et al.:
Myosin Heavy Chain 10 (MYH10) Gene Silencing Reduces Cell Migration and Invasion in the Glioma Cell Lines U251, T98G, and SHG44 by Inhibiting the Wnt/beta-Catenin Pathway
Med. Sci. Monit.
2018
24: 9110-9119
|
22740028 |
Anic GM et al.:
An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome
Cancer Causes Control
2012
23: 1443-1449
|
26152360 |
Seong MW et al.:
Deleterious c-Cbl Exon Skipping Contributes to Human Glioma
Neoplasia
2015
17: 518-524
|
19519315 |
Chien J et al.:
HtrA serine proteases as potential therapeutic targets in cancer
Curr Cancer Drug Targets
2009
9: 451-468
|
15341671 |
Cangul H et al.:
Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers
BMC Genet.
2004
5: 27
|
23661552 |
Hollstein PE et al.:
Identifying the Ubiquitin Ligase complex that regulates the NF1 tumor suppressor and Ras
Cancer Discov
2013
3: 880-893
|
25088200 |
Gurgis FM et al.:
The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1beta-driven IL-6 secretion in glioblastoma cells
Oncogene
2015
34: 2934-2942
|
26677976 |
Ohtsu N et al.:
Eva1 Maintains the Stem-like Character of Glioblastoma-Initiating Cells by Activating the Noncanonical NF-kappaB Signaling Pathway
Cancer Res.
2016
76: 171-181
|
29937354 |
Pavlyukov MS et al. et al.:
Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors
Cancer Cell
2018
34: 119-135.e10
|
27329597 |
Mao XG et al. et al.:
Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
Oncotarget
2016
7
|
29977365 |
Chen X et al.:
Knockdown of RWD domain containing 3 inhibits the malignant phenotypes of glioblastoma cells via inhibition of phosphoinositide 3-kinase/protein kinase B signaling
Exp Ther Med
2018
16: 384-393
|
18398573 |
Scrideli CA et al.:
Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR
J. Neurooncol.
2008
88: 281-291
|
26993504 |
D'Asti E et al.:
Extracellular Vesicles in Brain Tumor Progression
Cell. Mol. Neurobiol.
2016
36: 383-407
|
22843679 |
author information missing
article information missing
|
24606203 |
Blank AE et al.:
Tumour necrosis factor receptor superfamily member 9 (TNFRSF9) is up-regulated in reactive astrocytes in human gliomas
Neuropathol. Appl. Neurobiol.
2015
41: e56-e67
|
30863117 |
Wu R et al.:
Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion
Onco Targets Ther
2019
12: 1509-1520
|
28551850 |
Zhang J et al.:
MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma
J. Neurooncol.
2017
133: 553-559
|
28116547 |
Seo SB et al.:
14-3-3beta Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway
Mol. Neurobiol.
2018
55: 1259-1270
|
24065186 |
Gong F et al.:
14-3-3beta regulates the proliferation of glioma cells through the GSK3beta/beta-catenin signaling pathway
Oncol. Rep.
2013
30: 2976-2982
|
26976975 |
Kolodziej MA et al.:
NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors
Anticancer Res.
2016
36: 887-897
|
30514230 |
Li L et al.:
EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence
BMC Cancer
2018
18: 1215
|
27572852 |
Li Y et al.:
Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis
Int. J. Mol. Med.
2016
38: 1170-1178
|
24612214 |
Clara CA et al.:
Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1alpha in human glioblastoma
Neuropathology
2014
34: 343-352
|
31605013 |
Ji J et al. et al.:
PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
Oncogene
2020
39: 1125-1139
|
29966699 |
Panagopoulos AT et al.:
The prostanoid pathway contains potential prognostic markers for glioblastoma
Prostaglandins Other Lipid Mediat.
2018
137: 52-62
|
30590814 |
|